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Optical coherence tomography angiography
A B S T R A C T
Optical coherence tomography (OCT) was one of the biggest advances in ophthalmic imaging. Building on that
platform, OCT angiography (OCTA) provides depth resolved images of blood ﬂow in the retina and choroid with
levels of detail far exceeding that obtained with older forms of imaging. This new modality is challenging
because of the need for new equipment and processing techniques, current limitations of imaging capability, and
rapid advancements in both imaging and in our understanding of the imaging and applicable pathophysiology of
the retina and choroid. These factors lead to a steep learning curve, even for those with a working understanding
dye-based ocular angiography. All for a method of imaging that is a little more than 10 years old. This review
begins with a historical account of the development of OCTA, and the methods used in OCTA, including signal
processing, image generation, and display techniques. This forms the basis to understand what OCTA images
show as well as how image artifacts arise. The anatomy and imaging of speciﬁc vascular layers of the eye are
reviewed. The integration of OCTA in multimodal imaging in the evaluation of retinal vascular occlusive dis-
eases, diabetic retinopathy, uveitis, inherited diseases, age-related macular degeneration, and disorders of the
optic nerve is presented. OCTA is an exciting, disruptive technology. Its use is rapidly expanding in clinical
practice as well as for research into the pathophysiology of diseases of the posterior pole.
Abbreviations
AF Autoﬂuorescence
AMD Age-related macular degeneration
CCD Charge-coupled device
CME Cystoid macular edema
CMOS Complementary metal oxide semiconductor
CNV Choroidal neovascularization
CRORA Complete loss of the RPE and outer retina
FA Fluorescein angiography
ICG Indocyanine green
ICGA Indocyanine green angiography
MNV Macular neovascularization; includes choroidal
neovascularization and Type 3 neovascularization
OCT Optical coherence tomography
OCTA Optical coherence tomography angiography
OMAG Optical microangiography
RPE Retinal pigment epithelium
SD Spectral domain
SS Swept source
VEGF Vascular endothelial growth factor
VISTA Variable interscan time analysis
1. Introduction
Although still in development, optical coherence tomography (OCT)
angiography (OCTA) can produce images of blood ﬂow that have un-
precedented resolution of all the vascular layers of the retina in a rapid,
non-invasive fashion. Fluorescein angiography (FA), an alternate
method of imaging ﬂow, has been used in clinical practice for over 50
years. Unfortunately, FA cannot image several important layers of
blood vessels in the eye; essentially only the superﬁcial vascular plexus
can be seen. Still, FA was used to create the ﬁeld of medical retina. OCT
angiography (OCTA) oﬀers the possibility of also imaging the radial
peripapillary capillary network and the intermediate and deep capillary
plexuses. This capability opens a wealth of possibilities for disease de-
scription and quantiﬁcation, research into pathogenesis of disease, and
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development and evaluation of new treatments. OCTA comes at the
heels of development of higher speed structural OCT imaging, which
itself is under rapid development. Curiously much of the recent drive to
develop instrumentation platforms is to improve OCTA. Concurrently
the scanning strategies and software being developed for OCTA are
improving quickly. While the rate of change is breathtaking and ex-
citing, the challenge becomes trying to understand what OCTA is and
what it can accomplish. Understanding OCTA requires a comprehensive
knowledge of many facets of imaging, starting with how the imaging
works, what the potential deﬁciencies as well as strengths are. This
paper is an in-depth review of OCTA and serves as a guide to under-
stand OCTA in a practical way.
Many OCT instrument manufacturers are developing OCT angio-
graphy instruments. Custom made research prototype devices exist as
well. The authors have experience with most of these instruments. The
hardware and software of these instruments are changing rapidly. As
such, speciﬁc recommendations are constrained to the time period
when the particular software or hardware version of the instrument was
in use, which is likely to be for only a short time. In light of this, the
assessment below will try to be as generic as possible, but the reader
should be aware that features and performance of speciﬁc OCTA in-
struments may change.
OCT generates images by interferometrically measuring the ampli-
tude and delay of reﬂected or backscattered light. A beam of light is
scanned on the retina or anterior eye and depth ranging is performed by
interfering the reﬂected or backscattered from ocular structures with
light that has travelled a known reference path (Huang et al., 1991).
This method is a modiﬁcation of classic Michelson interferometry. The
interferograms that are generated vary in intensity with the amount of
light reﬂected from a structure in the eye and the frequency of the in-
terference fringes give information about the delay or optical path
length compared with the reference path. Stated another way, OCT
measures the depth of a given structure within the tissue as well as how
much it reﬂects or scatters light. This measurement is known as an axial
scan or A-scan, in analogy with ultrasound and because early OCT in-
struments used a scanning reference delay. A B-scan or cross sectional
image is generated by sequentially acquiring many A-scans as the light
beam is scanned in the transverse direction. Volumetric information is
generated by sequentially acquiring multiple B-scans which are dis-
placed perpendicular to the B-scan image, covering a region of the re-
tina or anterior eye using raster scan. The retina is a stationary object
for the most part, so if successive B-scans at the same position are ac-
quired, they will be largely similar, except for the motion of blood
within the tissue. At the sites of blood ﬂow, the reﬂectivity or scattering
changes from one scan to the next. By comparing repeated OCT B-scans,
it is possible to image blood ﬂow by looking for diﬀerences among the
scans on a pixel-by-pixel basis. How the scans are acquired, how dif-
ferences are determined, and what constitutes a diﬀerence are the core
issues in OCTA. The technology and methods of OCTA have been in-
vestigated over the last ten years, have been applied in multiple re-
search and clinical disciplines, and translated into a variety of instru-
ments for ophthalmology.
2. Review of OCTA development
2.1. Doppler OCT and the origins of OCTA
The development of OCTA has a long history which predates com-
mercial development in ophthalmology by more than ten years. The
earliest studies to detect and measure blood ﬂow used classic Doppler
techniques, which compared the phase of successive OCT A-scans (Chen
et al., 1997; Izatt et al., 1997). Doppler has limited ability to visualize
retinal vasculature because blood ﬂow is predominantly in the en face
direction, perpendicular to the OCT beam. Classic Doppler OCT can
quantitatively measure blood velocity along the direction of the OCT
beam, however, measurements of blood ﬂow require knowledge of the
Doppler angle, the angle between the blood vessel and the light beam.
The frequency shift of the interferometric fringe is measured over time.
The sensitivity to motion depends on how long the Doppler signal is
sampled at any given spot. Longer sampling times yields better sensi-
tivity at the cost of decreased scan speed and decreased spatial re-
solution. More than 15 years ago, it was recognized that blood vessels
could be visualized using Doppler OCT with time domain OCT by ex-
tracting and comparing the A-scan phase changes which are related to
the Doppler frequency shift (Zhao et al., 2000). This method was known
as Optical Doppler Tomography and was demonstrated for dermatolo-
gical imaging of blood vessels in the skin. High dynamic range Doppler
measurements were achieved using time domain OCT with a high speed
scanning at 8000 A-scans per second (Yang et al., 2003a) to image
cardiac dynamics in the Xenopus laevis (Yang et al., 2003d) and blood
ﬂow in the rat and human gastrointestinal tracts using endoscopic ac-
cess (Yang et al., 2003c). With the development of spectral domain OCT
(SD-OCT), the phase of the A-scans became directly accessible and
imaging speeds increased. Pulsatile blood ﬂow was measured in the
retina using SD-OCT at a 29,000 A-scan rate (White et al., 2003). As
early as 2005, researchers demonstrated that blood ﬂow could be vi-
sualized using swept source OCT (SS-OCT) by measuring the variance of
the Doppler signal and intensity variation without phase, to visualize
blood ﬂow in phantoms and the chick chorioallantoic membrane
(Zhang and Chen, 2005).
2.2. Ophthalmic OCTA
One of the ﬁrst demonstrations visualizing the vasculature in the
human eye was performed in 2006, using a method known as Optical
Coherence Angiography. After compensating for bulk eye motion,
Doppler phase as well as variance or power of the phase between suc-
cessive A-scans was measured at 18,700 A-scans per second (Makita
et al., 2006). This study demonstrated several important advances
which are used in current ophthalmic OCTA; volumetric data was ac-
quired; retinal layers were segmented and the vascular structure of the
retina and choriocapillaris were displayed in en face images. However,
phase based detection is very sensitive to bulk eye motion as well as
motion of other structures within the eye not directly related to blood
ﬂow. An early method, known as Optical Microangiography (also
commonly called OMAG) addressed the problem of bulk eye motion by
modifying OCT hardware to introduce a modulation or externally im-
posed phase variation which improved the diﬀerentiation between
stationary tissue and blood ﬂow (Wang et al., 2007a). These methods
were demonstrated in brain science for visualizing cerebral vasculature
through the intact skull in the mouse (Wang and Hurst, 2007). Imaging
of human retinal and choroidal vasculature using OMAG was demon-
strated in 2008 (An and Wang, 2008).
With the increased speed that was enabled by SS-OCT, speckle
variance detection methods were demonstrated by comparing repeated
B-scans rather than A-scans. In 2008, using a swept light source oper-
ating at 43,000 to 67,000 A-scans per second, imaging of micro-
vasculature in a rat dorsal skin ﬂap model was demonstrated by cal-
culating speckle variance, a measure of amplitude variation, between 3
repeated B-scans (Mariampillai et al., 2008). Other investigators using
SD-OCT at 25,000 A-scans per second, demonstrated imaging of retinal
microvasculature using phase variance between multiple B-scans which
are slightly displaced during raster scanning (Fingler et al., 2009). This
study described the need to motion correct successive B-scans as well to
threshold the phase variance data in order to remove unwanted signals
from bulk eye motion. These concepts are used in current ophthalmic
OCTA methods.
With advances in SD-OCT imaging speeds, phase variance OCT
imaging of retinal microvasculature was demonstrated at 125,000 A-
scans per second in 2011 (Kim et al., 2011). These increases in speed
were important in order to enable imaging larger regions, while redu-
cing the eﬀects of bulk eye motion which produce unwanted OCTA
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signals. This study demonstrated imaging over 3 mm × 3 mm regions
as well as stitching multiple regions in order to increase the ﬁeld of
view. Current commercial instruments operate at comparable speeds,
but image larger regions.
2.3. Commercialization
Multiple algorithms and scan protocols were investigated based on
logarithmic intensity and speckle contrast for imaging retinal micro-
vasculature with SS-OCT at 1050 nm wavelength and 50,000 A-scans
per second (Motaghiannezam and Fraser, 2012). In 2012, split spec-
trum amplitude decorrelation (SSADA) was demonstrated to improve
signal to noise and reduce sensitivity to bulk eye motion (Jia et al.,
2012b). This algorithm uses signal processing methods to divide the
OCT spectrum into multiple narrow band spectra, which reduces the
axial image resolution in order to reduce sensitivity to eye motion and
match the transverse OCT image resolution. Speckle decorrelations are
calculated on a B-scan to B-scan basis between the split spectral data
and then combined to generate a single data set with increased signal to
noise. There has been rapid commercial development of OCTA in recent
years. Optovue introduced the ﬁrst commercial OCTA product, the
AngioVue which was based on SD-OCT and released outside the US in
2014. The ﬁrst commercial SS-OCT instruments were introduced by
Topcon as the Atlantis and Triton product line, which image at 1050 nm
wavelength and 100,000 A-scans per second. Zeiss introduced the An-
gioVue OCTA using the SD-OCT platform and more recently, the An-
gioPlex OCTA using SS-OCT. The development of vertical cavity surface
emitting lasers (VCSEL) enabled imaging speeds of 400,000 A-scans per
second suggesting that higher imaging speeds will be commercially
available in the future (Choi et al., 2013a; Grulkowski et al., 2012;
Moult et al., 2014). The commercialization of OCTA is an important
milestone because it made the technology widely available to the
clinical research community and dramatically accelerated progress.
3. How OCT angiography works
3.1. Brief overview
OCTA is a functional extension of structural OCT which performs
repeated B-scans to detect motion contrast and visualize vasculature.
Stationary objects won't produce much of a change from one image to
the next, while moving objects will. By looking for change over time, an
image can be created that highlights movement. Since the only ex-
pected motion in the retina is blood ﬂow in vessels, the net expected
result is to visualize blood ﬂow. As with any simpliﬁcation to actual
practice, implementation decisions have to be made which can lead to
diﬀerences in function and performance. These implementation deci-
sions include how ﬂow is detected, what deﬁnes a diﬀerence between
B-scans, how bulk eye motion not caused by blood ﬂow is managed, and
how results are displayed. Each of these in turn prompts a series of
hardware and software decisions, each having some type of tradeoﬀ in
terms of performance, potential problems, or cost. Fig. 1 shows a sim-
pliﬁed schematic of how OCTA works compared with structural OCT
imaging. Conventional structural OCT imaging acquires a 3D volume or
image cube by performing successive B-scans at diﬀerent retinal loca-
tions in a “raster” scan pattern. The raster scan covers an area of the
fundus with a high density of A-scans. However, in order to detect
motion and generate vascular contrast, it is necessary to repeatedly
image the same retinal area multiple times. Multiple repeated B-scans
are performed in the same location (row L1, N1 to N3) and the struc-
tural images are compared on a pixel by pixel basis in order to detect
signal changes which occur because of ﬂowing erythrocytes. The
changes between repeated B-scans are then displayed as a motion
contrast image (rows L2 and L3). The repeated B-scan can be compared
in pairwise fashion or in various combinations using algorithms to
obtain a motion contrast image (row L3). In order to generate
volumetric OCTA data over an area of the retina, repeated B-scans are
performed at successively displaced locations in the retina, following a
raster scan pattern. The OCTA volume enables 3D visualization of the
microvasculature and is typically displayed by segmenting the diﬀerent
retinal layers and projecting an en face view in analogy with ﬂuorescein
or indocyanine green angiography (ICGA).
3.2. Advantages and limitations of OCTA
OCTA has the advantage that it can visualize microvasculature with
depth resolution, similar to structural OCT. In contrast to FA or ICGA,
OCTA images are not obscured by hyper-ﬂuorescence from dye leakage
and therefore OCTA can generate high contrast, well-deﬁned images of
the microvasculature. This high quality image data is amenable to
software based image processing which can provide quantitative mar-
kers for vascular pathology. Volumetric data can be segmented and
OCTA from diﬀerent retinal layers can be projected to enable separate
visualization of retinal capillary plexuses and the choriocapillaris, as
well as visualizing vascular pathologies including neovascularization
and alterations in retinal capillary as well as choriocapillaris structure.
In addition, OCTA images can be viewed in cross-section to conﬁrm the
depth location of vascular pathology. Structural OCT data is acquired
simultaneously with OCTA data and therefore it is possible to display en
face and cross-sectional structural OCT images which are intrinsically
co-registered with OCTA data. Since OCTA does not require adminis-
tration of exogenous contrast, it can be performed at any patient visit,
when FA or ICGA would not be indicated. OCTA can also be performed
repeatedly during a single imaging session to obtain comprehensive,
wide ﬁeld information on microvasculature or to assess microvascular
response to functional stimulation. Finally, OCTA can be performed
much more rapidly than FA or ICGA, streamlining clinical workﬂow.
At the same time, OCTA has important limitations. Since it visua-
lizes microvasculature using motion contrast, imaging protocols require
re-scanning the same retinal position multiple times. Therefore OCTA
requires higher imaging speeds (A-scan rates) or longer imaging times
than structural OCT. Imaging larger ﬁelds of view is especially chal-
lenging since the area and number of A-scans scales as the square of the
dimension. OCTA cannot assess alterations in vascular permeability or
leakage, which are typically visualized using FA or ICGA. In addition,
OCTA signals have limited dynamic range. Current technology and
OCTA methods provide limited quantitative information about actual
blood ﬂow, visualizing instead the structure of the vascular network.
The appearance of OCTA image data is highly dependent on details of
the OCT instrument, scan protocols, signal processing, and methods
used to generate OCTA information from structural OCT data.
Algorithms and display methods can vary dramatically between dif-
ferent instrument manufacturers and are often proprietary. Therefore,
special care is required when comparing results between diﬀerent in-
struments. Finally, OCTA images can exhibit many more types of arti-
facts than structural images and are therefore subject to mis-
interpretation (Cole et al., 2017a; Falavarjani et al., 2016; Spaide et al.,
2015a). However, with understanding and careful interpretation, OCTA
can provide powerful insight into disease pathogenesis and new sur-
rogate markers for diagnosis, assessing disease progression and treat-
ment response.
4. Details of OCT angiography signal processing and image
generation
The previous section presented a brief overview of how OCTA
works, but in order to develop a deeper understanding of OCTA, which
is necessary for expert interpretation, it is important to consider OCTA
data acquisition and processing in more detail.
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4.1. Repeated scanning to generate motion contrast
In order to detect motion from blood ﬂow, it is necessary to re-
peatedly image the same retinal location. OCT data is acquired in units
of B-scans and therefore OCTA involves repeated B-scans at the same
retinal location. A B-scan is performed with the OCT beam starting at
one edge of the imaged region and successive A-scans are acquired as
the OCT beam is scanned in the transverse direction across the imaged
region as shown by the arrow in the en face OCT image of Fig. 1. Ac-
quiring a B-scan image takes a time TS and the A-scans which compose
the B-scan image are acquired at sequential positions and at sequential
times as the OCT beam is scanned. The A-scans are acquired at an A-
scan rate determined by the OCT instrument. Typical commercial SD-
OCT instruments acquire approximately 70,000–85,000 A-scans per
second (70–85 kHz A-scan rate), while SS-OCT instruments acquire
100,000 A-scans per second (100 kHz). Research instruments can op-
erate at substantially faster acquisition speeds.
Before the B-scan can be repeated, the OCT beam must be rapidly
scanned back to the initial positon without acquiring data. This is
known as the ﬂy back and requires a time, TF, which can be 10%–20%
of the total time required to acquire the B-scan. The acquisition time, TS,
for each B-scan is given by the instrument A-scan rate times the number
of A-scans per B-scan. The B-scans are repeated after a time delay ΔT,
the interscan time, which is equal to the sum of the acquisition time and
the ﬂy back time. Note that repeated A-scans at corresponding positions
on the fundus are acquired at times separated by the interscan time.
Typical commercial instruments use OCTA acquisition protocols
with two to four repeated B-scans (although the Heidelberg Spectralis
uses a larger number of repeated scans), while high speed research
OCTA instruments can use protocols with more repeated B-scans. OCTA
volumes therefore require two or more times the data than structural
OCT volumes. Alternately, in order to acquire the same volume in the
same time, OCTA requires A-scan rates which are multiples of what
would be required for simple structural OCT images.
4.2. Interscan time determines OCTA sensitivity and saturation
The interscan time, ΔT, plays a critical role in OCTA motion contrast
detection (Braaf et al., 2012; Choi et al., 2015; Tokayer et al., 2013). If
other parameters are kept constant, longer interscan times increase
sensitivity to motion because more time has elapsed between the re-
peated B-scans. However, longer interscan times also mean that bulk
eye motion can occur and overwhelm the motion signal from ﬂowing
blood. Conversely, shorter interscan times will decrease sensitivity to
motion, but also reduce unwanted eﬀects from bulk eye motion. Shorter
interscan times are also more sensitive to ﬂow impairment (Moult et al.,
2016). Diﬀerent interscan times change the range of ﬂows that OCTA
detects and using diﬀerent interscan times can discriminate relative
blood ﬂow speeds, a technique known as variable interscan time ana-
lysis (VISTA) (Choi et al., 2015; Moult et al., 2016). Commercial in-
struments have interscan times of 4–5 ms, while high speed research
instruments can have interscan times of 1.5 ms or less. The interscan
time is governed by: (1) the A-scan rate of the instrument, (2) the A-
scan sampling density (i.e., number of A-scans per unit distance), and
(3) the B-scan dimension (i.e, the length of the B-scan). Slower A-scan
rates imply longer interscan times for a given A-scan density and B-scan
dimension.
4.3. Registration of repeated B-scans to correct eye motion
Fig. 2 shows a ﬂowchart of OCTA processing which describes details
of the processing in Fig. 1. The interscan times used in commercial
OCTA instruments are long enough that eye motion can accumulate in
the time between repeated B-scans (i.e., during the interscan time); and
this eye motion will generate an OCTA signal of its own, obfuscating the
OCTA signal generated by the ﬂowing blood cells. In particular, there
are movements of the eye by microsaccades and by expansion and
contraction of the uvea from ﬂuctuations in intraocular pressure during
the cardiac cycle. To understand the eﬀects of bulk eye motion which
occurs during the interscan time, it is important to consider the optical
resolution of the instrument, which, in commercial OCTA systems, are
Fig. 1. Simpliﬁed schematic of how optical coherence to-
mography angiography (OCTA) works. OCTA visualizes
vasculature by detecting motion contrast from moving
blood cells. Repeated B-scans (N1, N2, N3) are acquired
from the same retinal location (Line L1) and diﬀerences or
decorrelations between successive B-scans are calculated
(Line L2). The decorrelation data is combined into an OCTA
cross sectional image (Line 3) and the procedure is repeated
at successive positions to generate a volumetric data set.
The acquisition time (TS) for each B-scan is determined by
the A-scan rate times the number of A-scans per B-scan. The
OCT beam is rapidly scanned back to the initial positon
during the ﬂy back time (TF) and the B-scan is repeated
after a time delay (ΔT), the interscan time determined by
the sum of the acquisition and ﬂy back times. Each A-scan
which composes a B-scan is also repeated at the interscan time. The interscan time is an important parameter which determines OCTA sensitivity and saturation behavior.
Fig. 2. Detailed ﬂowchart of OCTA processing. Repeated B-
scans (block A) are acquired from the same location. The B-
scans have noise which is combined with the image (re-
presented by f). Motion contrast is generated by calculating
dissimilarity/decorrelation between pairs of B-scans (block
B) and an average is generated (block C) to increase the
signal to noise. Repeated B-scans (block A) are also aver-
aged to generate an OCT image with increased signal to
noise (block D). The OCT image signal (block D) is also
measured on a pixel by pixel basis and if the signal is below
a threshold, then a mask (block E) is generated. This
threshold mask is then used to remove invalid pixels from
the OCTA image (block F) which are associated with low or
noisy OCT pixels. The masked OCTA image is then displayed. OCTA images are highly dependent on processing details and parameters, however, this information is proprietary in
commercial instruments (From Cole et al., 2017).
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between 5 and 10 μm in the axial direction, and ∼20 μm in the
transverse direction (where these resolutions are the full-width-at-half-
maximum, in tissue). While improved (i.e., smaller) axial and trans-
verse resolutions are useful for resolving diﬀerent vascular features in
the eye, and also make the system more sensitive to blood ﬂows, there
is a tradeoﬀ, because ﬁner resolutions also make the system more
sensitive to unwanted bulk eye motion. Improved axial resolution im-
proves the diﬀerentiation of retinal architecture, but increases sensi-
tivity to eye motion. To reduce the OCTA signal artifacts generated by
bulk eye motion, the repeated B-scans can be registered to one another,
either rigidly or non-rigidly, prior to OCTA computation. However, it is
important to note that registration of repeated B-scans can only correct
for motion occurring within the B-scan image plane; motion occurring
out of the B-scan image plane, perpendicular to the OCT beam scan
direction, cannot be corrected. Fortunately, the largest contribution
from bulk eye motion is typically in the axial direction.
4.4. How blood ﬂow aﬀects OCT signals
After bulk eye motion is compensated by registering the repeated
B-scans, blood cell motion is detected by a pixel-by-pixel comparison
of the B-scans. Fig. 3 shows a schematic which shows how interscan
time aﬀects the detection of blood ﬂow. Long interscan times improve
sensitivity to the slowest detectable ﬂow, but also have a low sa-
turation limit and cannot distinguish diﬀerences in faster ﬂows.
Conversely, short interscan times have poor sensitivity to detect slow
ﬂows, but have a higher saturation limit to distinguish diﬀerences in
ﬂows. Each B-scan is composed of multiple A-scans which are se-
quentially acquired, so for simplicity it is helpful to consider an A-
scan at a given position within a B-scan. Fig. 3 shows three repeated
A-scan acquisitions, separated by the interscan time. The A-scans
shown are at the same position in the repeated B-scans and are also at
the same retinal position. The transverse dimension of the OCT beam
is shown schematically in yellow. If the OCT beam intercepts vascu-
lature, the blood cells will contribute to the OCT signal. In order to
produce a measurable change in the OCT signal, the blood cells must
be in a diﬀerent position relative to the OCT beam size when the A-
scan is repeated after the interscan time. If the blood cells are in
nearly the same position relative to the OCT beam, the change in OCT
signal will be too small to be detected. The blood cells will move a
distance given by their ﬂow speed times the interscan time. Therefore,
longer interscan times increase sensitivity to slow ﬂows. Conversely,
if the ﬂow is fast, the blood cells move a distance larger than the OCT
beam size when the A-scan is repeated. The blood cell that was in the
Fig. 3. Illustration of how blood ﬂow speed
and interscan time aﬀect OCTA signal. The
transverse width of the OCT beam is shown
in yellow. Black squiggly arrows indicate
light backscattered from red blood cells. The
rows correspond to diﬀerent blood ﬂow
speeds (va, vb, and vc, increasing by factors
2x in this example) and columns correspond
to three equally-separated time points of the
repeated A-scans (t1, t2, and t3). The time
between repeated A-scans is Δtα; the time
between the ﬁrst and third A-scans is Δtβ =
2 × Δtα. The left panels (A.1, B.2, and C.1)
are all identical, representing the initial po-
sitions of the cells; while subsequent col-
umns show the displaced blood cells (Δd,
2Δd, 4Δd). The graphs under each panel
show how the positions of the cells (x)
change with repeated A-scans (diﬀerent co-
lored dots showing diﬀerent cells). The dis-
placement of the blood cells depends on ﬂow
speed and interscan time (displacement =
speed × interscan time). Measurements with
twice the interscan time Δtβ = 2 × Δtα (i.e.,
ﬁrst-to-third column) are equivalent to dou-
bling the blood ﬂow speed for an interscan
time Δtα; thus, A.3 is identical to B.2, and B.3
is identical to C.2. When ﬂow is fast vc and
the interscan time is long Δtβ, a (purple) cell
at the edge of the OCT beam and passes
nearly to the other side (C.1 to C.3); this
corresponds to the maximum distinguishable
speed, or the saturation speed for that in-
terscan time. Conversely, when ﬂow is slow
va and interscan time short Δtα, the cell
translates very little during the interscan
time (A.1 to A.2); this corresponds to the
slowest detectable speed for that interscan
time. By shortening the interscan time from
Δtβ to Δtα (C.3 to C.2), the cell travels half
the distance and so the saturation speed is
halved and it is possible to distinguish dif-
ferences in ﬂow; conversely by lengthening
the interscan time from Δtα to Δtβ (C.2 to
C.3), the cell travels twice the distance and
so the slowest detectable speed is halved and
sensitivity is improved.
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OCT beam at the time of the initial A-scan has moved out of the OCT
beam at the time the A-scan is repeated. Other blood cells may have
moved into the OCT beam, but the blood cells are indistinguishable.
Therefore ﬂows which are above a fastest distinguishable ﬂow or
saturation limit will produce the same change in OCT signal and ﬂow
diﬀerences or ﬂow impairment cannot be distinguished by OCTA. In
order to distinguish diﬀerences in ﬂows, the interscan time must be
decreased, so that the A-scan is repeated before the initial blood cells
move out of the OCT-beam.
The preceding paragraph and Fig. 3 develop intuition about the
relationship between blood ﬂow and the corresponding OCT signal.
However the ﬁgure is simpliﬁed to facilitate explanation and there are
some inaccuracies. The transverse image resolution is determined by
the OCT beam size, which is much larger than a blood cell, so in-
dividual blood cells cannot be resolved. Blood cells scatter light from
the incident OCT beam and there is a phenomenon known as laser
speckle, where scattering from the blood cell as well as other struc-
tures combine to determine the OCT signal. If the blood cells move a
fraction of the OCT beam size during the repeated measurement, this
produces a detectable change in OCT signal even though the in-
dividual blood cell are not visualized. At any given time, the OCT
signal arises from a collection or ensemble of blood cells, because
blood cells are smaller than the OCT beam size and axial resolution. A
detailed analysis is beyond the scope of this review, however, there
has been extensive previous research on OCTA and a short overview is
helpful to place ophthalmic OCTA into historical context. If the in-
terscan time is very short and the OCT beam size is small, in principle
it is possible to count blood cells as they move through the OCT beam.
This technique requires an OCT with a highly focused spot, small
vessels and very rapid interscan times with large numbers of repeated
A-scans or images. Counting blood cell transit has been demonstrated
in small animal brain imaging using stereotactic immobilization with
high magniﬁcation and small imaging regions (Lee et al., 2014).
However, in ophthalmology, only a small number of repeated scans
are possible because of bulk eye motion and transverse resolution is
limited. For example, at ﬂow speeds of 1 mm/s, erythrocytes will
move 5 μm in an interscan time of 5 ms. The typical OCT beam is 20
μm and therefore can intercept multiple erythrocytes at any given
time. Blood ﬂow is not necessarily uniform in velocity, given the
pulsatile nature of blood ﬂow. As such, erythrocyte ﬂow causes sta-
tistical changes in the OCT signal. If large numbers of repeated scans
are performed rapidly and the phase as well as the amplitude of the
OCT signal is measured, it is in principle possible to characterize the
ﬂux as well as diﬀusive motion of erythrocytes using statistical
methods (Lee et al., 2012). However, the limited amount of statistical
information that is obtained with only 2–4 repeated scans makes it
challenging to directly relate changes in the OCT signal to erythrocyte
ﬂux. For this reason, the majority of OCTA methods simply detect the
presence or absence of ﬂow above a sensitivity threshold and the
fastest distinguishable ﬂow is also limited. OCTA characterizes the
size and geometry of microvasculature based on a nearly binary re-
presentation of ﬂow information, rather than quantifying blood ﬂow.
4.5. Motion contrast algorithms in OCTA
There are several possible methods or algorithms for using re-
peated B-scan OCT images to calculate motion contrast. In the absence
of multiple scattering, Doppler detects motion along the OCT beam
direction by measuring phase changes between repeated A-scans
(Chen et al., 1997; Choi et al., 2013b; Leitgeb et al., 2003b; Wang
et al., 2007b). However, ﬂow in the retinal microvasculature for the
most part is perpendicular to the OCT beam. OCTA algorithms can use
the OCT signal amplitude, the OCT signal phase or both amplitude
and phase (known as complex amplitude) to detect motion perpen-
dicular to the direction of the OCT beam. The most widely used OCTA
algorithms use the OCT signal amplitude. The SSADA algorithm
divides the OCT signal into multiple lower axial resolution images,
splitting the OCT signal spectrum to reduce eﬀects of axial eye mo-
tion, then combining data to improve signal to noise (Jia et al.,
2012b). SSADA was the ﬁrst algorithm to be extensively used in a
commercially available ophthalmic OCTA instrument. Algorithms
which use both amplitude and phase of the OCT signal spectrum can
potentially be more sensitive to small changes than those which use
amplitude alone, but there is a trade-oﬀ in noise and artifacts arising
from eye motion. There are many possible algorithms which can be
used to generate motion contrast signals for OCTA. Diﬀerences in
motion contrast algorithms, combined with diﬀerences in thresh-
olding, display and other image processing methods will cause dif-
ferences in the sensitivity and saturation characteristics of the OCTA
signal vs blood ﬂow as well as diﬀerences in the appearance of mi-
crovasculature across diﬀerent instruments.
4.6. The relationship OCTA signal and ﬂow
The majority of OCTA motion contrast algorithms have a sigmodal
like relationship between ﬂow and OCTA signal as shown in Fig. 4
(Choi et al., 2015, 2016; Tokayer et al., 2013). The OCTA signal is
typically normalized between 0 and 1. The slowest detectable ﬂow is
determined by the interscan time. An erythrocyte must move a suﬃ-
cient distance within the interscan time ΔT between repeated mea-
surements to cause the OCT signal to change. In addition, any diﬀer-
ence in signals from one image to the next must be greater than the
background noise level in order to detect the erythrocyte motion. Ty-
pically, erythrocyte motion which is even a fraction of the OCT beam
spot size can be detected. This sets a sensitivity limit, below which slower
ﬂows cannot be detected. At the same time, the OCTA signal has a
limited dynamic range over which it can discern ﬂows. Flows which are
faster than a fastest distinguishable ﬂow will have the same OCTA signal
(Choi et al., 2015). The signal is said to be saturated because faster
ﬂows will not increase the signal. Fast ﬂows are visible on OCTA, but
diﬀerences in ﬂow cannot be distinguished because they are above the
saturation limit.
The diﬀerent regions in the ﬂow vs OCTA signal curve of Fig. 4
correspond to the diﬀerent regimes shown schematically in Fig. 3.
When interscan times ΔT are long, as in current commercial instru-
ments, the sensitivity is good and the slowest detectable ﬂow is small,
however, the ability to distinguish diﬀerences in faster ﬂows is com-
promised. Using prototype or future instruments with higher A-scan
rates, or by acquiring B-scans with fewer A-scans, it is possible to de-
crease the interscan time ΔT. This scales the relationship between ﬂow
and OCTA signal (Fig. 4). The ability to distinguish faster ﬂows is im-
proved, but the sensitivity to slower ﬂows is compromised. Fig. 4 shows
examples the VISTA technique where OCTA images are generated using
variable interscan times ΔT of 3 ms and 1.5 ms. The OCTA generated
using 3 ms interscan time (top) is sensitive to slow ﬂows, visualizing
more of the capillary structure, but diﬀerences in ﬂow cannot be dis-
tinguished, while the OCTA using 1.5 ms interscan time (bottom) does
not detect vessels with slower ﬂows and can therefore distinguish these
ﬂow diﬀerences. The combination of these two images using VISTA can
be used to assess which vessels have slower vs faster ﬂows (Choi et al.,
2015; Moult et al., 2014).
Fig. 5 shows an example of how VISTA can be used to assess ﬂow
impairment. The top row shows a fundus image, fundus auto-
ﬂuorescence (AF) and an en face OCT of a 75 year old patient with
GA. The bottom row shows en face OCTA images of the chor-
iocapillaris using interscan times ΔT of 1.5 ms and 3 ms. The short
interscan time OCTA image shows reduced signal from the GA region
as well as from the choriocapillaris on the periphery of the GA, while
the longer interscan time OCTA shows additional vessels in the GA
region and higher choriocapillaris signal peripheral to the GA. Longer
interscan times are sensitive to slow ﬂows but poorly distinguish ﬂow
diﬀerences. The information in the two images can be combined into a
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single image for ease of visualization, where relative diﬀerences in
ﬂow are mapped to a false color scale with red and blue representing
fast vs slow ﬂows respectively. The VISTA technique using false color
visualization facilitates rapid interpretation and diﬀerentiates regions
of ﬂow impairment (Ploner et al., 2016).
4.7. Threshold masking to remove noise and attenuation artifacts
OCTA computations of motion contrast essentially measure pixel to
pixel ﬂuctuations between repeated OCT B-scans. Although the objec-
tive is to detect blood ﬂow, many OCTA motion contrast algorithms will
Fig. 4. Sigmodal relationship between ﬂow and OCTA signal. Motion contrast algorithms for OCTA typically have a sigmoidal relationship between ﬂow and OCTA signal. Decorrelation
signal (vertical axis) versus ﬂow speed (horizontal) is shown for long (top) and short (bottom) interscan times. Current commercial instruments use long interscan times (top) and have
good sensitivity to slow ﬂows (slowest detectable ﬂow). However, faster ﬂows (above the fastest distinguishable ﬂow) have a saturated OCTA signal and cannot be diﬀerentiated. If faster
interscan times are used (bottom), the sensitivity to slow ﬂow is lost, but faster ﬂows are no longer saturated, enabling the detection of ﬂow impairment. OCTA using slow interscan times
(3.0 ms) detect large numbers of vessels, but poorly detect diﬀerences in faster ﬂow. OCTA using fast interscan times (1.5 ms) do not detect vessels having slower ﬂow speeds, but detect
diﬀerences in faster ﬂow. Using variable interscan times it is possible to diﬀerentiate ﬂow impairment. The scale bars are 500 μm and the images are enlarged from a 6 mm× 6 mm ﬁeld
of view (Modiﬁed from Choi, Ophthalmology 2015).
Fig. 5. Variable interscan time analysis (VISTA) visualiza-
tion. Example of VISTA visualization of choriocapillaris
ﬂow impairment in a 75-year-old GA patient. SS-OCT and
OCTA acquired with 400,000 A-scans per second with
6 mm × 6 mm ﬁeld of view. (A) Fundus photo cropped to
OCT ﬁeld of view. (B) Fundus autoﬂuorescence. (C) OCT en
face image, mean projection. (D) OCTA en face image with
1.5 ms interscan time, mean projection through ∼90 μm
slab below Bruch's membrane. (E) OCTA with 3.0 ms in-
terscan time, mean projection through ∼90 μm slab below
Bruch's membrane. Comparing the 3.0 ms–1.5 ms interscan
time images shows regions of choriocapillaris ﬂow impair-
ment. (F) VISTA image with red vs blue false color indicate
faster vs slow erythrocyte speed. The left margin of the GA
exhibits a region of ﬂow impairment (From Ploner et al.
Retina, 2016).
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also detect ﬂuctuations from noise in the OCT signals. Some algorithms
use techniques to suppress noise ﬂuctuations (Makita et al., 2016),
however in general OCTA requires careful instrument design and signal
processing to reduce noise sources. Even if OCT instruments have high
sensitivity, all OCT images have regions such as the vitreous and
choroid which have low signal and consist mainly of noise. This noise
can generate false ﬂow OCTA signals (Cole et al., 2017), and methods
aimed at removing these false OCTA signals can themselves generate
artifacts where OCTA signals are absent even in the presence of ﬂow.
In order to remove pixels in OCTA volumes where there is in-
suﬃcient OCT signal to obtain a valid OCTA measurement and the
OCTA is produced by noise rather than real blood ﬂow, a threshold
masking or thresholding operation is performed before OCTA data is
displayed. OCT signals should be above a certain threshold in order to
obtain valid OCTA measurements which correspond to ﬂow and regions
which have low OCT signals, where the OCTA would be generated by
noise, are thresholded and displayed as black. The OCT signal threshold
is often an arbitrary level determined empirically. It is possible that
some areas of slow ﬂow will be incorrectly displayed as black on OCTA
or conversely, areas of OCT noise displayed as false ﬂow on OCTA.
Fig. 2 shows how threshold masking is used in OCT and OCTA signal
processing. The OCT signal is measured on a pixel by pixel basis in the
repeated B-scans. If the OCT signal is below an empirical threshold, the
corresponding OCTA pixels are assumed to be invalid and are masked
Fig. 6. OCTA attenuation artifacts from threshold masking. Valid OCTA information can only be obtained from regions with high OCT signal. Example data from a 78-year-old male GA
patient. (A.1) En face OCT, mean projection of the entire retina. (A.2) OCT B-scan at position of dashed black line in en face OCT. (A.3) OCTA thresholded at mean + 2x standard
deviation (SD) of the noise in OCT. (A.4) OCTA thresholded at mean + 6x SD of the noise. (A.5) OCTA without thresholding. Rows B-E, 2–5 show en face OCTA images summed between
the red contours shown on the OCT B-scan (left column). The columns 2–5 show en face OCTA thresholded at mean + 2x SD, mean + 6x SD, and unthresholded. (1–5b) are enlargements
of the dashed white boxes shown in (B–E). OCTA with low threshold has masked regions where the OCT signal is low. Vitreous and sclera appear dark (A.3) and regions within the
choriocapillaris appear dark (E.3a and E.3b). OCTA with high thresholds or unthresholded appears bright within the vitreous and sclera, extending below the sclera (A.5). These regions
do not have ﬂow, but OCTA decorrelations are generated by noise in the OCT image.
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(displayed as black). Valid OCTA information can only be obtained
from regions which have suﬃciently strong OCT signals. If OCT signals
are weak, it is impossible to obtain valid OCTA information. This is
referred to as an attenuation artifact. Structures which attenuate the
OCT signal will cause the OCTA to be masked (because it is impossible
to obtain an OCTA measurement) even if there is real blood ﬂow pre-
sent.
Fig. 6 shows how threshold levels can aﬀect OCTA display (adapted
from Cole et al., 2017). The top row (A.2 to A5) shows a representative
OCT cross-section (A.1) and OCTAs with diﬀerent threshold levels. En
face OCTA projections of retinal layers (indicated in the left column
(B.1 to E1) are shown with diﬀerent thresholds (rows B.2 to B.5 through
E.2 to E.5)). If the OCTA signal is displayed without threshold masking
(column 5), there are high OCTA signals in the vitreous and choroid as
well as below the sclera, even though there is no blood ﬂow in these
regions. This false ﬂow artifact is produced by noise ﬂuctuations in the
OCT signal which are indistinguishable from ﬂuctuations caused by
blood ﬂow. Setting progressively higher threshold levels (columns 3
and 4), removes OCTA artifacts from low signal regions, however,
higher thresholds tend to remove OCTA signals from regions of low
OCT signal, such as below the RPE. The OCTA information is invalid
and is masked out because the OCT signal is attenuated.
OCT signals from choroidal vessels can be attenuated because the
vessels are deeper and have low signal, largely secondary to attenuation
from optical scattering by overlying tissue. The OCT signal can also be
lost if a vessel has high blood ﬂow resulting in a “fringe averaging”
eﬀect in the OCT interferometric detection resulting in low or absent
OCT signal (Hendargo et al., 2011; Yun et al., 2004). Because the inner
portions of large vessels show little or no reﬂectivity or backscattering
in OCT images, a valid OCTA cannot be obtained and the image appears
dark even if there is ﬂow (E2b vs E3b). Conversely, smaller choroidal
vessels have greater OCT reﬂectivity or backscatting from within ves-
sels and are the corresponding OCTA signal is demonstrable. Larger
choroidal vessels are also deeper in the choroid, a region with poor
penetration and high scattering, which reduces OCT signal levels in the
ﬁrst place.
This example shows that the threshold setting can have a dramatic
eﬀect on the appearance of the OCTA data. The threshold settings can
vary between instrument manufacturers. Threshold masking avoids
displaying false ﬂow OCTA signals from regions where it is invalid
because of low or noisy OCT. However, threshold masking can also
create attenuation artifact interpretation errors. The key point for ex-
pert interpretation is to recognize that absence of OCTA signal does not
necessarily imply the absence of ﬂow and corresponding OCT images
must be visualized along with OCTA in order to conﬁrm validity.
5. Visualization methods for OCTA
OCTA data is inherently three dimensional and has the advantage
that is it intrinsically co-registered to three-dimensional structural OCT
data. The three dimensions of a volume of tissue scanned are mapped to
a representation stored in the computer memory, where numerical
values correspond to OCT or OCTA signals derived from the volume of
tissue. There are multiple approaches for visualizing this data.
5.1. En face OCTA and projection
The retina and choroid naturally are arranged in layers. The layers
of the retina can be detected and demarcated by image processing
methods known as segmentation, and the corresponding ﬂow in-
formation can be shown for these individual layers. The OCTA volume
containing ﬂow data is segmented based on the tissue architectural
morphology in the structural OCT. This separates layers of ﬂow in-
formation that in turn are used to create images to display on a com-
puter monitor. A common method is to poll columns of voxels and
display the brightest voxel. This process projects the maximal intensity
from each column onto a ﬂat two-dimensional image, in a process
called maximal intensity projection. The advantage of a maximal in-
tensity projection is that it can show the ﬂow in small vessels; the
disadvantage is that it is sensitive to noise, since statistical outliers
would be shown. There are other ways to select the value to display
such as average or mean intensity projection, which displays the
average brightness in a column of voxels and is less sensitive to noise,
but does not show small vessels well. That is because the contribution to
the total column made by ﬂow in a small vessel may be only one voxel
in a column of many. It is also possible to generate a projection based
on the histogram distribution of values found in the column of voxels,
in an attempt to balance noise versus showing ﬂow in small vessels.
Using this strategy, the three dimensional OCTA ﬂow data in any
given layer are summed or projected into a two-dimensional en face
image that can be displayed or printed. Note that there may be more
than one blood vessel layer present, but the representation shows the
brightest voxel, no matter where it originates from within the seg-
mented volume. This same ﬂattening eﬀect occurs with any means of
selecting a value from a column of voxels such as average intensity
projection. When using en face imaging, the depth information within
the segmented volume is lost. However, en face imaging is powerful
because of the underlying structure of the retina and provides simple
representations of ﬂow. Essentially no user input is required to obtain
the images once the OCT and OCTA information is obtained, provided
that the segmentation is correct, which unfortunately is often not the
case in disease. Fig. 7 shows an example of how retinal capillary plexus
and choriocapillaris images are generated. Although this example
shows three capillary plexuses, most commercial instruments use a
simpler segmentation protocol to visualize two capillary plexuses. The
risk of errors increases if additional layers are segmented. In addition, it
is important to note that en face OCTA images of the capillary plexuses
are not always generated by projecting speciﬁc retinal layers, but rather
by oﬀsetting the projection ranges relative to the retinal layers to en-
compass the expected depth ranges of capillary plexuses. If these layers
diﬀer from the expected thicknesses, by normal variation or by disease,
the segmentation may not be accurate. En face OCTA images do not
necessary correspond to the standard deﬁnitions of retinal capillary
vasculature. For example, many manufacturers incorrectly segment the
vascular layers adjacent to the fovea (Spaide and Curcio, 2017). In
addition to displaying the capillaries, it is also helpful to generate an en
face OCTA of structures such as the outer nuclear layer which are
normally avascular. This enables the presence of neovascularization,
such as type 2 or Type 3 macular neovascularization to be readily vi-
sualized. En face OCTA images at diﬀerent depth levels can be dis-
played in multiple windows or as a single image where each depth is
color coded. Many manufacturers use color coding which facilities
rapid reading, but the color choice is somewhat arbitrary and diﬀers
between manufacturers.
It is also possible to visualize vasculature below the retina, such as
the choriocapillaris. Fig. 8 shows an example of the choriocapillaris
(Braaf et al., 2012; Choi et al., 2013a). En face OCTA images were
generated by segmenting the RPE plus Bruch's membrane position and
projecting a several micrometers deep range below the RPE. Images
further from the macula exhibit a lobular pattern which is characteristic
of the choriocapillaris architecture. The challenge is that the chor-
iocapillaris is extremely thin and possible errors in segmentation can
result in the segmented region missing the choriocapillaris. At the same
time, blood ﬂow in the choriocapillaris produces an OCTA signal that
can aﬀect structures below it through projection artifact which can be
used to assess the choriocapillaris.
5.2. En face vs B-scan OCTA images
To date most OCTA literature has emphasized using en face OCTA
viewing because of its natural correspondence with fundus imaging.
However, en face OCTA is extremely susceptible to segmentation
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errors in the retinal layers, especially in eyes with pathology. Retinal
segmentation strategies are inherently based on the anatomy of the
normal retina. Normal retinas have well deﬁned variations in archi-
tecture, while a retina with pathology can be abnormal in a myriad of
ways. Given the complexity of pathologies such as edema, cyst for-
mation, subretinal ﬂuid, pigment epithelial detachment, neovascu-
larization and geographic atrophy, it is currently virtually impossible
for a computer algorithm to accurately identify retinal layers in the
presence of all types of pathology. For this reason, viewing cross-
sectional OCT scans with an OCTA ﬂow overlay is very helpful. These
OCTA B-scans typically show ﬂow in color over a grayscale OCT
image. Cross sectional viewing using B-scans can help obviate de-
pendence on en face imaging with inherent segmentation errors and
also be used to evaluate for the potential for projection artifacts. Fig. 9
shows an example of OCT and OCTA en face vs B-scan visualization of
macular neovascularization (MNV) lesions with both classic and
occult components. En face OCT (A) and OCTA images with a full
projection (B) vs projection through the depths spanned by the lesion
(E) are shown along with a cross sectional OCTA (G) and OCT (H). FA
shows the classic component of the lesion (C) and ICGA the occult
component (D). Panels I though L show the OCTA signal overlaid on
the OCT structural image in orthoplane view (I), cross sections (J, K)
and en face (L). Cross sectional OCTA images enable the location of
vascular pathology to be assessed without possible segmentation er-
rors which can cause artifacts in en face OCTA images. This approach
is especially powerful because it is possible to display structural OCT
cross sectional images which are intrinsically co-registered with the
OCTA cross sections. The advantage of examining cross sectional
images is the precise visualization of ﬂow information versus depth in
the tissue. The disadvantages are the need to scroll through numerous
images and the absence of an image showing the entire extent of
neovascularization in an en face sense. At the same time, if there are
Fig. 7. How retinal capillary plexus and choriocapillaris images are generated. Vascular layers can be independently displayed by segmenting retinal architecture in OCT structural
images and projecting the OCTA over axial depth ranges in order to generate en face images. (A) En face OCT image. (B) OCT B-scan through the macula with enlargement (C) showing
retinal layers. (D) Retinal layers showing segmentation contours; D1 indicates the ILM; D2 indicates contour C3 oﬀset by half the INL width; D3 indicates the IPL-INL boundary; D4
indicates the midline between contours D3 and D5; D5 indicates the INL-OPL boundary; D6 indicates contour D5 oﬀset by half the INL width; contour D7 indicates the Bruch's membrane.
(E) En face OCTA of the choriocapillaris was generated by projecting a thin slab below Bruch's membrane D7. (F) En face OCTA of the total retinal vasculature, projecting from the ILM to
the RPE (contour not shown). En face OCTA images of diﬀerent capillary plexuses generated by summing over depth ranges. OCTA of the surﬁcial (G), intermediate (H) and deep plexus
(I) were generated by projecting between contours D1 to D2, D2 to D4, and D4 to D6 respectively. (Adapted from Choi et al. Retina, 2017).
Fig. 8. OCTA of the choriocapillaris. Mosaicked OCT and
OCTA of the choriocapillaris spanning ∼32 mm across the
retina. Imaging performed using an SS OCT with 400,000
A-scans per second. Four repeated horizontal B-scans of 800
A-scans each were acquired over 400 vertical positions on a
3 mm× 3 mm ﬁelds. En face OCT retinal images (top row)
and OCTA of choriocapillaris (bottom row). OCTA shows
that choriocapillaris has densely packed honeycomb struc-
ture near macula and sparser, lobular structure towards the
periphery. (Adapted from Choi et al., 2013a).
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questionable ﬁndings in en face OCTA images, it is important to re-
view cross sectional OCT and OCTA images in order to check for
possible segmentation errors, projection artifacts or attenuation arti-
facts.
Commercial OCT instruments have implemented diﬀerent methods
for visualizing OCTA and OCT data. Fig. 10 shows examples of the
graphic user interfaces for several instruments. Multiple pane displays
typically show en face OCTA projections of diﬀerent retinal layers as
well as registered cross sectional OCT images. En face OCT projections
are sometimes color coded according to layer or depth and overlaid to
facilitate rapid interpretation. Cross sectional OCTA images are less
frequently displayed, but are gaining popularity. Segmentation errors,
which can cause errors in en face OCTA, remain a challenging problem
in situations where pathology distorts the normal retinal architecture.
5.3. Volume rendering
The weaknesses of en face imaging include the ﬂattening of data in
any given segmented volume and segmentation errors from patholo-
gical tissue in the ﬁrst place. En face imaging not only ﬂattens the
volume within the region imaged, it also merges ﬂow information be-
tween vessels. There are three important consequences of this. First,
tissue perfusion can be underestimated since superjacent or subjacent
vessels may not be imaged. Second if projection is used, (that is if the
data in the slab is shown as a single pixel layer) vessels separated in
space but overlapping in along the projected direction can appear to be
merged. Thus two vessels overlying each other that diverge can appear
identical to one vessel that branches. Third, blood vessels that are not
related can appear to anastomose. Thus using en face imaging with
projection, it may not be possible to adequately model blood ﬂow into
and out of a volume of tissue. Abnormalities of segmentation can lead to
Fig. 9. En face and B-scan visualization of OCTA. OCT, OCTA, and FA, and ICGA images from an 87-year-old with a CNV lesion exhibiting both occult and classic component. (A) En face
OCT projection through the entire volume. (B) En face OCTA projection over the retinal vasculature. The dark rectangles are missing data from saccadic eye motion. (C) Early-phase FA.
Arrows point to the classic component of the lesion. (D) Early-phase ICGA. Arrows point to the occult component of the lesion. (E) En face OCTA projection through the depths spanned by
the lesion. (F) Corresponding en face OCT projection. (G–H) OCT and OCTA B-scans at position of the dashed arrows in E, and F, respectively. (I) Orthoplane visualization, where the
OCTA is overlayed red on the OCT. (J) B-scan at the plane indicated with the solid arrow in (I). (K) B-scan at the plane indicated by the dashed arrow in the (I). (L) En face image at the
plane indicated by the intersecting arrows in (L). Orthoplane visualization can reduce the risk of misinterpretation.
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either lack of visualization of true ﬂow or incorrect attribution of ﬂow
to a speciﬁc layer within the retina.
One method to avoid both problems is to use volume rendering of
the underlying data. Volume rendering allows visualization of all layers
of ﬂow in the retina and also permits manipulation of the data in 3 axes
of rotation. Volume rendering does not depend on layer segmentation.
Retinal structures such as cystoid spaces or tumefactions can be seg-
mented from the structural OCT and integrated with the volume ren-
dered OCTA data, since both are ultimately derived from the structural
OCT (Fig. 11). This imaging modality has proven useful in evaluating
cystoid macular edema due to retinal vascular causes and also macular
telangiectasis type 2 (Spaide et al., 2017). Examining the relationships
between abnormalities in the retina, such as cystoid spaces and vascular
anatomy is relatively easy with volume rendering, whereas the same
assessment would be very diﬃcult with en face imaging. A hybrid ap-
proach can be taken in which layers are color-coded for easier inter-
pretation of the images (Fig. 12). Volume rendering has not been im-
plemented yet in most commercial instruments.
6. The role of instrumentation in OCTA
Since OCTA requires re-scanning the same retinal area, there are
tradeoﬀs between ﬁeld of view, axial scan density and acquisition time.
For structural OCT images, a column of voxels is captured in one A-
scan. For OCTA images, multiple repeated axial scans are needed to
detect motion. Therefore, OCTA requires high axial scan rates or in-
creased imaging times. The development of Fourier domain detection
enabled a ∼20 dB increase in sensitivity because signals from the full
depth of the tissue are detected at once. This can be translated into a 50
to 100 times increase in imaging speeds as compared with early time
domain detection (Choma et al., 2003; de Boer et al., 2003; Leitgeb
et al., 2003a). These high speeds were critical for OCTA because of the
high data requirements which increase in proportion to area as wider
ﬁelds of view on the retina are imaged.
6.1. Spectral domain and swept source detection
Spectral domain OCT (SD-OCT) uses a spectrometer and a line scan
camera for detection. The limited spectrometer resolution causes the
detection sensitivity to vary for OCT signals at diﬀerent axial ranges, a
Fig. 10. Graphic user interfaces in commercial instruments. Representative screenshots from commercial OCTA instruments, including the Optovue (top left), Zeiss (top right) and Topcon
(bottom) OCTA displays. Commercial displays and user interfaces enable segmentation of retinal layers as well as simultaneous viewing of OCT and OCTA data. Many commercial
instruments use false coloring to diﬀerentiate depths of vasculature or diﬀerent retinal capillary plexuses. At the time of this writing, commercial software is still rapidly evolving. The
challenge will be to achieve consistent notation and quantitative measurements between instruments from diﬀerent manufacturers.
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phenomenon known as sensitivity roll oﬀ. Axial scan rates are de-
termined by the camera reading rate. Speeds of 300,000 axial scans per
second have been demonstrated in research systems (Potsaid et al.,
2008), however, commercial OCT instruments typically operate at
70,000 axial scans per second. Swept source OCT (SS-OCT) uses a fre-
quency swept laser and a high-speed detector, without requiring a
spectrometer. The sensitivity roll oﬀ is much less in SS-OCT compared
with SD-OCT because frequency swept lasers can have narrow fre-
quency linewidths. Although the detection system for SS-OCT is less
expensive than the spectrometer and line scan camera used for SD-OCT,
laser light sources used in SS-OCT are currently expensive, making SS-
OCT costlier. SS-OCT using commercially available lasers (short cavity
lasers) has been demonstrated at 100,000 axial scans per second several
years ago (Potsaid et al., 2010). The next generation SS-OCT systems
based on vertical cavity surface emitting lasers (VCSELs) can achieve
400,000 to 500,000 axial scans per second (Grulkowski et al., 2012).
Akinetic lasers capable of 400,000 axial scans per second through
software control are entering the market and may be useful for future
instrumentation (Chen et al., 2016b; Xu et al., 2017). Akinetic lasers
have high sweep linearity, extremely low phase jitter, and a very
narrow linewidth. Record imaging speeds of more than 1,000,000 axial
scans per second have been demonstrated using Fourier domain mode-
locked laser technologies (Klein et al., 2011; Mohler et al., 2015). Safe
ocular exposure limits vary with wavelength and longer wavelengths
have higher permissible exposure (typically measured at the cornea). At
the same time, increases in imaging speed will decrease the OCT signal
and speed is ultimately limited by allowable light exposure and signal
to noise requirements. Very high scan speeds can be obtained by sa-
criﬁcing signal and averaging multiple images. However since OCTA
requires OCT images with high signal to noise ratio, there will be an
upper limit to the speed.
6.2. Increased image penetration with long wavelength OCT
Historically, OCT imaging was performed at 840 nm because su-
perluminescent diode light sources used for laser gyroscopes were at
these wavelengths. In SD-OCT, 840 nm also had the advantage that it
was detectable using silicon based CCD or CMOS camera technology.
The wavelength ranges which can be used for retinal imaging are
constrained by water absorption in the vitreous. Longer wavelength
light at 1050 nm has been shown to have reduced attenuation from
ocular opacities and improved penetration into the choroid (Povazay
et al., 2003, 2007; Unterhuber et al., 2005). This wavelength was
chosen because it is in a transmission window of the eye, as chieﬂy
governed by water absorption, between a 950 nm absorption peak and
rapidly increasing absorption at 1100 nm. Thus, the usable bandwidth
of a 1050 nm light source may be limited, or at least aﬀected by water
absorption as bounded between these two peaks. Early studies used
time domain detection, however SD-OCT at 47,000 axial scans per
second was demonstrated a decade ago using InGaAs camera tech-
nology which was sensitive to longer wavelengths (Povazay et al.,
2007; Puvanathasan et al., 2008). SS-OCT can achieve higher speeds as
well as operate at 1050 nm wavelengths. Although higher light ex-
posure is permissible at 1050 nm as compared with 840 nm, there is
also greater absorption of longer wavelength light by water. There is
still a net beneﬁt, particularly when imaging the choroid because of
decreased scattering by pigment in the RPE and the choriocapillaris.
Fig. 13 shows an example which demonstrates diﬀerences in image
depth between 840 nm and 1050 nm wavelength OCT and OCTA.
Fig. 13 A-B are acquired with 840 nm show OCT and OCTA projections
over the choriocapillaris depth range while Fig. 13 C-D are acquired at
1050 nm and show corresponding OCT and OCTA projections. The OCT
images at 840 nm exhibit attenuation under the drusen which is evident
in the en face and cross sectional images and causes a loss of OCTA
signal in the en face OCTA. As note previously this has been referred to
as an attenuation artifact where ﬂow is present but not displayed in the
OCTA. Conversely, the OCT images at 1050 nm have higher signal
under the drusen and the corresponding en face OCTA shows that the
choriocapillaris appears intact. There may be an artifactual increase in
brightness in the 1050 nm images because of increased ﬂuctuation in
the OCT below the drusen, possibly caused by lipid in the drusen. The
artefactual loss of the choriocapillaris signal or attenuation artifact in
the 840 nm OCTA image is the result of threshold masking because of
low OCT signal. This example demonstrates that 1050 nm wavelengths
can have superior image penetration and less attenuation than 840 nm
wavelength. It also points out that expert interpretation of OCTA
images requires the examination of corresponding OCT images to
conﬁrm that suﬃcient OCT signal is present to obtain valid OCTA data.
7. Artifacts in OCTA
7.1. Low signal strength
Any medical image information contains information derived from
the object or tissue being investigated and also contains spurious al-
terations in the information arising from a variety of sources. The ratio
between the signal, which is the information component directly re-
lated to the tissue being imaged, and the noise or non-signal compo-
nent, is a parameter which can be used to characterize the information
content. For example, cataracts or media opacities decrease the signal
to noise ratio because they decrease the OCT signal, but don't directly
inﬂuence the instrument noise. The grayscale range of the display de-
vice is adjusted to display the image. In this process the image will
Fig. 11. This 64 year-old male with MacTel2 had a visual acuity of 20/30 in each eye and
was imaged with volume rendered OCTA with segmentation of the retinal cavitations
from the structural OCT data. There are prominent right-angle veins in each eye. (A) The
exit point of the right-angle vein from the substance of the retina in the right eye is at the
nexus of a network of vessels, which appear to be drawn into a central focus. Retinal
arterioles, venules, and small order vessels appear to be involved. The foveal avascular
zone is distorted and appears to be pulled toward the temporal macula. There is a group
of neighboring (and in the image, overlapping) foveal cavitations (cyan) that are on the
temporal side of the foveal avascular zone. (B) Viewed from the choroidal side, the deeper
penetrating vessels appear as yellow. This region corresponded to the area of late ﬂuor-
escein staining. (C) More prominent traction on the vessels are evident in the left eye with
pulling of the perifoveal vessels into an apex of a triangle (open arrow). (D) Viewed from
the choroidal side the vessels deep to the deep vascular plexus are shown in yellow. The
cystoid space in the left eye (cyan) has a complex outer boundary (From Spaide et al.
Retina, 2017).
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appear noisier, since the signal is a smaller proportion of the whole.
Thus, while low signal is a defect and not an artifact, it is accompanied
by greater noise or “snow” in an image, which is an artifact. In some
situations, it is possible to detect the useful information even when the
signal is weak and large amounts of noise are present. However the
human visual system requires a higher signal to noise ratio, about 5
depending on the spatial frequency as deﬁned by the Rose criterion
(Burgess, 1999), in order to accurately identifying features in noisy
environments. Ideally the signal to noise ratio should be as high as
possible to allow easy, conﬁdent interpretations of images.
Instrument manufacturers report a signal strength score, but the
derivation of how these scores are calculated is often proprietary.
Lower signal strengths compound the diﬃculty of clearly and unequi-
vocally being certain smaller vessels are being visualized in their en-
tirety. Smaller vessels produce smaller signals, which may be lost in
background noise. This loss may not be obvious as many instruments
take steps to reduce the appearance of noise in the images they display.
In reducing noise, the signal from smaller vessels may be attenuated as
well, leaving no signs of their existence. The approaches to reduce noise
are manufacturer speciﬁc and there is limited published information to
enable understanding of what the instruments actually are doing.
Diﬀuse media opacity, most commonly secondary to cataract, can ac-
count for low signal strength, but other factors such as dry eyes or in-
correct positioning the OCT instrument relative to the eye can also
decrease signal strength. Therefore reimaging the patient after ocular
lubrication or optimizing the OCT imaging technique can often improve
the signal strength. Some commercial OCTA instruments report what
seems like spuriously high signal strength scores if the patient has nu-
merous eye movements. Defocus can occur through various
mechanisms such as operator error or astigmatism in the optical system
and this can cause a general decrease in signal strength.
7.2. Localized loss of signal strength
Vitreous ﬂoaters, even if relatively transparent, can produce aber-
rations on the OCT beam and reduce the OCT signal, even though the
actual attenuation of light may be small. This produces a region of the
retina where the reﬂected or backscattered light is not well collected by
the OCT interferometer. Thus, the shadowed areas are darkened to the
point where ﬂow may not be visible. Besides large ﬂoaters, wisps of
vitreous hemorrhage, inﬂammatory cell aggregates, and potentially
early amyloidosis can also cause shadowing. With discrete ﬂoaters it is
often possible to either wait for the ﬂoater to leave the ﬁeld of view or
have the patient move their eye to shift the ﬂoater to a position not in
the image area. The loss of signal can be related more to loss of spatial
coherence or mode structure and not as much to light absorption. The
aberration means that the reﬂected or backscattered OCT beam cannot
be collected eﬃciently by the optical ﬁber in the OCT interferometer
because it is no longer a diﬀraction limited focused spot. Tumefactions
can cause a regional defocus with a localized loss of signal, which can
attenuate the image from blood vessels in regions other than the plane
of focus.
Fig. 12. (A) Mactel2 in a 58-year-old with right-angle veins and cavitations imaged with
volume rendered OCTA with segmentation of the retinal cavitations from the structural
OCT data. The foveal avascular zone is smaller and displaced toward the central focus of
the vascular lesion in the temporal macula. Note the vessels of the perifoveal ring are
drawn toward the center of the vascular aggregate and for angular ﬁgures and their apices
(one of which is shown by the open arrow) point toward the center of the vascular ag-
gregate (Modiﬁed from Spaide et al. Retina, 2017). (B) A vector ﬁeld map showing the
retinal displacement over a 10 year period. The tissue displacement reveals an epicenter
in the temporal juxtafoveal macula. (C) A color-coded volume rendering with the su-
perﬁcial vessels shown in blue, the deep plexus red, the vessels deeper than the deep
plexus (as occurs in MacTel2), yellow and vessels below the level of the RPE, green. (D)
When viewed from the choroid, the proliferating vessels under the RPE have an enlarged
saccular nature, which is diﬀerent from the vessels in the overlying layers.
Fig. 13. The eﬀects of imaging wavelength on image penetration and attenuation arti-
facts. (A) OCT images from a spectral domain SD-OCT instrument operating at 840 nm
wavelength compared with (C) images form a swept source SS-OCT instrument at
1050 nm. The en face OCT images (A.1 and C.1) are from the depth ranges shown in the
respective cross-sectional images (A.2, A.3 and C.2, C3). B-scans at 840 nm (A.2 and A.3)
exhibit more attention below the retina and drusen than B-scans at 1050 nm (C.2 and
C.3). OCTA images at 840 nm wavelength and 1050 nm are shown in (B) and (D) re-
spectively. The OCTA images represent the choriocapillaris and are from depth ranges
shown in the respective cross-sectional images (A.2, A.3 and C.2, C.3). Drusen produce
OCT signal attention for structures below them. The attenuation is appreciable for 840 nm
as seen in the en face (A.1) and cross-sectional images (A.2, A.3) and corresponding re-
gions of the OCTA (C) do not have valid OCTA signal. Attenuation is less at 1050 nm as
seen in the en face (C.1) and cross-sectional images (C.2, C.3) and corresponding regions
of the OCTA (D) show the presence of signal. Projection artifacts from retinal vasculature
are observed OCTA images at both wavelengths.
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7.3. Movement of the eye
OCTA signals are generated by detecting motion between repeated
B-scans using decorrelation or ﬂuctuations on a pixel by pixel basis.
Movement of the patient's eye, head, or body results in widespread
decorrelation over the entire B-scan. The clinically evident decorrela-
tions due to bulk motion and not blood ﬂow are referred to as motion
artifacts. Movement is a very important source of artifacts in OCTA
images. OCTA images are typically viewed en face and have much
higher contrast than OCT images, therefore eye motion produces
shearing distortion or gaps in en face images that are much more evi-
dent and distracting than in en face OCT images. For the sake of
discussion, movement will be divided into two broad categories. The
ﬁrst category is caused by gross movement of the eye and the second is
caused by movement within the eye.
The eye moves by action of the extraocular muscles and also from
movements of the head, neck and body. This motion can be broken
down into components. For small motions in the ﬁeld of view of an
instrument, the motion can be approximated as largely translational.
Although the eye rotates about a horizontal or vertical axis through its
center, the depth range of the retinal vasculature imaged is much
smaller than the radius of rotation. Saccades are only one form of eye
motion. Another is slow drift, in which the eye moves oﬀ of ﬁxation. In
eyes with good visual acuity, the velocity range of slow drift is
Fig. 14. Schematic showing how software motion correc-
tion works. Software motion correction can estimate and
compensate for eye motion on a per A-scan basis in all three
dimensions. Two volumes with perpendicular raster scans
are acquired (XFast vs YFast raster directions). These two
volumes will have motion distortion in diﬀerent directions.
Displacements are estimated for all A-scans in each of the
volumes with the objective of generating undistorted, mo-
tion corrected volumes. The two volumes are assumed to be
motion corrected if they are similar. The A-scan displace-
ments are calculated using iterative, multi-resolution tech-
niques with a nonlinear optimizer and the resulting motion
corrected volumes are merged or averaged to increase the
signal to noise. Unlike eye tracking, software methods can
correct motion in all three dimensions and can be im-
plemented on diﬀerent instruments since they do not re-
quire hardware modiﬁcations.
Fig. 15. Example of software motion correction and arti-
facts. Eﬀect of patient eye motion and software motion
correction on en face OCT and OCTA data. Data is from an
87-year-old patient with a CNV lesion exhibiting both oc-
cult and classic components. (A) En face projection of the Y-
fast OCT volume through the depths spanned by the lesion.
(B) En face projection of the X-fast volume through the
depths spanned by the lesion. (C) En face projection of the
motion corrected and merged OCT volumes (A) and (B),
with the projection is taken through the depths spanned by
the lesion. (D–F) OCTA volumes corresponding to (A–C),
respectively. The image data (C, F, I) is motion corrected in
all three dimensions and signal to noise is improved.
However, there are regions where data is missing due to eye
motion. These are evident as rectangular gaps in the en face
OCTA image (I).
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substantial, and the speed and amplitude of slow drift in eyes with
amblyopia or scotomas can be much greater, as much as 3° per second
(Yang et al., 2003b, 2003c; Zhao et al., 2000).
7.3.1. Tracking and software correction
Every manufacturer of OCT angiography instruments now has some
form of active eye tracking. With eye tracking, the eye position is ra-
pidly measured and corrective measures are taken if the motion is
greater than some established threshold (Ferguson et al., 2004;
Hammer et al., 2005; Vienola et al., 2012). Alternate approaches rescan
portions of the fundus aﬀected by a saccade and the rescanned section
is stitched into the original scan, replacing the region aﬀected by the
eye movement. The speed of detection and the delay in modifying the
OCT scan, known as latency, diﬀers between manufacturers. These
methods were ﬁrst implemented commercially in the Spectralis OCT
using scanning laser ophthalmoscopy and later in the Cirrus OCT using
a line scan laser ophthalmoscopy. Optovue and Topcon use a fundus
image from an infrared camera. Eye tracking has the important ad-
vantage that it can extend the available imaging time beyond the few
seconds when patients can ﬁxate without saccades or blinking. Eye
tracking also facilitates registration of one image to another taken at a
later date. Accurate comparisons over time can be performed.
Software registration and motion correction represents a second,
complementary method for eye motion correction. Since there is always
a latency in eye tracking, software techniques have the potentially can
correct for some errors that are not correctable by eye tracking. Fig. 14
shows a software motion correction technique which estimates and
corrects for eye motion (Kraus et al., 2012, 2014). Two OCT volumes
are acquired using diﬀerent raster scan patterns. One volume is scanned
using a horizontal raster which is typically used in OCT and a second
volume is scanned using a vertical raster pattern. Since eye motion
accumulates with time, each volume is assumed to be most accurate in
the direction of the “fast” scan and has progressively more motion ar-
tifacts from B-scan to B-scan in the “slow” scan direction. Software
motion correction estimates the displacements of each A-scan in each
volume, applying the displacements to the two volumes and then
comparing them for similarity. If the displacements which correct for
eye motion are accurate, then the two motion corrected volumes will
match. Fig. 15 shows an example of software motion correction. En face
OCT images of the two input raster scans are shown in 15 A and B with
corresponding cross sections 15 D, E. The motion corrected, merged
image is shown in 15 C and F where correction of axial eye motion can
be clearly seen in the cross-sectional image. Fig. 15 G, H, I show cor-
responding en face OCTA images before and after motion correction
and merging. The en face OCTA image in Fig. 15 illustrates an im-
portant limitation of software motion correction, eye motion produces
gaps in each of the volumetric data sets where some regions of the
retina are not imaged. These gaps in data appear as horizontal or
vertical defects in each of the data sets, and appear as rectangles in the
merged data set. Since OCTA images are high contrast and continuity of
vascular features in the en face plane is important, these data gaps are
especially evident. The motion control software can introduce artifac-
tual errors of its own into the image with creation of quilting (a
patchwork appearance of the image) and vascular doubling as a con-
sequence (Spaide et al., 2015a).
The combination of eye tracking to software motion correction has
been shown to reduce artifacts associated with software motion cor-
rection alone (Camino et al., 2016). Fig. 16 shows a comparison of
software motion correction (top row) versus eye tracking and software
motion correction (bottom row). Eye tracking and software motion
correction reduces white line motion artifacts, gaps in data and residual
motion error compared with software motion correction alone. There
are high frequency eye movements in some patients, either from a
Fig. 16. Combined software motion correction and eye
tracking. Top row shows software motion correction only,
bottom row shows eye tracking and software motion cor-
rection. En face OCTA with perpendicular raster scans (A)
and (B) have discontinuities from eye motion. Eye tracking
reduces the eﬀects of eye motion in (E) and (F). Reducing
motion in the initial data improves the results of software
motion correction (G, H) compared with software motion
correct without eye tracking (C, D). Eye tracking enables
longer data acquisition times and large data sets, while also
avoiding gaps in data which can occur with software mo-
tion correct alone.
Fig. 17. OCTA artifacts from lipid deposits. OCTA decorrelation artifacts generated by
intraretinal lipid in a patient with radiation retinopathy aﬀecting the peripapillary retina.
(A) There is an area of edema ringed by lipoprotein precipitates in this color image taken
a few months prior to OCTA imaging. (B) OCTA projection, segmented at Henle's ﬁber
layer which is normally an avascular area. Note the lipid generates a high decorrelation
signal. (C) Segmented, albeit somewhat inaccurately at the deep vascular plexus, there
are artifacts from the lipid as well (arrowheads). (D) Note that even at this level, the false
color ﬂow density map shows the lipid as high ﬂow regions (arrowheads). Lipoprotein
precipitates generate motion contrast, which resemble blood ﬂow on OCTA.
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tremor or fast nystagmus that are beyond the capabilities of current eye
tracking, software correction or combined approaches. There are a
number of possible strategies to use eye tracking and software to
compensate for the image degradation caused by eye motion, and in-
dividual manufacturers maintain their approaches as proprietary.
7.4. Movement within the eye
The position of the retina is constantly changing in the axial di-
rection due to pulsatile expansion of the choroid and possible ﬂuctua-
tions in intraocular pressure from the cardiac cycle. Prior to OCTA
signal calculation, most OCTA algorithms perform a motion correction
of repeated B-scans to reduce the eﬀects caused by bulk eye motion. In
OCTA there are some subtle eﬀects that could be magniﬁed. The ﬁlling
of choroidal lobules is pulsatile and out of phase with each other as well
as varying over time (Flower, 1993; Flower et al., 1995). The posterior
pole is a curved surface and the underlying choroid is not uniform in
thickness, producing a non-uniform axial motion of the retina. Reﬂec-
tions from retinal features or pathology could produce false OCTA ﬂow
signals because of variations in OCT signals which are unrelated to
blood ﬂow within the pathology itself. This axial motion artifact from
smaller particles is very common and is seen in such conditions as
diabetic retinopathy and veno-occlusive disease. There are two related
artifacts; the ﬁrst is decorrelation with larger lipid deposits in the retina
(Fig. 17). Light may reﬂect from the surface of the deposits as well as
from internal conﬁnes, creating a decorrelation because of very small
changes in the angles of reﬂection (Fig. 18). The second is generation of
an OCTA decorrelation signal from the walls of cystoid macular edema
(Fig. 19). Vascular density maps created by various OCT angiographic
instruments are confounded by both of these artifacts and may give the
impression that perfusion is better than it really is. Axial motion arti-
facts can be diﬃcult to discern or compensate because the motion of the
choroid is not necessarily uniform or predictable. Transverse motion
can also cause a change in reﬂectivity that would not be compensated
for by eye tracking.
Fig. 18. Schematic showing how changes in axial position of a reﬂective structure, such
as a lipoprotein granule, could cause subtle changes in the intensity of the detected re-
ﬂection. This could cause a decorrelation, which would incorrectly be rendered as a ﬂow
signal. Similar changes in reﬂectivity could occur with transverse motion.
Fig. 19. OCTA artifacts from cystoid macular edema. OCTA decorrelation artifacts can be
generated by the walls around cystoid spaces. (A) OCTA artifact in an eye with diabetic
cystoid macular edema (arrow). There are no blood vessels in the wall of the cystoid
space. (B) The false color ﬂow density map shows a low level of ﬂow in the corresponding
area (arrow) although no ﬂow is present. These structures exhibit small displacements
between repeated B-scans, generating false OCTA signals.
Fig. 20. Demonstration showing how OCTA projection artifacts are generated. (A–C)
Water is ﬂowing in the clear channel and in repeated images over time, are seen as a
region of variable reﬂections. However, the light transmitted through the water illumi-
nates the background and the illumination also changes over time. The variance (D) of the
images can be computed to show motion contrast. The changing background illumination
is detected even though the background itself is not moving. Similarly, ﬂowing blood cells
can generate motion contrast for stationary structures which are below them. (From
Spaide et al., 2015a).
Fig. 21. Projection artifacts in OCTA. (A) The inner vascular plexus is shown in an en face
OCTA image (top), along with a B-scan and ﬂow overlay (bottom). (B) An en face OCTA at
the level of the RPE exhibits a ﬂow signal that looks like the inner vascular plexus. The B-
scan with ﬂow overlay and an enlarged inset are shown (bottom). The vessels with ﬂow in
the inner plexus produce projection artifacts in the RPE and subretinal structures which
are stationary (arrows).
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7.5. Projection artifacts or decorrelation tails
Projection artifacts, also referred to as decorrelation tails, are one of
the most important artifacts in OCTA. In order to image deeper struc-
tures such as the photoreceptors or RPE, the OCT beam passes through
retinal blood vessels where it may be reﬂected, absorbed, refracted or
scattered. Light reaching deeper structures is inﬂuenced by overlying
retina features, in the case of blood vessels, the transmitted light has
time varying ﬂuctuations because it propagates through ﬂowing blood.
The deeper features are illuminated by this ﬂuctuating light. Even if
these features do not themselves change with time, the changing illu-
mination can create a decorrelation from one B-scan to the next,
creating a false impression that there is blood ﬂow in reﬂective layers
below a vessel. Fig. 20 shows an experiment which demonstrates how
ﬂowing water can create time varying images of stationary structures
below it. To create a projection artifact, a source of varying light is
needed, for example a blood vessel, combined with a reﬂective surface
to act as a projection screen. There are several layers in the fundus that
act as natural reﬂectors, such as the plexiform layers and the retinal
pigment epithelium. In high myopes, the sclera can exhibit projection
artifacts from the choroid. Sometimes projection artifacts can be used to
enhance visualization. The choroidal vasculature can sometimes be
imaged in high myope eyes better by looking at the projection artifact
than by visualizing the choroid directly. This is because the choroid is
diﬃcult to isolate using current segmentation algorithms in commercial
instruments and the sclera is a good reﬂector, enhancing the projection
eﬀect (Maruko et al., 2016). The choriocapillaris is dense vascular
structure which produces strong OCTA projection artifacts for choroidal
structures below it. For example, the stroma between larger deeper
vessels in the choroid appears bright, presumably from a projection
artifact from the choriocapillaris.
The classic example of a projection artifact occurs when visualizing
the retinal blood vessels at the level of the RPE (Fig. 21), and nearly
every OCTA image exhibits these projection artifacts. Examining the
cross-sectional B-scan image along with the cross sectional OCTA which
overlays ﬂow information is one way to estimate the amount of pro-
jection artifact present. The projection artifact occurs at reﬂective
layers, such as the RPE which directly underlie the more superﬁcial
vessel. The reﬂective structure can also be drusen, focal pigmentation,
or lipid, so care should be used in assessing the OCTA appearance of
ﬂow in the deep retina or subretinal space. (Lipid can serve as a screen
for projection artifact in addition to having axial motion artifact.) The
projection artifacts from the retina are attenuated by the RPE, so that
choriocapillaris images often have only subtle projection artifacts. More
signiﬁcant retinal vessel projection artifacts occur on the chor-
iocapillaris is in cases where the overlying pigment is attenuated or
counterintuitively, in cases where the signal strength for the scan is
very high.
Multiple approaches have been investigated for removing or redu-
cing projection artifacts (Zhang et al., 2015a, 2016). A number of
techniques have been implemented in commercial instruments and the
exact algorithms are proprietary. One of the simplest methods is to
subtract the OCTA en face image of the superﬁcial vessels from a deeper
layer. This removes the bright projections, but replaces them with dark
versions of the vessels, producing an unacceptable artifact in its own
right. Other methods borrow from techniques used in microscopy and
astronomy. The idea is that the reﬂectance from a sample is related to
the amount of light available, changes in thickness of the sample, and
the optical transmission of the instrument making the image. For ex-
ample, if one part of the sample is illuminated half as much as another
part, that region would be darker. We can compensate numerically for
some of these alterations by dividing the image of the sample by a
proﬁle established for the illumination. This can be adapted to OCTA.
The image of the outer retina, which ordinarily has no vessels, suﬀers
projection artifact from the overlying retina. As a consequence, there
will be ambiguity in OCTA images of MNV from this region. By taking
the image of the outer retina and dividing that by an image of the
retinal vasculature, the projection artifact can be reduced (Zhang et al.,
Fig. 22. Projection artifact removal. The en face OCTA image in (A) is at the level of the
choriocapillaris, but exhibits projection artifacts from the retinal circulation. These pro-
jection artifacts can make interpretation diﬃcult because vascular features can appear in
structures without vasculature. (B) The OCTA signal from the retinal circulation was used
to remove the projection artifact from the en face OCTA image of the choriocapillaris.
Manufacturers have implemented diﬀerent algorithms to reduce or remove projection
artifacts.
Fig. 23. Segmentation errors. Example showing segmentation error in a patient with high
myopia. The en face OCTA image (top) shows blood vessels of many diﬀerent sizes. The
upper left does not appear to show any ﬂow. (Bottom) The segmentation contours, shown
in a B-scan with a ﬂow overlay, exhibits serious errors. The segmentation contour was
intended to be the choriocapillaris but deviates into the choroid, sclera and is outside of
the eye entirely (left side). This produces the black area in the upper left corner of the en
face OCTA image because the image contains information from the wrong depth.
Segmentation errors can cause severe errors in interpretation. The risk of errors can be
reduced by viewing cross sectional images to conﬁrm the integrity of the en face pro-
jection images.
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2015a). This method also can lead to dark vessel artifacts. However, if
the division is done in a graded manner by adjusting the opacity of the
dividing layer, fairly good results can be obtained. In addition to this
modiﬁcation, the approach can be generalized to remove artifacts from
other layers. For example, Fig. 22 shows an image of the chor-
iocapillaris without and with projection artifact removal. The problem
of the slab based approach is that segmentation is needed and this
segmentation can have errors. In addition, the weighting of the over-
lying blood vessels in terms of their contribution to the projection ar-
tifact cannot be easily modiﬁed with this approach. A more recent
method to reduce OCTA projection artifacts operates on individual A-
scans and is known as projection resolved OCTA (PR-OCTA). This al-
gorithm identiﬁes OCTA voxels with ﬂow by normalized value of the
OCTA decorrelation with OCT intensity and comparing it to shallower
voxels in the same A-scan (Zhang et al., 2016). The values deeper than
the peak level are converted to zero. Projection resolved OCTA has been
shown to preserve the continuity of deeper vascular layers better than
previous methods. This technique theoretically would have diﬃculties
in regions where more than one layer of vessels exist. Research on this
topic is ongoing and it is likely that algorithms will continue to im-
prove.
7.6. Segmentation artifacts
The most important set of artifacts are secondary to segmentation
errors (Spaide et al., 2015a). En face images are created by selecting
one or more layers of the retina and viewing the vessels summed or
projected over the desired layers. The volumetric retinal OCT data is
ﬁrst processed to detect various retinal layers using a software image
processing approach known as segmentation. The strategy to detect
layers initially starts with healthy eyes and good quality OCT data.
Potential parameters to diﬀerentiate layers can be based on reﬂectivity,
texture, or other attributes, directly or using Bayesian inference, deep
learning, etc. Continuity of layers is also often used in segmentation
algorithms. The problem is that these parameters rarely are eﬀective in
eyes with pathology which disrupts the normal retinal architecture.
OCTA data can have surprisingly serious errors from incorrect seg-
mentation. The typical problems associated with segmentation errors
are that layer thickness can be thinner or thicker than normal, there can
be an absence of layers, or altered curvature of the eye, such as in high
myopes.
Automatic segmentation of vascular layers in a high myope with a
staphyloma is rarely correct with current instruments, even in the ab-
sence of complicating factors such as choroidal neovascularization
(CNV) or schisis. Fig. 23 shows a high myope with the choriocapillaris
as the intended segmentation. Note the segmentation in the B-scan with
the OCTA ﬂow overlay is in the sclera and on the left side of the image,
the segmentation leaves the eye entirely. Eyes with pronounced ma-
cular edema secondary to diabetic retinopathy or veno-occlusive dis-
ease are almost never segmented correctly. The edematous layers are
thicker than the segmentation slabs used and the segmentation slabs are
often not in the correct layer to begin with. This yields a vascular
image, but often without clinical meaning because the image is a
merger of disparate vascular layers.
Interpretation errors from incorrect segmentation can be avoided by
viewing the segmentation contours in sequential OCT B-scan images to
conﬁrm that they are correctly located. Many instrument manufacturers
have software that enables hand correction of segmentation errors and
propagation of corrections across multiple B-scans, however this can be
a time consuming process. Orthoplane viewing will reduce interpreta-
tion errors in OCTA because it enables vascular features to be localized
in depth, while also viewing en face structure across the fundus.
Research in segmentation is ongoing, however because of the com-
plexity of retinal pathology and the pronounced distortion of archi-
tecture that is associated with advanced disease, segmentation is likely
to remain a challenging problem.
8. The multimodal imaging approach
The last two decades have witnessed dramatic advances in retinal
imaging with a variety of new technologies, such as OCT, auto-
ﬂuorescence, and confocal multicolor imaging, becoming widely
available to complement previous imaging technologies such as ﬂash
fundus photography and dye-based angiography. The capability of
each, in turn, was extended by newer wide-angle imaging technology.
OCTA is in the succession of ocular imaging techniques, but enters into
a family of inter-related modalities used to evaluate ocular health and
disease. As such no one modality reveals all information about every
disease. It is imperative to keep the ﬁndings of any one modality in
perspective by integrating that information with potentially useful data
obtained by other imaging methods. The principles and merits and
limitations of these various imaging technologies are brieﬂy reviewed
in this section, particularly with regards to their visualization of the
retinal microvasculature.
8.1. Color fundus photography
Color fundus photography has been the centerpiece of imaging in
ophthalmic clinical trials and clinical practice for several decades (Klein
et al., 1991). A major advantage of color fundus photography is that it
replicates the view of the retina that the physician sees when examining
the patient with ophthalmoscopy. As such, color fundus images are easy
to interpret and are useful tools for documenting ﬁndings seen on ex-
amination, and vessels and vascular abnormalities are visible as reddish
structures (Creuzot-Garcher et al., 2014; Higgs et al., 1991). Color
photography can produce realistic colors by using combinations of red,
green, and blue (Fig. V1-A). Though the larger retinal blood vessels are
evident on color photography, there is insuﬃcient contrast to visualize
the capillary circulation. It is possible to look at the individual color
channels. Examining the green channel, which is created by wave-
lengths in the green portion of the spectrum shows a monochromatic
image in which blood vessels are dark because blood absorbs green
light. Color fundus photographs have traditionally been captured using
ﬂash-based systems using white light, with instruments ranging from
large table-top devices to smartphones (Němčanský et al., 2014). A
limitation of ﬂash-based systems is that they are prone to a variety of
image artifacts and quality problems such as poor contrast, lighting
irregularity, and over- and under-exposure (Heaven et al., 1993;
Johnson et al., 2003). Many of these problems are easily addressed by
an experienced photographer. Some of these quality issues have been
addressed by the recent introduction of devices using white light but
featuring a confocal pinhole (Malinovsky, 1996) (Fig. 24-B). Pseudo-
color images can be generated by scanning laser ophthalmoscopic
(SLO) acquisition through the use of multiple lasers of diﬀerent wave-
lengths (Moussa et al., 2015; Tan et al., 2016a). Some SLO systems use
infrared instead of actual red light and bluish green light instead of blue
light. The resultant images are therefore pseudocolor representations
(Fig. 24-C). SLO systems require more time per channel to acquire
images increasing the possibility of image distortion caused by patient
movement. The diﬀerential ability of these newer pseudocolor imaging
approaches to visualize retinal features seen on standard color photo-
graphs is still under investigation. The theoretical resolution obtained
with a SLO system may exceed that of a fundus camera system.
8.2. Autoﬂuorescence imaging
In AF imaging (Fig. 25), the retinal tissue is exposed with light of a
given set of wavelengths, and ﬂuorophores in the tissue intrinsically
emit light with a longer wavelength (Delori et al., 2001; Schmitz-
Valckenberg et al., 2008; Weinhaus et al., 1995). This is in contrast to
standard reﬂectance imaging, where the reﬂected light is of the same
wavelength. Thus to isolate the AF signal, barrier ﬁlters are also in-
troduced into the light return path to exclude reﬂected light. By the
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introduction of appropriate excitation and barrier ﬁlters, Spaide and
colleagues demonstrated that a standard ﬂash fundus camera can cap-
ture AF images (Spaide, 2003) (Fig. 25-D). The wavelengths available
for AF imaging using a ﬂash fundus camera, however, are restricted by
the properties of the anterior segment of the eye. For example a yel-
lowish cataractous lens can demonstrate signiﬁcant AF for blue light-
this signal may be diﬃcult to diﬀerentiate from AF originating from the
retina and reduce the overall image contrast. Shifting the excitation to
the green portion of the visible light spectrum reduces the amount of
lens derived autoﬂuorescence. Another strategy to suppress this inter-
fering signal from the lens, however, is to introduce a confocal pinhole
(Fig. 25-A), which allows for rejection of AF from the crystalline lens.
Confocal systems image light from conjugate planes and therefore ac-
cept light from a narrow depth within the eye. The AF image can be
further improved by using SLO acquisition and averaging multiple
frames collected over time to enhance the signal-to-noise ratio. Using a
confocal SLO allows blue light to be used for excitation; it is a simple
matter to use the same excitation wavelengths for FA.
The AF signal has been of particular interest as much of it appears to
originate from lipofuscin accumulating in the RPE, and may thus pro-
vide information regarding RPE function and physiology. AF is known
to increase slowly over time with age, but can be dramatically increased
in certain diseases such as Stargardt's disease (Strauss et al., 2016a,
2016b). Increased AF may be produced by ﬂuorophores in locations
other than the RPE. A common pathophysiologic mechanism is ob-
served with detachment of the macula. The photoreceptors are sepa-
rated from the underlying RPE, which ordinarily phagocytizes the outer
segments. These can accumulate and over time develop increasing
amounts of ﬂuorophore as seen in central serous chorioretinopathy or
vitelliform macular dystrophy (Fig. 25-B) (Chung and Spaide, 2004;
Ferrara et al., 2010). Decreased AF may be observed as a result of lack
of excitation light reaching the ﬂuorophores – this is observed in the
Fig. 24. Fundus photos of the left eye of a patient with
advanced non-neovascular age-related macular degenera-
tion and geographic atrophy (GA). A. Image with a typical
ﬂash white-light fundus camera system (Kowa VX-20). Note
natural appearance of the retinal blood vessels and drusen.
The borders of the GA are diﬃcult to discern. Confocal
white light (B, Centervue Eidon) and multicolor (C,
Heidelberg Spectralis) of the same eye. The appearance of
the color is diﬀerent, especially for the multicolor image,
but the borders of the atrophy are easier to discern with the
confocal systems.
Fig. 25. Fundus autoﬂuorescence (AF) imaging. A. Blue-light scanning laser ophthal-
moscope FAF image of a normal right eye. Retinal blood vessels are dark and seen in
sharp contrast as they block the AF from the retinal pigment epithelium (RPE). The optic
nerve head is similarly dark due to the absence of RPE at this location. In addition, as blue
light is absorbed by the macular pigment, the central macula (fovea) is also relatively
hypo-autoﬂuorescent. B. FAF image of the eye of a patient with Best's vitelliform macular
dystrophy. The vitelliform lesion is intensely autoﬂuroescent. Blue-light scanning laser
ophthalmoscope (C) and green-light ﬂash fundus camera (D) FAF imaging of a patient
with geographic atrophy (GA). The high contrast of FAF imaging, with absence of the AF
in the region of photoreceptor and RPE loss allows the borders of the atrophy to be
precisely deﬁned.
Fig. 26. (A) Flourescein angiogram of the macula of a normal eye using a confocal
scanning laser ophthalmoscopic system. The parafoveal capillaries and the foveal avas-
cular zone may be discerned, but the capillary circulation outside this region are not
evident. (B) Fluorecein angiographic image of an eye with a classic choroidal neo-
vascularization (CNV). Although hyperﬂuroescence from the vascular lesion is evident,
the microvascular network of the CNV lesion is not apparent. Leakage of dye, however, is
evident. (C) Wideﬁeld ﬂuorescein angiographic image (Optos 200Tx) of an eye with
diabetic retinopathy. The eripheral non-perfusion temporally can be recognized by the
absence of the large vessels and the feature-less appearance of the retina. The capillary
circulation outside of the central macula is not evident. Multiple small areas of retinal
neovascularization are identiﬁed by the hyperﬂuorescent leakage of dye, but the ﬁne
vessels of the neovascular tufts cannot be seen.
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normal macula with absorption of blue light by luteal pigment. De-
creased or absence of AF may also be an indication of loss of the RPE
and photoreceptors, with geographic atrophy being the prime example
(Bearelly and Cousins, 2010; Holz et al., 2001). The high contrast of AF
imaging for identifying areas of atrophy (Fig. 25-C and D) has driven
the use of this technology as an eﬃcacy end point for major trials. With
blue light AF, areas of decreased AF must be distinguished from blood
vessels which appear dark due to blocking of the signal from the un-
derlying RPE as well as from macular pigment (at highest density in the
fovea) which absorbs blue light (Fig. 25-A). Alternate AF imaging wa-
velengths (green or near infrared) can mitigate this absorption eﬀect
because they are outside of the absorption spectrum of macula pigment.
Although, there is good contrast for visualizing blood vessels on AF
images, the capillaries are not visualized.
8.3. Dye-based angiography
To enhance contrast for visualizing the capillary circulation, exo-
genous intravenous ﬂuorescent dyes may be used. FA in humans was
ﬁrst described by Novotny and Alvis in 1961 (Novotny and Alvis,
1961), and has revolutionized the study of retinal diseases
(Chakravarthy et al., 2007). Fluorescein absorbs blue-green light and
emits green light similar to lipofuscin, but the magnitude of the signal is
several orders greater than intrinsic AF. FA for the ﬁrst time provided in
vivo visualization of the retinal capillary circulation with exquisite
detail (Fig. 26-A). Careful comparisons with retinal whole mounts by
Weinhaus et al., however, revealed that visibility of the capillaries ra-
pidly decreases with increasing distance from the foveal center, espe-
cially for the deeper capillary circulation (Weinhaus et al., 1995). In
addition, capillary visualization rapidly dropped with capillary size,
with only 40% of capillaries under 4.5 microns evident on FA. Using
adaptive optics to improve transverse resolution can dramatically en-
hance capillary visualization and adaptive optics-based FA (Chui et al.,
2014; Pinhas et al., 2014) has demonstrated the radial peripapillary
capillary network not visible on conventional FA. Adaptive optics
imaging, however, is limited by a small ﬁeld of view, expense, and lack
of commercial instruments for FA. In addition, it also has limited depth
resolution and thus the examiner would need to preselect imaging the
superﬁcial vascular versus the deeper capillary circulations. Despite
these limitations, FA imaging oﬀers many other advantages including
dynamic information regarding the transit of blood as well as identiﬁ-
cation of dye leakage from disruption of the blood-retinal barrier by
disease (Fig. 26-B). It is simple, widely available, captures large areas of
the fundus in a single image, and each image can be captured in a
fraction of a second. For example, a high quality angiogram can be
obtained in a patient with nystagmus even though the eye is in constant
motion.
FA imaging is also limited in that it provides limited information
about the choroidal circulation. This is because ﬂuorescein is a small
molecule and it rapidly exits from the fenestrations of choriocapillaris
which creates an early “choroidal blush” which obscures details of the
deeper choroid (Mames et al., 1991). This problem may be addressed by
the use of an alternative dye, indocyanine green (ICG), which is imaged
in the infrared wavelength regime. ICG is signiﬁcantly protein bound
and thus remains within the choroidal vasculature in the absence of
disease, providing excellent visualization of the medium and larger-
sized choroidal vessels (Yannuzzi et al., 1993). Because the resolution is
limited, the ﬁne details of the choriocapillaris cannot be seen. The
image in dye based angiography changes over time after the injection
and additional information can be gleaned from these images.
Although dye-based angiography has been the gold standard for
imaging the retinal and choroidal circulation for several decades, other
limitations of the technique must also be considered including the need
for intravenous injection, allergic and anaphylactic reactions, and the
need for skilled personnel to perform the injections.
8.4. Wide angle imaging
A limitation of conventional color fundus photography and dye-
based angiography is the ﬁeld of view (typically 30–50°) which allows
only a portion of the fundus to be sampled at one time. This can be
partially overcome by obtaining multiple images and montaging them
together. It may still be diﬃcult, however, to access the far periphery
beyond the equator. In addition, for dynamic studies such as dye-based
angiography, the separately-acquired images may be from diﬀerent
phases of the angiographic sequence. These limitations are largely ad-
dressed by the recent broad availability of wideﬁeld imaging (Fig. 26-
C), including contact and non-contact (Spaide et al., 1998; Staurenghi
et al., 2005) devices such as the Optos instruments (Klufas et al., 2015;
Nagiel et al., 2016) and the wide-angle module for the Heidelberg
Spectralis (Witmer and Kiss, 2013). Wide-angle imaging, however, does
not overcome the other limitations of pseudocolor photography and
dye-based angiography. In fact, the larger ﬁeld of view can further limit
resolution and impair visualization of the ﬁner capillaries (Tan et al.,
2016c).
8.5. Optical coherence tomography
OCT has transformed ophthalmic imaging over the last two decades.
The many advantages of OCT include the excellent axial resolution
(allowing the depth of structures and abnormalities to be precisely
deﬁned), speed of acquisition, patient comfort, and limited training
required for high-quality imaging. By providing detailed visualization
of the various retinal and choroidal layers, OCT has transformed our
understanding of numerous retinal diseases (Pappuru et al., 2012).
Larger retinal blood vessels are well seen on both structural OCT B-
Fig. 27. (A) Swept source OCT (Topcon Triton OCT) B-scan of the macula and optic nerve
of a normal eye. The choroid and lamina cribosa of the optic nerve are well-seen as are the
various layers of the neural retina. The hyper-reﬂective oval proﬁles of the large vessels of
the optic nerve head are also evident. (B) En face OCT from a dense swept source OCT
acquisition (1024 × 1024 A-scans). Though the retinal vessels are well-seen, even at this
“megapixel” resolution, the retinal capillaries cannot be visualized.
Fig. 28. Swept source OCT B-scan (Topcon Trion OCT) of a paramacular region of a
normal eye. The approximate vertical dimensions of the various vascular layers are shown
with colored calipers: what is referred to as the choriocapillaris (yellow), Sattler's layer of
medium-sized vessels (green), Haller's layer of large-sized vessels (blue). Note, no clear
demarcation can be discerned between these various layers and the depth of the chor-
iocapillaris is much less in life than what is commonly depicted in OCT sections.
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scans and en face OCT images (Dansingani et al., 2016). Current
structural OCT, however, lacks the transverse resolution or contrast to
visualize the capillary circulation (Fig. 27). The signal arising from the
internal portions of deeper larger choroidal blood vessels is very low
due to the loss of signal with depth, scattering by the RPE and chor-
iocapillaris, and because blood is not a good reﬂector of infrared light.
Loss of signal with depth can be partially compensated for with en-
hanced depth imaging (EDI) or swept source (SS) OCT (Tan et al.,
2016b). The net result is the blood ﬂow cannot be visualized within the
larger choroidal vessels if the RPE and choriocapillaris is intact.
Nonetheless, the ﬁne details and organization of the choriocapillaris are
diﬃcult to discern with structural OCT and so are not well imaged with
OCT no matter what the implementation, be it SD or SS OCT.
9. Normal circulation in the eye
The retina has one of the highest oxygen consumption rates of any
tissue in the body and is highly susceptible to irreversible injury during
states of vascular compromise (Anderson Jr., 1968; Yu et al., 2007). The
vascular supply to the eye is provided by the ophthalmic artery which
originates from the internal carotid artery. The ophthalmic artery
branches to form the central retinal artery, the short and long posterior
ciliary arteries, and the anterior ciliary arteries (Hayreh, 1975; Kiel,
2011). Blood enters the choroid through the posterior ciliary arteries.
The short posterior ciliary arteries, generally 15–20 in number, perfo-
rate the sclera around the optic nerve then arborize to form the arter-
ioles of the outer layer of the choroid. These arterioles terminate in the
choriocapillaris (Hayreh, 1975; Kiel, 2011). The choriocapillaris is a
single continuous layer of wide-lumen fenestrated capillaries arranged
in one thin sheet plane creating an anastomotic network. The basement
membrane of the capillary endothelial cells forms the outermost layer
of Bruch's membrane (Nickla and Wallman, 2010).
Blood is collected by postcapillary venules, which anastomose
creating medium-sized vessels in Sattler's layer and larger vessels in
Haller's layer (Nickla and Wallman, 2010). Sattler described the histo-
logic structure of the choroid in detail, including the choriocapillaris,
which he concluded was a layer of capillaries that had an endothelial
lining similar to small veins. He also found several layers of elastic ﬁ-
bers, some forming a membrane under the choriocapillaris that con-
tained small arteries and medium sized veins. Other anatomists were
less able to visualize the elastic membranes, but named the region of
vessels in the middle of the choroid, Sattler's layer anyway. Haller
corrected a previous anatomic assumption by positing that the outer
vessels coursing toward the 'vasa vorticosa' were actually veins, not
arteries. The entire layer of outer vessels of the choroid was given the
name Haller's layer, even though the outer layer of the choroid contains
more than large veins. The names Sattler's layer and Haller's layer are
used to this day, although there are no real anatomic boundaries be-
tween them (Fig. 28). In addition, the choriocapillaris layer is often
shown as a layer many times thicker than its true anatomic depth.
The long posterior ciliary arteries, generally two, the medial and the
lateral according to their relationship with the optic nerve at the point
of penetration into the sclera, run anteriorly between the sclera and
choroid with anastomotic connections from the anterior choroid. They
join the anterior ciliary arteries forming the major arterial circle of the
iris. The anterior ciliary arteries travel with the extraocular muscles and
perforate the sclera near the limbus to join the major arterial circle of
the iris (Hayreh, 1975; Kiel, 2011). The venous drainage from the
anterior segment is directed posteriorly into the choroid where blood is
collected in venules, which coalesce into collecting channels, or am-
pullae, of the vortex veins (commonly four in number, but may vary).
The central retinal artery travels in the optic nerve, perforates the
sclera and then progressively branches into smaller retinal arterioles.
The central retinal vein, derived from retinal venules and vein, leaves
the eye with the optic nerve parallel and counter-current to the central
retinal artery draining the retinal tissue. From the optic nerve to the
extreme periphery, the retinal arterioles provide retinal capillaries
which supply the inner two-thirds of the retina, as the outer third is
supplied by the choriocapillaris.
The precise organization of vascular structures must achieve neu-
ronal nutrition without compromising the optical properties of the
pathway transmitting light to the photoreceptor layer in the outer re-
tina (Tan et al., 2012). In particular, the foveal avascular zone contains
no blood vessels but is surrounded by a continuous network of capil-
laries. Four morphologically varied retinal vascular networks have been
identiﬁed. In the nerve ﬁber layer, long capillary segments are oriented
parallel to the direction of retinal ganglion cell axons and is called the
radial peripapillary capillary network or plexus (Fig. 29). In the retinal
ganglion cell layer, a dense meshwork of vessels is arranged in a lattice
pattern with reduced inter-capillary spaces (Chan et al., 2012; Tan
et al., 2012). These capillaries are supplied by a branching vascular
network starting with the arcade vessels that successively branch in a
fractal manner to ﬁnally reach the capillaries. In a balanced manner,
smaller collecting venules anastomose into larger venules and even-
tually form the veins in the arcades. This circuit is known as the su-
perﬁcial vascular plexus (SVP) (Fig. 29). Recently the RPCP and SVP
taken together have been proposed to be termed the superﬁcial vascular
complex (SVC) (Campbell et al., 2017), but the need for this grouping is
not apparent. The RPCP and the SVP have diﬀerent anatomic features
as dictated by their respective retinal layers. From the superﬁcial vas-
cular plexus small capillary sized vessels dive deeper into the retinal
tissue. These anastomose with capillary-sized vessels forming networks
on either side of the inner nuclear layer. These vessels send small
draining vessels up through the substance of the retina that then merge
with the retinal venules. The two layers are the intermediate and deep
capillary plexuses. The anatomy of these layers is not fully delineated,
but the intermediate capillary plexus has an irregular shaped loop
conﬁguration with vertical and oblique orientation (Tan et al., 2012).
In the deep capillary plexus, vessels are arranged in a one-dimensional
curvilinear mesh. The distribution of capillary networks within the
retina is correlated with the metabolic demands of soma, dendrites and
neuronal layers (Kiryu et al., 1995; Yu and Cringle, 2001). The super-
ﬁcial vascular network is the only one with arterioles or larger venules.
Because the intermediate and deep plexuses are composed of similarly
sized vessels and are separated by only a small distance, they are
sometimes grouped together as the deep capillary plexus or deep vas-
cular complex (DVC) (Campbell et al., 2017).
Fig. 29. Swept source montage OCT-Angiogram illustrating the superﬁcial capillary cir-
culation of the macular and peripapillary retina. Whereas the central macular circulation
is oriented in a more circular fashion around the foveal avascular zone, the superﬁcial
peripapillary capillaries have a distinct radial orientation resembling the orientation of
the retina nerve ﬁber layer.
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10. Vascular layers in the fundus as imaged by OCTA
The high-resolution in the axial direction has allowed the various
layers of the retinal and choroidal microcirculation to be selectively
evaluated (Choi et al., 2017; Kuehlewein et al., 2015c; Spaide et al.,
2015b; Tan et al., 2016c) (Fig. 30). As noted above, the vascular ar-
chitecture is arranged in 3-dimensions, and to some extent one could
produce many “diﬀerent layers” by selecting various boundaries. In
addition, the number of layers that may be visualized is highly de-
pendent on location, as areas of thicker retina (e.g. parafoveal) will, not
surprisingly, require more layers of vessels for adequate blood supply
(Kuehlewein et al., 2015c). In fact, Snodderly noted that if desired, one
could deﬁne up to 8 layers of capillaries in the temporal peripapillary
retina (Max Snodderly and Weinhaus, 1990). Though there is some
degree of arbitrariness in deﬁning the number of retinal capillary
layers, a higher density of vessels within certain structural layers of the
retina, does lend itself to deﬁning speciﬁc vascular layers which may
have a beneﬁt of enhancing our understanding of speciﬁc diseases as
described in subsequent sections (Al-Sheikh et al., 2017). In a normal
retina these layers may be segmented for inspection and analysis.
10.1. Retinal circulation
Our ability to conﬁdently resolve the microcirculation into speciﬁc
layers has been somewhat impaired by projection artifact as described
in the previous section. The recent introduction of techniques for pro-
jection removal, though still needing further validation, have suggested
that the macular retinal circulation can be visualized in its principle
component parts, the radial peripapillary capillary plexus, the super-
ﬁcial vascular plexus, the intermediate capillary plexus, and the deep
capillary plexus (Campbell et al., 2017; Zhang et al., 2016). In the
peripapillary region, the radial peripapillary capillary network supplies
the unmyelinated nerve ﬁbers there (Snodderly et al., 1992). The me-
tabolic demands are great to maintain electrolyte concentration gra-
dients for the axons in the absence of myelin. As a consequence, the
radial peripapillary capillary network is correspondingly dense. These
vessels are located around the nervehead and extend for a few milli-
meters along the arcades. Despite the anatomic location of the radial
peripapillary capillary network in the most superﬁcial portions of the
retina, which itself is transparent, the radial peripapillary capillary
network is not particularly visible during FA. One possible reason is
that the nerve ﬁbers may cause so much scattering and diﬀusion of light
the individual capillaries are not visible. The intermediate and deep
vascular plexuses have a spider like character (Paula et al., 2010;
Weinhaus et al., 1995). The small diameter of the feeding vessels and
the loose netting like character of the vessels do not appear to be op-
timized for oxygen delivery, although that would be at least one ex-
pected function to supply the metabolically active retina. Lack of per-
fusion of these layers has been considered to be a cause or contribute to
retinal ischemic diseases (Chen et al., 2015). The intermediate and deep
plexuses can be visualized with OCTA, although without projection
artifact removal the layers are contaminated by projections from the
inner retina and they are hard to separate from each other. In ischemic
diseases there is varying opaciﬁcation and whitening of the retina,
compounding problems of both visualization and of projection artifact.
The foveal avascular zone (FAZ) represents a region of absent
Fig. 30. Optical coherence tomography angiography shows
four morphologically varied retinal capillary networks
along the maculo-papillary axis. A radial peripapillary ca-
pillary plexus is located in the nerve ﬁber layer slab (A).
The superﬁcial vascular plexus slab is found in the ganglion
cell layer, and is segmented as the inner 80% of the gang-
lion cell complex, excluding the nerve ﬁber layer (B). The
intermediate capillary plexus is segmented between the
outer 20% of the ganglion cell complex to the inner of the
inner nuclear layer (C). Finally, the deep capillary plexus is
segmented between the outer 50% of the inner nuclear
layer and the outer plexiform layer (D).
Fig. 31. Macular OCT angiograms (full retinal thickness)
from one eye of six normal subjects. Note considerable
variation in the size and shape of the foveal avascular zone
(FAZ). OCT = optical coherence tomography.
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capillaries at the center of the fovea and can show considerable varia-
tion in dimension even among normals (Fig. 31). The layers of vessels in
the retina terminate as they approach the center of the fovea. The su-
perﬁcial vascular plexus, which invests the ganglion cell layer, termi-
nates slightly further from the center of the fovea than does the deep
vascular layer. Polyak considered the perifoveal vascular ring to be part
of the deep capillary plexus. At the time of this writing, most com-
mercial OCTA instruments incorrectly segment the vascular layers in
the central macula (Spaide and Curcio, 2017). The superﬁcial vascular
network is correctly identiﬁed, for the most part, outside of the central
macula. The superﬁcial vascular plexus terminates near the upper edge
of the clivus. Instead most instruments segment a relatively uniform
thickness of the inner retina through the central macula, even through
the foveal avascular zone. The net eﬀect of this is to include all of the
superﬁcial vascular plexus and much of the inner deep plexus together
as what would be considered the superﬁcial plexus. A secondary eﬀect
of this segmentation is the deep capillary plexus is imaged to start at
some arbitrary distance distal to the edge of the perifoveal capillary
ring. Improvements in segmentation algorithms will correct this error.
Independent of segmentation, OCTA is a great way to image the peri-
foveal capillary network. It provides a high-resolution method to




Imaging the vessels in the choriocapillaris in vivo using standard
modalities is diﬃcult because of light scattering within overlying tissue,
particularly the retinal pigment epithelium (RPE). Although the chor-
iocapillaris is composed of relatively large-diameter capillaries, they
are interconnected in a densely packed arrangement with very small
intercapillary pillars (Fryczkowski, 1994; Singh Hayreh, 1974). The size
of the separation is often less than the lateral resolution aﬀorded by
dye-based angiography. Fluorescein readily leaks from the chor-
iocapillaris. The ﬂow in the choriocapillaris is fast and because of the
prominent leakage vascular structure is obscured. Eﬀorts to slow the
ﬂow, such as increasing the intraocular pressure, result in a ﬂuorescein
angiogram that shows a lobular pattern to the ﬁlling, but the actual
vessels in any given lobule are not seen (Singh Hayreh, 1974). Although
indocyanine green dye shows less leakage than ﬂuorescein, it still leaks
from the choriocapillaris and stains Bruch's membrane and the chor-
oidal stroma (Chang et al., 1998). Optical coherence tomography (OCT)
has high axial resolution, but without adaptive optics, the lateral re-
solution is insuﬃcient to visualize the choriocapillaris clearly in the
posterior pole. While OCTA has comparable lateral resolution to
structural OCT, it can detect choriocapillaris blood ﬂow, producing
contrast between the RPE and choriocapillaris (Choi et al., 2013a;
Motaghiannezam et al., 2012; Sohrab et al., 2012; Spaide et al., 2015b).
When the inner most thickness of the choroid is imaged with OCTA
a granular image is obtained that is suggestive of the choriocapillaris
(Fig. 32). Since OCTA has similar resolution to structural OCT, it may
seem paradoxical that ﬂow can be detected. In the early days of radio it
was common to for enterprising individuals to make crystal radios,
which could passively detect radio signals, at the time often originating
from a radio station in the local town. The selectivity of the crystal
radio was typically limited, which means the ability to diﬀerentiate
closely spaced stations on the radio frequency spectrum would be im-
paired. In this case, both stations would be heard, and it would not be
possible with the primitive tuning used in early crystal sets to separate
them. In an analogous manner even though structural OCT may not be
able to separate closely placed capillaries, an OCTA ﬂow signal may still
be detected. This signal is used to create an image of the chor-
iocapillaris.
The resultant image shows a granular pattern of bright and dark
areas of varying sizes (Fig. 32). The anatomic structure of the chor-
iocapillaris does not appear to explain the dark areas, since the in-
dividual capillaries in the choriocapillaris can't be seen. For there to be
a dark area there has to be a relative decrease in local ﬂow signal, either
because of low or absent ﬂow in the small region. As such, these small
areas are called signal voids (Spaide, 2015a). The number of signal
voids at any given size can be analyzed (Fig. 33). When the number of
ﬂow voids is compared to the size, a peculiar relationship is seen. Over
log units of range, the log number of voids is seen to be linearly related
Fig. 32. Choriocapillaris images from subjects of varying
ages obtained using optical coherence tomography angio-
graphy of the central macula. Each image represents an
area of 3000 × 3000 μm. The bright areas correspond to
high ﬂow signal while the dark regions are called ﬂow voids
and represent areas where there is a lack of ﬂow signal. The
age range is from 27 years (upper left) to 88 years (lower
right). The bottom row of images shows not only those of
increasing age, but also with choroidal neovascularization
in the fellow eye. Reprinted from Spaide (2016a).
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to the log size of the voids. The ﬁxed slope in the log transform re-
lationship means the data showed similarity across units of scale,
known as scale invariance, which is equivalent to stating the process is
fractal in nature. This simple relationship, known as a power law dis-
tribution has numerous implications in terms of physiology of chor-
iocapillaris ﬂow, potential mechanisms of ﬂow alteration in aging and
disease, transitions to late-AMD, and grading of changes associated with
disease (Spaide, 2016a). This novel non-invasive approach may have
utility in evaluating ocular disease, and possibly may be a method to
evaluate systemic microvascular health.
Given the skewed (non-normal) nature of the distribution, calcula-
tion of mean and standard deviation is not possible. A trend line can be
Fig. 33. Number and sizes of the thresholded ﬂow voids of a representative eye. (A) The
distribution of the number of ﬂow voids versus linearly binned sizes shows a high amount
of skew with a long tail. (B) The probability density function shown in a log-log plot is
nearly linear, demonstrating the power law characteristics. Because of the ﬁnite size of
the image and the imaging of deeper vessels that have a looser packing density the actual
relationship was hypothesized to be a truncated power law, which was conﬁrmed by
maximal likelihood methods. (C) The log number versus log size of the ﬂow voids is
shown in a log-log plot with logarithmic binning showing the linear relationship char-
acteristic of a power law. Reprinted from Spaide (2016a).
Fig. 34. In a log-log plot the data follows a y = mx + b slope intercept relationship and
provides parameters that can be evaluated using statistical analysis. The signiﬁcant
predictors of slope were age and hypertension; increasing age and the diagnosis of hy-
pertension were both associated with decreasing slope. The parameter b represents the
oﬀset, which is decreased by increasing age, the diagnosis of hypertension, and the
presence of late age related macular degeneration (AMD) in the fellow eye. Flow voids
having larger regions, as would be shown along the right side of the slope, are more likely
to occur in older patients, those with pseudodrusen, and in association with late AMD in
the fellow eye. Reprinted from Spaide (2016a).
Fig. 35. Potential explanation for observed ﬂow patterns in the choriocapillaris. (A) The
choriocapillaris is a dense mesh of capillaries as shown in red and in the posterior pole the
intercapillary pillars are small (shown in black). (B) The presence of ghost segments
(white arrow) occurs with age, but is more common in eyes with drusen and with
pseudodrusen. (C) The induced ﬂow abnormality is larger than the segment and is shown
in as the blue gradient. (D) To produce a power law relationship, two features need to be
present. Additional segments need to become nonfunctional over time and the location of
these nonfunctioning segments should have a tendency to occur in the vicinity of an
already nonfunctional segment. Reprinted from Spaide (2016a).
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ﬁtted to the data as shown in a log-log plot and this trend line has a
simple slope intercept formula log (number) = mlog (size) + b. Using
generalized estimating equations the predictors of m were age and
hypertension. The predictors of b were age, hypertension, and a diag-
nosis of late AMD in the fellow eye and for large signal voids, age, late
AMD in the fellow eye, and the presence of pseudodrusen. A con-
solidated summary of the ﬁndings in terms of a slope intercept sche-
matic is shown in Fig. 34. The ﬂow in any given region of the chor-
iocapillaris plexus would be expected to be decreased if one or more
segments are non-functional (Fig. 35). By analogy the traﬃc in Man-
hattan is greater in the region around a street closure. For a power law
relationship to occur there should be additional regions of capillary
ﬂow abnormalities and these need to occur in the region of previous
problems. Stated in a more formal way, a Barabási–Albert model scale
free networks (that is those that show a power law relationship) is
formed if there are additional nodes and the new nodes show pre-
ferential attachment to older nodes. In this case a node would represent
an area of decreased ﬂow (Barabási and Albert, 1999).
Our understanding of the blood ﬂow in the choroid underwent a
large advance in the 1970s because of the seminal work of Sohan Singh
Hayreh (Hayreh, 1974, 1975; Singh Hayreh, 1974). He established that
choroidal blood ﬂow was segmental in nature with arterioles branching
to smaller vessels that supplied discrete units of capillaries in the
choriocapillaris, known as lobules. By elevating the intraocular pressure
to slow down the ﬂow he could show the ﬁlling of the choriocapillaris
occurred in quantized units of area corresponding to the anatomic size
of the lobules. Thus the choriocapillaris appears to be a uniform
meshwork of densely packed and interconnected capillaries when
viewed from the retinal side, but functions in a lobular mode in terms of
blood ﬂow. The morphology of some disease presentations have been
theorized to be inﬂuenced by the lobular nature of choriocapillaris ﬂow
(de Venecia et al., 1980; Deutman, 1983; Holt et al., 1976).
Histologic evaluation of the choriocapillaris was done by Mullins
and coworkers (Mullins et al., 2011). They found evidence of ghost
vessels, which essentially are nonfunctional capillary segments, in the
choriocapillaris meshwork. The number of ghost vessels was positively
correlated with age and the presence of drusen. Curcio and coworkers
found there were ghost vessels in older eyes and the proportion of ghost
vessels increased in eyes with basal linear deposit, mounds of which
appear as drusen, and also in eyes with subretinal drusenoid deposits,
which appear clinically as pseudodrusen (Curcio et al., 2013). Biese-
meier and colleagues found choriocapillaris loss in histologic section in
controls and more extensive loss in eyes with AMD (Biesemeier et al.,
2014). A major diﬃculty is tying in cross-sectional images showing
choriocapillary absence with ﬂow through the capillary network. Flow
in the ghost vessels is assumed to be absent – the vessels do not appear
to be viable, and they contain no blood cells. Blood ﬂow is lacking in
the speciﬁc ghost vessel segment, but also could be compromised in
vessels adjacent to the occluded segment. Thus the area of abnormal
ﬂow would be the same size or larger than the aﬀected segment, but not
necessarily aﬀecting the whole lobule. The ﬂow abnormalities implied
by the signal voids are almost always smaller than the size of a chor-
iocapillaris lobule. There is a wide range of estimates for lobule size in
the macular region of humans, but typically range from 400 to 800
microns in diameter (Fryczkowski, 1994; Olver, 1990; Yoneya and Tso,
1987; Yoneya et al., 1983). The signal voids range in size over several
log units starting with 100 μm2, with only the largest exceeding the size
of a choriocapillaris lobule. The skewed distribution of values for the
size of the signal voids in the choriocapillaris because of the power law
distribution also means simple descriptors such as mean size and
standard deviation are not mathematically rational; there is no char-
acteristic size or scale for a scale free system.
Using microspheres and by evaluating tracer washout, myocardial
tissue shows features that imply the ﬂow must have a power-law
characteristic, although these can't be directly imaged in vivo
(Bassingthwaighte and Beard, 1995; Beard and Bassingthwaighte,
1998, 2000; Kendal, 2001; King et al., 1996). The high axial resolution
and high transverse pixel density in OCT images possible make direct
observation of the power-law characteristics of the ﬂow voids in the
choriocapillaris possible in vivo. The signal voids in the choriocapillaris
showed measurable changes in association with age and hypertension.
Additional research into choriocapillaris ﬂow characteristics may help
evaluate the possibility that the choriocapillaris, the densest layer of
capillaries in the body, could serve as a gauge of microvascular ab-
normalities in the body in general.
Decreases in local choriocapillaris perfusion of the choriocapillaris
may put the overlying retinal pigment epithelium at risk, which may
lead to further compromise of the choriocapillaris. In dynamic systems
self-similarity following a power law characteristic can develop in a
robust way from self-organized criticality. This was ﬁrst modeled using
sand falling onto a pile and observing small avalanches of sand (Bak
et al., 1988), and later discoveries found power law distributions ex-
plained frequency and severity of real avalanches, earthquakes, mate-
rial failure, transitions in shape memory metals, cancer metastasis,
biologic evolution, traﬃc jam propagation, and epidemic transitions of
disease (Bak, 1996; Hüfner and Mukhopadhyay, 1986; Lukierska-
Walasek and Topolski, 2014; Nagatani, 1998; Newman, 2005; Vives
et al., 1994). In a loose analogous sense, late AMD may be viewed as a
phase change inﬂuenced in part by a positive feedback loop between
the power law related ﬂow heterogeneities in choriocapillaris ﬂow and
the retinal pigment epithelium.
10.2.2. Sattler's and Haller's layers
Flow in deeper layers of the choroid is not detected by OCTA,
mostly because of scattering by the pigment in the RPE and by the
choriocapillaris. The ﬂow in vessels in the deep choroid is visible if
there is geographic atrophy (Fig. 36). In some eyes, particularly in those
with thin choroids such as high myopes, OCTA can show ﬂow in the
medium sized vessels of Sattler's layer. However, because of signal loss,
fringe wash-out, and thresholding used in signal processing, the vessels
in Sattler's layer and certainly in Haller's layer appear dark in normal
eyes (Fig. 37). They may appear bright (showing evidence of ﬂow),
however, in areas with overlying RPE loss or depigmentation with ab-
sence of the choriocapillaris allowing greater penetration of light into
Fig. 36. An OCTA image of the submacular choroid obtained in a patient with geographic
atrophy. There is atrophy to the right of the dashed yellow line. The larger choroidal
vessels show visible ﬂow signal while they do not in the areas with extant retinal pigment
epithelium. Note the course of one large choroidal vessel from an area under the RPE
(open arrow) to the area of atrophy (white arrow.).
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the choroid. As a result, in eyes with high myopia or atrophy, the
deeper choroidal vessels are well seen.
Swept source OCT, by oﬀering less sensitivity loss with depth has
the theoretical advantage of oﬀering better visualization of the choroid
(Ferrara et al., 2016). Even with swept source OCT, ﬂow in the larger
vessels cannot be visualized without atrophy of the RPE and chor-
iocapillaris. However, careful comparative studies are still required to
best deﬁne its advantage in this setting. The method of OCTA acquisi-
tion may also impact the quality of the choroidal imaging. Gorczynska
et al. compared amplitude-decorrelation (AD) and phase-variance (PV)
based methods for imaging the retinal and choroidal circulations
(Gorczynska et al., 2016). They observed better signal strength in the
choroid with the PV-based methods but also more overlying retinal
vessel projection artifact. However, visualization was relatively similar
between methods.
11. Optical coherence tomography angiography in ocular diseases
11.1. Diabetic retinopathy
Diabetic retinopathy is a disease that has profound eﬀects on the
retinal vasculature (Antonetti et al., 2012), is rapidly becoming more
prevalent world-wide, and, as such, is a disease for which OCT angio-
graphy may be profoundly useful. The current gold standard for as-
sessing the severity of diabetic retinopathy consists of discrete stages
and relies on comparing the numbers of various vascular features with
standard reference photographs. This grading system was shown to
correlate with the risk of disease progression (Wilkinson et al., 2003).
Fig. 37. Swept source OCT angiogram (OCTA) of the ma-
cular choroid of a normal eye. The upper panels show the
slab en face OCTA image through the vascular layer of in-
terest. The lower panels demonstrate the slab (blue-lines)
location of the en face image on a corresponding B-scan.
The en face OCTA is shown at the level of the choriocaillaris
(left panel), presumed Sattler's layer (middle), and pre-
sumed Haller's layer (right). The choriocapillaris has a
granular texture, but the individual capillaries are not seen.
Also, it is important to note that Sattler and Haller layers as
histologically deﬁned do not have precise borders or a
precise axial position relative to the RPE, and hence these
slabs represent approximations. The larger choroidal ves-
sels appear dark, presumably due to loss of signal with
depth, projection artifact and decorrelation from overlying
retinal vessels and choriocapillaris, and image processing or
thresholding artifact.
Fig. 38. Fluorescein angiography (FA) of a diabetic eye (A)
and the corresponding OCTA image segmented at the su-
perﬁcial retinal capillary plexus (B) and the deep capillary
plexus (C). Note the microvascular changes seen on the
OCTA including microaneurysms, vascular dropout and a
ragged appearance of the foveal avascular zone. Figure D is
the FA cropped to a 3 × 3mm size to correspond to the
OCTA image. Blue circles show microaneurysms visualized
better on the superﬁcial capillary layer of the OCTA and
yellow circles show some examples of microaneurysms vi-
sualized better on the deep retinal capillary layer of the
OCTA. The red circle demonstrates a microvascular ab-
normality that spans both the superﬁcial and the deep plexi.
Note that there are some microaneurysms that are seen on
the FA but not seen on the OCTA. Figure E is a corre-
sponding image of the choriocapillaris showing areas of
choriocapillaris dropout.
Fig. 39. This is an overlay of the OCTA of diabetic microaneurysms with the size of the
microaneurysm as measured on the structural OCT scan. The superﬁcial vascular plexus
ﬂow is shown in red while the structural OCT information is shown in green. Signal
common to both is yellow. Note the microaneurysms visible centrally have yellow cores
with a relatively thick wall. Microaneurysms may have thrombi and regions of slow ﬂow
that may be below the detection threshold of OCTA.
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Clinical grading of retinopathy in large epidemiologic was dependent
primarily on vascular features seen in color photographs. Clinical eva-
luation traditionally used FA as well (Panel, 2003). Many features of
diabetic retinopathy have the potential to be imaged and more accu-
rately classiﬁed with OCTA. In addition by showing us various retinal
vascular layers, OCTA oﬀers the opportunity for greater understanding
of disease processes.
Clinical features of non-proliferative diabetic retinopathy (NPDR)
include the presence of microaneurysms, intraretinal hemorrhages, in-
traretinal microvascular abnormalities, venous beading, cotton wool
spots, hard exudates and neovascularization (Group, 1991c). Of these,
the presence of cotton wool spots and hard exudates have not been
associated with an increased risk of progression to PDR and therefore
NPDR is stratiﬁed into mild, moderate and severe based on the presence
and severity of the ﬁrst 4 features. On the other hand, proliferative
diabetic retinopathy is characterized by the presence of neovascular-
ization of the retina or the iris (Group, 1991c).
In addition to the clinical features, angiographic features using FA
are enlargement and irregularity of the foveal avascular zone (FAZ),
microaneurysms, capillary loss, capillary dilation, intraretinal micro-
vascular abnormalities, focal narrowing and pruning of arterioles, and
retinal neovascularization. FA is also useful in the setting of diabetic
macular edema and may show leaking microaneurysms, diﬀuse capil-
lary leakage, and capillary nonperfusion associated with the areas of
retinal thickening (Group, 1991a, b). FA is also invaluable clinically for
the evaluation of macular ischemia.
11.1.1. Optical coherence tomography angiography
One of the major limitations of FA is that light scattering in the
retina renders it unable to capture the alterations in the deep capillary
plexus of the retina, which, per histopathologic studies, is the site of a
majority of the changes that happen especially early on in diabetic
retinopathy (Moore et al., 1999). Besides the other obvious advantages
of OCT angiography (patient comfort, lower patient risk, shorter ac-
quisition time), OCT angiography is able to penetrate into the retinal
layers and image the various diﬀerent capillary plexuses, thereby pro-
viding us the unique ability to reconstruct and view the retinal vascu-
lature in a 3-dimensional fashion, as well as to visualize in isolation the
individual retinal plexuses. This may be critical in diabetes, since this
enables us to evaluate independently the changes that occur in the
superﬁcial, intermediate, and deep capillary plexuses of the retina. In-
dividual visualization of the retinal plexuses allows for better identiﬁ-
cation of the changes associated with diabetic retinopathy such as ca-
pillary dropout and enlargement of the foveal avascular zone. In the
future it may allow for a better understanding of disease pathogenesis
and progression as well as a better way to screen for and follow diabetic
vascular changes (Fig. 38) (Choi et al., 2017; Salz et al., 2016).
Microaneurysms that are seen as focal dilations of the retinal ca-
pillaries on FA are a hallmark of the disease and can be visualized on
OCTA as small focal dilations of the vessels (Fig. 38) (Ishibazawa et al.,
2015; Jia et al., 2015; Matsunaga et al., 2015). However, studies show
that only around half of the microaneurysms seen on FA are visualized
on OCTA (Ishibazawa et al., 2015; Miwa et al., 2016; Salz et al., 2016).
This is thought to be because of the inability of OCTA to measure slow
ﬂow. This is demonstrated in Fig. 39 which is an overlay of the ‘ﬂow
area’ of microaneurysms as seen on OCTA to true area as visualized on
structural OCT scans. Imaging very slow ﬂow may be limited by bulk
eye motion (Moult et al., 2016). In addition, some of the volume of a
microaneurysm may be occupied by thrombus, which has no ﬂow.
Microaneurysms that appear hyporeﬂective in structural OCT are more
likely to be not visualized by OCTA (Parravano et al., 2017). Similarly,
other vascular abnormalities such as areas of capillary dropout, tortu-
osity and enlargement of the foveal avascular zone are visualized in
better detail and with greater resolution than on FA (Ishibazawa et al.,
2015; Miwa et al., 2016). Pre-retinal neovascularization can be seen as
vessels projecting into the hyaloid cavity and intraretinal microvascular
abnormalities are seen as abnormal vessels still within the retinal plane
(Figs. 34 and 40).
11.1.2. Vascular perfusion
The advent of OCTA and the ability to study the 3-dimensional
vascular changes in vivo provides us with important insights into the
pathogenesis of diabetic retinopathy and allows for in-vivo visualiza-
tion of changes that were previously only seen in histopathologic spe-
cimens. For example, Scarinci et al. reported that capillary dropout in
the deep capillary plexus imaged by OCTA is associated with macular
photoreceptor disruption on SDOCT in patients with diabetic
Fig. 40. Neovascularization of the disc is seen in this OCTA
image projecting into the vitreous space (A). 4 and 8 weeks
after treatment with anti-VEGF injections, the pre-retinal
neovascularization is seen to regress (B and C panel re-
spectively).
Fig. 41. Volume rendered optical coherence tomography angiography of the right eye
with areas of absent ﬂow signal. (A) There is attenuation of vascular ﬂow density in the
inferior temporal macula of the inner vascular plexus. The double white arrow shows the
extent of absence of underlying ﬂow signal from the underlying deep plexus. (B) The
opacity of the inner vascular layer was reduced to allow visualization of the deep plexus.
Note the absence of ﬂow signal inferotemporally. (C) The structural optical coherence
tomography image used to derive the ﬂow data. The double white arrow is scaled to show
the same lateral extent as the double white arrow in the picture in the upper left. There is
absence of laminar detail associated with retinal thinning, which is consistent with the
entity disorganization of retinal inner layers (DRIL). Note the inner nuclear layer is not
clearly visible and as such more than the inner retinal layers are involved. Reprinted from
Spaide (2015c).
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retinopathy (Scarinci et al., 2016), as was found years earlier by his-
topathology (Tso, 1982). OCTA has conﬁrmed the histopathologic ob-
servation (Moore et al., 1999) that many of the vascular changes in
diabetics, such as the development of microaneurysms, happen sooner
and are more severe in the deep capillary plexus than in the superﬁcial
capillary plexus and that there may possibly be an even more pro-
nounced increase in the number of microaneurysms in the deep plexus
of patients with diabetic macular edema (DME) (Hasegawa et al.,
2016). DME may be associated with a profusion of microaneurysms
especially in the deep retinal plexus, and it has also been associated
with loss of vascular perfusion in the area of the edema that does not
usually recover with resolution of the edema (Bradley et al., 2016;
Spaide, 2015c). While conﬁrming the heterogeneity of the size of the
foveal avascular zone (FAZ), OCTA has shown us that, on average, the
size of the FAZ tends to increase with increasing severity of diabetic
retinopathy (Di et al., 2016; Jia et al., 2014; Kim et al., 2012; Schwartz
et al., 2014; Takase et al., 2015) conﬁrming studies done with FA
decades earlier (Bresnick et al., 1984). Automated vascular density al-
gorithms developed for OCTA demonstrate a decrease in the vascular
density in both the superﬁcial and deep retinal plexuses of patients with
diabetic retinopathy (Agemy et al., 2015; de Carlo et al., 2015b; Hwang
et al., 2016). There is an alteration in the pattern of vessels in the deep
plexus (Bonnin et al., 2015; Couturier et al., 2015). These reductions in
the deep plexus, in particular, have been shown to correlate with dis-
organization of the retinal inner layers (DRIL) which is associated with
decreased visual function (Spaide, 2015c) (Fig. 41). In addition, cystoid
macular edema seems to preferentially occur in regions with absent
deep plexus ﬂow (Mané et al., 2016; Spaide, 2015c). Moreover, these
microvascular alterations in diabetic retinopathy can begin very early.
OCT angiography is able to detect vascular changes in patients with
diabetes but without clinically detectable diabetic retinopathy (de Carlo
et al., 2015b; Dimitrova et al., 2017). It has also been demonstrated that
vascular dropout in the choriocapillaris of diabetics, previously de-
scribed on histopathologic sections (Farkas et al., 1970; Fryczkowski,
1987), can also be observed on OCTA (Fig. 38) (Choi et al., 2017).
Another advantage of obtaining a reliable, reproducible and re-
peatable vascular map is that image processing techniques can then be
applied to get quantitative parameters of the vasculature in diabetics.
Vascular density maps initially developed for adaptive optics imaging
have been applied to patients with diabetic retinopathy and have been
Fig. 42. Images of a patient with diabetic macular edema.
(A) FA early frame (A1) and late frame (A2) showing that
some microaneurysms are leaking while others are not. This
is somewhat diﬃcult to identify because of previous focal
laser. B1 is a magniﬁed FA image. The 3 mm × 3 mm OCT
angiogram is overlaid on the FA image (B2) to show which
microaneurysms on the OCT angiogram correspond to those
on the FA. Note that not all microaneurysms seen on the FA
are seen on the OCTA. (B3) The OCT thickness map is su-
perimposed over the OCTA image to show that there is
thickening due to leakage at and around some micro-
aneurysms, while the non-leaking microaneurysms do not
show any ﬂuid accumulation. (C1-C3) OCT b-scan, OCT
thickness map and OCTA image from the same patient visit
in A-B showing edema. (D1-3) OCT b-scan, thickness map
and OCTA from the same patient in A-B after intravitreal
injections of anti-vascular endothelial growth factor agents.
The edema has improved.
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shown to correlate to the severity of diabetic retinopathy (Agemy et al.,
2015). Other approaches have also been investigated including inter-
capillary area as well as investigation of the branching patterns of the
capillary network (Cheung et al., 2009). The intercapillary area in
diabetics shows increased heterogeneity with increasing levels of dia-
betic retinopathy (Schottenhamml et al., 2016). Ultimately, these
techniques may provide an objective, automated and quantiﬁable
measure of the progression of retinopathy over time and may be useful
adjuncts in the clinical and clinical trial setting.
One of the challenges in the current treatment paradigms of diabetic
macular edema is that treatment is often initiated at a time when vas-
cular damage has already occurred. Treatments may reverse some but
not all of the vision loss, and may not reverse many of the vascular
changes that are seen to occur in diabetic macular edema. The ability to
visualize vascular changes and to perhaps predict which of these
changes will correlate with vision loss may enable us to intervene
earlier with disease modifying agents to try to prevent irreversible
damage to the retina.
11.1.3. Diabetic macular edema
One of the limitations of OCTA is its inability to detect leakage and
therefore its inability to diﬀerentiate between leaking and non-leaking
microaneurysms in diabetic macular edema (DME). A second limitation
of en face imaging is that segmentation defects are common in ede-
matous maculas. The diagnosis of DME is typically determined by
structural OCT, reducing the need to image leakage, per se. Treatment
of DME currently relies primarily on intravitreal agents and not as much
on focal laser (Panel, 2003; Virgili et al., 2017; Wells et al., 2016),
detection of leaking microaneurysms has become of less critical im-
portance. The OCTA images are intrinsically co-registered with struc-
tural OCT, so speciﬁc microaneurysms can be registered with areas of
cystoid change and edema, thereby clearly showing the relationship of
the edema and the cystoid spaces to the microvascular alterations,
without the obfuscation in detail that may occur as a result of leakage in
FA (Hasegawa et al., 2016) (Fig. 42). The response of these micro-
aneurysms to treatment can also be followed over time (Falavarjani
et al., 2017b).
OCTA can also be invaluable in the evaluation of patients with
proliferative diabetic retinopathy (Choi et al., 2017; de Carlo et al.,
2016; Ishibazawa et al., 2016; Savastano et al., 2016; Stanga et al.,
2016). Retinal neovascularization is seen to project into the vitreous
cavity. This distinguishes it from intraretinal microvascular abnormal-
ities, which is intraretinal and does not extend past the posterior hya-
loid. Areas of neovascularization can be precisely quantiﬁed on OCTA,
since the margins are not obfuscated by leakage as happens on FA.
Moreover, these areas of NV are seen to decrease in size or regress on
treatment with laser and anti-vascular endothelial growth factor
(VEGF) agents. These can subsequently be followed up and serve as
markers of VEGF levels in the vitreous, guiding re-treatment decisions.
A study using VISTA on OCTA to study blood ﬂow speeds in the
retinal vasculature of patients with diabetes found relatively slower
blood ﬂow in microaneurysms and neovascularization (Moult et al.,
2016). Studies on patients with diabetic retinopathy show slow and
turbulent ﬂow in areas of microaneurysms and vascular pruning,
compared to the speed of ﬂow in similar sized vessels without these
alterations (Ishibazawa et al., 2016). Moreover, OCT based Doppler
techniques suggest a reduction in total retinal blood ﬂow in patients
with diabetic macular edema, which is consistent with the extensive
peripheral non-perfusion that is often seen on wide ﬁeld imaging in
these patients (Lee et al., 2017; Sadda et al., 2017a).
Also intriguing is correlating the OCTA features in diabetic retino-
pathy with systemic control. Some early studies have suggested that
worse diabetic control may be associated with worse OCTA features
(Bhanushali et al., 2016). However, larger studies controlled for mul-
tiple confounding factors such as duration of the diabetes and other
systemic risk factors are needed to better understand this relationship
and to better deﬁne the potential role of OCTA in systemic screening. In
the future, application of ‘big data’ techniques to diabetic eye disease
may be able to identify risk factors not only for diabetic retinopathy
progression but also, possibly, for systemic morbidity in these patients.
OCTA has a relatively small ﬁeld of view compared to FA, which can
make it unsuitable for assessing areas of non-perfusion or peripheral
neovascularization in diabetic patients. It is theoretically possible to
image patients all the way to the mid-periphery using image montaging
on OCTA. Wide ﬁeld imaging has been achieved on commercial OCTA
devices using strategies such as montaging multiple images. This be-
comes clinically practicable with the integration of eye tracking into
OCTA machines (Camino et al., 2016; Coscas et al., 2016b; Lauermann
et al., 2017; Rosenfeld et al., 2016; Zhang et al., 2015b). Moreover,
with the introduction of the higher speed OCTA machines, larger
scanning areas such as 12 mm × 12 mm still give reasonable quality
images and allow for evaluation of larger areas. On currently available
devices, the ﬁeld of view is still very much less than it is with ultra-wide
ﬁeld FA (Nagiel et al., 2016; Wessel et al., 2012).
11.1.4. Clinical trials
OCTA is currently being integrated into clinical trials of patients
with diabetic retinopathy. While it provides important information on
diabetic retinopathy progression, integration into clinical trials and use
in a reading center faces some challenges that will need to be overcome
before OCTA can be integrated in wide scale clinical trials. Because the
various diﬀerent commercial devices use diﬀerent algorithms to com-
pute OCTA images, and because there are various post-processing steps
employed after the analysis, comparative studies are needed to evaluate
whether quantiﬁable metrics applied to the vasculature on OCTA are
comparable between devices. Segmentation challenges in patients with
altered retinal anatomy, such as in diabetic macular edema, also make
standardized evaluation and quantiﬁcation challenging. However,
being cognizant of these challenges allows for the use of strategies that
achieve acceptably reproducible and reliable use of OCTA in the clinical
trial and reading center setting. For example, a study that assesses al-
terations in vessel density over time may allow patients to only follow-
up on the same device every time.
OCT angiography provides us with the exciting ability to correlate
structural and retinal vascular information and to better understand the
role of the diﬀerent retinal vascular plexuses the evolution of diabetic
retinopathy and diabetic macular edema. In the research and drug de-
velopment setting, this is a powerful tool, particularly since anti-an-
giogenic therapies have been shown to have an eﬀect on the underlying
background retinopathy. As OCTA lends itself to quantiﬁcation of
perfusion through vascular density maps, and the potential for feature
identiﬁcation such as identifying microaneurysms or speciﬁed regions
of non-perfusion, there may be opportunities to more precisely describe
the evolution of the retinopathy. To that end, while OCTA has been
utilized in cross sectional studies, its true power will be unleashed when
it is integrated into longitudinal studies. In this setting, it has the po-
tential to identify markers that predict worsening in patients with
diabetic eye disease. In a clinical setting, OCTA can be used to follow
patients with diabetic macular edema or ischemia over time, and pro-
vides a rapid, non-invasive way to repetitively monitor evolution of
vascular changes.
11.2. Retinal vein occlusion
In veno-occlusive disease there is an impediment to venous outﬂow
leading to decreased perfusion of and increased back pressure in the
retinal circulation. It is the second most common retinal vascular dis-
ease. A vein occlusion may occur at any level of the vascular circuit in
the eye. Blockage of the main trunk leaving the eye creates a central
retinal vein occlusion, while blockage of a branch of the vein produces,
appropriately enough a branch retinal vein occlusion. A hemi-central
retinal vein occlusion is caused by the blockage of primary superior or
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inferior branches of the retinal vein, and produces altitudinal eﬀects.
The ophthalmoscopic signs are the familiar venous dilation, tortuosity,
intraretinal hemorrhage, retinal edema and hemorrhage in the dis-
tribution of the occluded vein. Central retinal vein occlusions were
analyzed for gross measures of perfusion and divided into “ischemic”
and non-ischemic” forms (Group, 1995, 1997). Since then it was de-
termined that many of the manifestations of veno-occlusive disease
could be emulated by increased intraocular VEGF levels (Tolentino
et al., 1996). Blocking the increased VEGF agents with pharmacologic
agents reduced the disease manifestations. As such an ocular disease
caused by a vascular occlusion that causes increased VEGF levels could
hardly be called “non-ischemic”. Treatment with intravitreal anti-VEGF
agents or corticosteroids causes a reduction or resolution of the edema
(Campochiaro et al., 2011; Ip et al., 2009; Scott et al., 2017). This
edema typically returns as the intraocular drug concentration de-
creases. The cystoid spaces recur in the same locations as they once
were (Spaide, 2016c).
Color fundus photography shows a blood and thunder appearance of
edema and multiple intraretinal hemorrhages with dilated tortuous
veins. There is often perivenular retinal whitening (Browning, 2002).
FA shows delayed ﬁlling in the distribution of the involved retinal
vessels. The veins are dilated and tortuous. There is leakage from ca-
pillaries during the ﬂuorescein angiogram with dye accumulating in the
substance of the retina or within cystoid spaces. OCT shows thickening
of the retina with accumulation of ﬂuid in cystoid spaces. There are
variable amounts of retinal vascular non-perfusion present. In a branch
or hemi-central retinal vein occlusion hemorrhages often persist at the
border of the perfused and non-perfused regions. If there is extensive
retinal nonperfusion it is possible that retinal neovascularization can be
seen as well. Treatment with anti-VEGF agents causes a reduction in the
amount of leakage and also regression in the retinal neovascularization
as well.
Optical coherence tomography shows dilated venous segments
within edematous tissue. Collateral vessels can be seen and these ves-
sels may meander through more than one layer (Muraoka et al., 2014).
There may be cystoid spaces present. Some patients with veno-occlusive
disease have large amounts of edema, which can be associated with
serous detachment of the retina. There may also be loss of the ellipsoid
zone. Treatment with anti-VEGF agents causes reduction in the edema
leading to a reduction in retinal thickness. After resolution of edema
there may be abnormally thin inner retinal layers, reﬂecting the is-
chemic loss of tissue there (Ford et al., 2014; Ho et al., 2016; Patel
et al., 2016; Yeh et al., 2015).
11.2.1. Optical coherence tomography angiography
Optical coherence tomography highlights the dilated tortuous ve-
nous segments. The microvascular complications may be obscured by
intraretinal hemorrhages. Areas of vascular non-perfusion are detect-
able using OCTA. The diﬃculty with en face imaging is that selective
engorgement of retinal layers occurs and these layers are typically not
segmented correctly. En face imaging typically only shows part of any
one layer and since the segmentation is not correct, manually ex-
panding the depth of the segmentation often includes regionally
varying amounts of alternate vascular layers. The resultant en face
vascular images may not show accurate representations of the actual
ﬂow characteristics in the tissue. The authors of some publications did
not appear to consider that incorrect segmentation could occur (Suzuki
et al., 2016). However, the ﬁndings obtained by conventional methods
of examination can also be imaged using OCTA (Novais and Waheed,
2016), and given the depth resolved nature of OCTA, it is possible to
learn more about various retinal vascular layers in this condition. In
addition to en face imaging volume rendering may help visualize the
nature of vascular perfusion abnormalities. In areas of chronic edema
there is pronounced loss of the deep vascular plexus (Spaide, 2016c;
Tsuboi et al., 2017).
The amount of microvascular occlusion appears to be more
pronounced in the deep vascular plexus as compared with the super-
ﬁcial plexus and appears to also be related to the appearance of para-
central acute middle maculopathy (Sellam et al., 2017b). Following
anti-VEGF treatment most studies showed the vascular density does not
change (Falavarjani et al., 2017; Rodolfo et al., 2017b), although some
studies found a slight decrease in vascularity following treatment
(Glacet-Bernard et al., 2016; Sellam et al., 2017a). Spatial correlation
showed a loss of the ellipsoid band in regions where there was a loss of
the deep capillary plexus (Kanakis et al., 2017). The foveal avascular
zone can be enlarged after vein occlusion (Adhi et al., 2016; Kang et al.,
2016; Salles et al., 2016; Wons et al., 2016). The quantity of residual
perfusion is correlated with visual acuity (Kang et al., 2016; Samara
et al., 2016). The deep vascular plexus appears to be aﬀected more than
the superﬁcial plexus (Coscas et al., 2016a), particularly in areas of
cystoid macular edema. Volume rendering can overcome some of these
problems since it doesn't rely on segmentation. Retinal neovascular-
ization is obvious as vascular proliferation above the internal limiting
membrane. Treatment with anti-VEGF agents causes a decrease in the
amount of edema, but no signiﬁcant improvement in vascular perfusion
once any potential abnormalities in segmentation are corrected. In
branch retinal vein occlusion, visual acuity was related to parafoveal
areas of nonperfusion and abnormalities in perfusion of the superﬁcial
and deep vascular plexuses (Kadomoto et al., 2017). Segmentation in en
face imaging often is not correct in areas of inner retinal thinning.
11.3. Retinal artery occlusion
Acute occlusion of the main or branch retinal artery causes a re-
duction in ﬂow in the aﬀected vessel ranging from reduced to complete
loss of low. The occlusion can be secondary to embolism, thrombosis,
elevated intraocular pressure, especially from direct pressure or in-
ﬂammation. The occlusion from any of these causes can be temporary,
inducing damage in minutes even though ﬂow may be restored later.
Central retinal artery occlusion causes ischemic necrosis, whitening,
and opaciﬁcation of the inner retina. The opaciﬁcation may persist for
hours to days and causes the cherry-red spot appearance because the
central fovea remains unchanged in color. Mild retinal artery occlusions
are often overlooked because of the modest amount of associated ret-
inal opaciﬁcation. About ¼ of patients have a cilioretinal artery, which
may perfuse a variable amount of the maculopapillary bundle and nasal
fovea.
11.3.1. Optical coherence tomography angiography ﬁndings
OCTA ﬁndings of a limited number of cases have been reported,
with ﬁndings that for the most part would be expected given the known
pathophysiology and ﬁndings in other means of imaging (Damento
et al., 2016; Hwang et al., 2017). Of interest was the ﬁnding that
variable amounts of nonperfusion in the superﬁcial and dep plexuses
occur and these areas do not necessarily overlap. Paracentesis in one
case showed a dramatic improvement in retinal blood ﬂow. As with
other forms of imaging, some reperfusion can be seen during follow-up
after arterial occlusion (Bonini Filho et al., 2015a).
11.4. Retinal vascular cystoid macular edema
Cystoid macular edema (CME) is one of the leading causes of vision
loss related to retinal vascular disease. There are more than 1/3 of a
billion people in the world with diabetes; this number is expected to
reach nearly 600 million by 2035 (Guariguata et al., 2014; Hu, 2011).
The most common sequella of diabetes causing vision loss is macular
edema (Aiello, 2003; Bresnick, 1983; Davidson et al., 2007; Ferris and
Patz, 1984). The second most common retinal vascular disease is retinal
vein occlusion (Cugati et al., 2006; Klein et al., 2008), of which cystoid
macular edema is a common vision threatening consequence. The pa-
thophysiologic steps involved in CME from retinal vascular disease are
not completely known. Elucidation of the pathophysiology of CME can
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lead to increased understanding of the disease and potential for new
therapeutic insights for a vision threatening condition expected to be-
come more common.
Fluorescein angiographic abnormalities seen in diabetic macular
edema include capillary non-perfusion, microaneurysms and capillary
telangiectasis, with leakage of ﬂuorescein from segments or regions of
capillaries. In retinal vein occlusions the vascular abnormalities include
capillary non-perfusion, capillary telangiectasis, with leakage of ﬂuor-
escein from segments or regions of capillaries with dilated and tortuous
venous segments. The pattern of diabetic macular edema shows poor
correlation to the location of microaneurysms (Blair et al., 2008) and
only a modest correlation to ﬂuorescein leakage patterns (Bolz et al.,
2009; Neubauer et al., 2007). In evaluating normal monkeys using
histopathology, Weinhaus et al. (1995). determined that FA also did not
show deeper planes of vessels in the retina. The deep capillary plexus
was shown to be not visible in ﬂuorescein angiograms in humans
(Spaide et al., 2015c). Our ideas of the pathophysiology of retinal
vascular CME have been formed using FA, which doesn't visualize all
relevant vessel layers in the retina. OCTA oﬀers the ability to image all
Fig. 43. Müller cell schematic. (A) Müller cells traverse
most of the thickness of the retina and are the major de-
terminant of retinal ﬂuid movement. Müller cells extend
from the inner retina to the inner segments of the photo-
receptors, where they form junctional bonds with the
photoreceptors. This establishes a boundary at the outer
border of the retina that has limited permeability to the
passage of water. (B) The footplates of the Müller cells form
the internal limiting membrane of the retina. At the inner
border of the Müller cell there are highly concentrated ag-
gregates of aquaporin 4 channels (schematically shown as
blue rectangles) that colocalize with potassium channels
(not shown). There are aquaporin channels scattered over
the surface of the Müller cell, but at a much lower fre-
quency. (C) Müller cell processes surround the retinal ves-
sels of the inner and deep vascular layers. The appositional
surface has densely packed aquaporin 4 channels along
with potassium transport channels (not shown). Reprinted
from Spaide (2016b).
Fig. 44. Schematic drawing of the retina highlighting the Müller cells, which can buﬀer
both K+ ions and water (double arrows), which move in tandem. Reprinted from Spaide
(2016b).
Fig. 45. Excessive water, potassium, or both may be transported to the vitreous or to the
superﬁcial or deep plexus via potassium pumps and aquaporin 4 channels. The spatial
buﬀering of potassium by this mechanism and that shown in Figure is called the po-
tassium siphon.
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relevant vascular layers on the retina and is not aﬀected by ﬂuorescein
leakage.
Fluid entry into and out of the macula may occur at four main sites:
the outer retinal border with the subretinal space, the inner retinal
border with the vitreous, and the superﬁcial and deep vascular plexus.
The outer retina has the external limiting membrane, which is the term
given to the linear aggregate of junctions between the outer portions of
Müller cells and the inner segments of the photoreceptors (Fig. 43).
These junctions show labeling of occludin, junctional adhesion mole-
cules, and zonula occludens-1, typical of tight junctions and also have
proteins associated with adherens junctions (Campbell et al., 2006;
Matsunaga et al., 1988; Paﬀenholz et al., 1999). If the external limiting
membrane is intact, exudation from the below the retina would cause
serous detachment of the retina; if the external limiting membrane is
defective there can be passage of ﬂuid into the outer retina. The ex-
ternal limiting membrane may serve as a barrier for ﬂuid leaving the
retina to be pumped from the subretinal space by the retinal pigment
epithelium (RPE). Fluid can be produced internally within the retina
from metabolism; oxidation of glucose, a preferred substrate of the
retina, generates 6 H2O. Metabolism of fatty acids produces a large
numbers of water molecules. Müller cells are one of the most important
actors in controlling homeostasis of the water and ionic concentrations
in the retinal interstitial areas. The aquaporin tetramers are densely
packed at the Müller cell footplate and on the Müller cell processes
surrounding retinal vessels in the superﬁcial and deep vascular plexus.
When potassium ions are transported, water is induced to move as well
through aquaporin 4 channels (Figs. 44 and 45) (Jin et al., 2011).218
Thus Müller cells can pump ﬂuid to and from the blood supply provided
by the superﬁcial and deep plexus and also the vitreous cavity. Müller
cells have huge amounts of active carbonic anhydrase (Newman and
Reichenbach, 1996; Newman, 1994; Ochrietor et al., 2005), which is
important in regulation of pH, CO2 and bicarbonate management, and
water transport (Ogilvie et al., 2007). Bicarbonate related transport
mechanisms are present in Müller cells (Newman, 1999) and also are
involved in or eﬀect transport of K+ and Na+ ions.
In retinal vascular CME FA demonstrates increased leakage from the
superﬁcial vascular plexus. OCT angiography, particularly combined
volume rendered angiographic and structural OCT, shows cystoid
spaces in diabetic retinopathy and veno-occlusive disease occurs in
regions where there are abnormalities in the inner vascular plexus such
as telangiectasis and microaneurysms and regions where there is de-
creased or absent deep plexus ﬂow (Figs. 46–50) (Spaide, 2015c,
2016b, c). Treatment with resolution of the edema is not associated
with signiﬁcant restoration of ﬂow in the compromised deep plexus and
when edema returns it occurs in the same areas of decreased or absent
deep plexus ﬂow. The vessels of the deep plexus are not simply dis-
placed by the cystoid spaces. There is no evidence of vessels ‘piled-up’
or aggregated around the outer borders of the cystoid spaces, either by
the present OCT angiography or past ﬂuorescein angiographic or his-
topathologic studies. On the contrary, the vessels around the areas of
cystoid spaces often show poor deep vascular plexus ﬂow surrounding
areas of absent ﬂow in OCT angiographic imaging. In larger areas of
lack of perfusion in both the inner and deep vascular layers, there is
generally no edema (Spaide, 2016b).
Increased leakage from the retinal vessels as seen during FA is an
integral feature of retinal vascular CME. Leakage does not necessarily
mean CME, so other factors must be involved. The formation of CME
implies an increase in ﬂuid accumulation within the macula that during
Fig. 46. Varying sized ﬂow voids in the deep vascular plexus in eyes with diabetic ma-
cular edema. (A) The cystoid spaces (in teal) are integrated into the volume rendered
vascular structure. The cystoid spaces are located below the superﬁcial vascular plexus.
(B) The data set was rotated to show the view of the retina from below. The structure of
the cystoid spaces is evident and there is a loss of ﬂow signal from the deep vascular layer
larger in extent than the cystoid spaces. (C) The imaging data from the cystoid spaces was
not shown. The absence of the deep plexus under some areas of the superﬁcial vascular
plexus can be seen. (D) With the dataset rotated so the deep plexus is on top, the group of
larger cystoid spaces is seen to correlate to a region in which the deep plexus ﬂow data is
not apparent. The smaller region of edema has an even smaller ﬂow void (arrow).
Reprinted from Spaide (2016b).
Fig. 47. Volume rendered angiographic and structural optical coherence tomography of
central retinal vein occlusion. (A) View of the retina from the vitreous side; the superﬁcial
plexus is blue, the deep plexus red, and the cystoid spaces are cyan. Note the decreased
vascular density overlying areas of cystoid edema. (B) When viewed from the underside of
the retina the extent of the cystoid spaces is easier to visualize. (C) After an intravitreal
injection of ranibizumab the cystoid edema has temporarily resolved. The vascular ab-
normalities in both the superﬁcial vascular plexus and deep plexus show signiﬁcant ab-
normalities. (D) There are several subtle aspects in the macular regions. Thinning of the
macula allows some of the superﬁcial vessels to be at the same level of the surrounding
deep plexus. These vessels can have segments that are red (open arrowheads). Small
particulate areas of decorrelation (white arrow) likely represent protein or lipoprotein
aggregates. Larger collections are also present (yellow arrow). Note the small and large
particles are not vessels because they are spherical, don't connect to any other structure,
and don't necessarily have sizes corresponding to the surrounding vessels. Modiﬁed from
Spaide (2016b).
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the formation of the edema outpaces the ability of ﬂuid removing
mechanisms to compensate. One mechanism by which ﬂuid is removed
from the retina is the pumping ability of the RPE. There are some
physiologic considerations that mitigate against the role of the RPE in
many cases of retinal vascular CME. The external limiting membrane
limits passage of water in both directions, and so would impede the
ability of the RPE pump to eﬀectively remove water from the mid-re-
tina. The passage of water and solutes is also partially restricted by the
outer plexiform layer, which would form another barrier of sorts be-
tween where the cystoid spaces are most commonly found, the inner
nuclear layer, and the RPE.
In normal circumstances ﬂuid production may originate from the
superﬁcial retinal vascular layer that courses through the interstitial
tissue of the retina to be absorbed through the actions of Müller cells
and the deep capillary plexus (Spaide et al., 2017). Increased leakage
from the superﬁcial vascular layer (Fig. 46) could potentially reach a
level that the ﬂuid removing capabilities would be overwhelmed. The
clinical observation that cystoid spaces occur in regions that have de-
creased or absent deep plexus ﬂow suggests the deep plexus may be
involved in removal of ﬂuid from the retina as potentially mediated by
the deep plexus (Figs. 47–49). If there is absent ﬂow in the deep plexus
the Müller cells couldn't traﬃc excess ﬂuid out of the retina from that
site. This would lead to accumulation of ﬂuid within the retina as
constrained by barriers to hydraulic conductivity. The deep plexus
vascular plexus may also be a source of excess ﬂuid. Leakage from the
deep plexus (Figs. 50 and 51), something that can't be quantiﬁed or
imaged at present, could contribute to the excess ﬂuid in the middle
layers of the retina and would cause ﬂuid loading into the deeper
portions of the retina. This may play a role in the development of serous
detachment. It is also possible leakage from the deep plexus may occur
in acute Irvine-Gass syndrome.
11.5. OCT angiography in non-exudative AMD
Non-neovascular AMD is characterized by abnormalities of the RPE,
Bruch's membrane, outer retina and the choriocapillaris and may be
associated with normal or compromised vision. Early non-neovascular
AMD can either progress to advanced dry AMD (atrophy) or to neo-
vascular disease. OCT angiography has provided us the unique ability to
correlate vascular changes to structural changes and to follow them
longitudinally in vivo. It has also led to the conﬁrmation of the pre-
viously described asymptomatic MNV (Bird et al., 1995; Group, 2008;
Hanutsaha et al., 1998).
11.5.1. Pitfalls to the evaluation of choriocapillaris with OCTA
The evaluation of the choroidal vasculature is of interest in the
study of non-exudative age related macular degeneration. However,
evaluation of structures beneath the RPE on OCT is confounded by
shadowing from the RPE and the structures overlying the chor-
iocapillaris, such as drusen and RPE clumping. Therefore it is very
important to evaluate OCTA images of the choriocapillaris with care to
avoid attenuation artifacts when evaluating for choriocapillaris dropout
(Mullins et al., 2011). OCTA images must always be evaluated with the
corresponding en face OCT structural scans segmented at the same level
as the choriocapillaris. Dark areas on the OCTA may represent areas of
true choriocapillaris loss or may represent areas of shadowing arising
from attenuation of OCT signal (Cole et al., 2017). When there is a low
or noisy OCT signal, accurate OCTA decorrelation signals cannot be
obtained and these regions are threshold masked to remove the invalid
OCTA data. Therefore, in regions with low or noisy OCT signals, the
absence of an OCTA signal does not necessarily represent chor-
iocapillaris loss. When evaluating OCTA with the corresponding struc-
tural en face OCT scan, if there is a dark area on the OCTA and the
corresponding area on the OCT is dark as well, this area represents
signal loss and an attenuation artifact. However, if the area is dark on
OCTA, but the en face OCT shows the presence of signal, the OCTA
measurement is valid and there is with true loss or ﬂow impairment of
the choriocapillaris. Areas of ambiguity, with some, but not all loss of
signal, must be interpreted with extreme caution, since threshold
masking in these areas may give a false impression of vascular atrophy
or ﬂow impairment (Cole et al., 2017). Alternatively, the presence of
low OCT signal but above the threshold level may give an OCTA dec-
orrelation arising from noise, making it appear as if there is ﬂow, when
there is none. Overall, spectral domain OCTA is more prone to at-
tenuation artifacts than the longer wavelength swept source OCT de-
vices, and therefore the choriocapillaris can be more reliably visualized
on swept source OCTA than on spectral domain OCTA (Bloom and
Singal, 2011; Choi et al., 2013a; Lane et al., 2016; McLeod et al., 2002;
Pepple and Mruthyunjaya, 2011).
11.5.2. Non-neovascular AMD
Drusen are the hallmark of age related macular degeneration and
appear clinically as yellow-white excrescences deep to the retina
varying in size, number and location. In OCT images, drusen appear as
discrete excrescences overlying the inner collagenous layer of Bruch's
membrane and with the RPE draped over them. Histopathologic studies
by Mullins and group have shown that there is a trend to decreasing
choriocapillaris density with increasing AMD severity (Biesemeier
et al., 2014; McLeod et al., 2002; Mullins et al., 2011). Structural OCT
can be used to evaluate the volume of drusen, thereby quantifying
drusen burden, as well as the integrity of the RPE and the outer retinal
layers overlying the drusen. OCT angiography shows loss of chor-
iocapillaris associated with some but not all drusen (Sarks et al., 1999;
Zweifel et al., 2010) (Fig. 52). Another interesting feature to note is that
Fig. 48. The patient had a recurrence of edema visible from the top (A) and bottom (B) of
the retina. Note the similarity in the distribution of cystoid spaces to that seen in Fig. 47.
Note the particulate dots of decorrelation that are not attached to any vascular structure.
Reprinted from Spaide (2016b).
Fig. 49. Volume rendered angiographic and structural optical coherence tomography of
an eye with a branch retinal vein occlusion. (A) The superﬁcial vascular plexus is shown
in blue, the deep in red. The cystoid spaces were derived from the matched structural
optical coherence tomography scan and are shown in cyan. Some of the deep vascular
plexus is seen above the cystoid spaces (open arrows). (B) The cystoid spaces are easier to
visualize when the imaged is ﬂipped about the vertical axis. Note the extent and dis-
tribution of the cystoid spaces.
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the highly reﬂective RPE overlying drusen can cause the appearance of
intense projection artifacts from the overlying retinal vessels. These
may make it appear as if there is neovascularization in association with
the drusen when there is none.
At some point along the progression of non-neovascular AMD down
the pathway of atrophy, OCT imaging can show thinning of RPE with
increased light penetration or hyper-transmission below the level of the
RPE into the underlying choroid and sclera (Schaal et al., 2017; Wu
et al., 2014, 2015) (Fig. 53). This can start over a large druse, prior to
the loss of substance of the druse. The color photographic diagnosis of
geographic atrophy (GA), is made when there is a sharply deﬁned area
of decreased pigmentation allowing improved visualization of the un-
derlying choroidal vessels (Fig. 54). The OCT ﬁndings of RPE thinning
and hyper-transmission appear to be a preceding ﬁnding that is a point
of no return along the pathway of RPE loss, but doesn't meet the color
photographic diagnosis of GA since the underlying choroidal vessels
may not be visible. There may be a loss of the outer nuclear layer over
the thinning creating a wedge-shaped depression of the outer retina.
This has been called nascent GA. On using variable interscan time
Fig. 50. Fluid is potentially removed from the retina by action of the Müller cells and the
deep vascular plexus. There is no functional mechanism to clear excess ﬂuid through the
deep plexus if that layer has no ﬂow. Reprinted from Spaide (2016b).
Fig. 51. Without a mechanism to evacuate excess ﬂuid, cystoid spaces are created.
Reprinted from Spaide (2016b).
Fig. 52. Choriocapillaris loss under drusen. A1 is the intensity B scan image and A2 is a
magniﬁed view of the druse in A1 showing good penetration of light under the druse (i.e.
no shadowing). B1 is the angiographic image and B2 is a magniﬁed angiographic image.
Note the loss of choriocapillaris ﬂow on the OCTA image noted under the druse (yellow
arrow).
Fig. 53. A. structural OCT B-scan. The black arrow shows choroidal Haller layer vessel
not penetrated by the light. White arrows show choroidal Haller layer vessel penetrated
by the light. Dotted line shows the separation between the area with and without RPE.
Asterisk shows the eﬀect of the projection artifact of the choriocapillaris B: OCTA B-scan.
Stars identify area without choriocapillaris. C: OCTA en face image of the same region
sampled at the level of the Haller layer as shown by the red lines.
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analysis (VISTA), these ﬂow alterations mostly represent slowing of
ﬂow (Fig. 55).
OCTA has also recently demonstrated the presence of type 1 MNV in
asymptomatic eyes that would otherwise be classiﬁed as intermediate
AMD. This may occur in up to 30% of all patients with intermediate
AMD per a small published case series (Carnevali et al., 2016). This
ﬁnding supports a larger study done nearly 20 years previously in
which approximately one-quarter of eyes harboring drusen alone of
patients with fellow eyes having exudative AMD had ICGA evidence of
asymptomatic MNV. This study by Hanutsaha has shown that pro-
gression to frank exudative disease is much higher in this group than it
is in patients without neovascular plaques (Hanutsaha et al., 1998). The
designation intermediate AMD is a holdover from earlier times when
eyes were graded with color photography alone. Multimodal imaging
provides more accurate ability to evaluate eyes, and the use of non-
neovascular AMD to describe eyes with neovascularization is not ap-
propriate.
The evolution of atrophy in eyes with AMD occurs with a ﬁnal de-
cline in visual function. Loss of the outer retinal structure, including the
outer retinal bands and much of the thickness of the outer nuclear layer
creates a condition known as outer retinal atrophy. This often occurs
following the regression of subretinal drusenoid deposits, also known as
pseudodrusen, and prior to the development of any RPE loss (Spaide,
2013). Once loss of the RPE occurs, and there is a complete loss of the
RPE and outer retina, which has been called CRORA (Sadda et al.,
2017b; Spaide, 2017c). Imaging of CRORA can be done with a variety
of modalities, that show somewhat diﬀering results; the color photo-
graphy of CRORA yields what is termed GA. Histopathologic studies
have shown RPE cell loss as well as choriocapillaris atrophy underlying
the areas of geographic atrophy (Lutty et al., 1999; McLeod et al.,
2002). Lipofuscin accumulates in RPE cells over life and can be used as
a measure of the presence of RPE cells. However the retina often shows
areas of atrophy that are larger than the corresponding size of the RPE
loss (Bird et al., 2014). In addition, OCTA imaging shows chor-
iocapillaris ﬂow abnormalities as evidenced by areas of slower ﬂow and
measurable alterations in the distribution of signal void sizes.
Several concurrent changes occur with the development of CRORA:
there is loss of the RPE and its contained melanosomes and liposomes,
the choriocapillaris is lost, the middle portions of the choroid re-
sponsible for providing blood ﬂow also regress causing the deeper,
larger choroidal vessels to come to lie in the inner choroid. These
vessels can be seen spanning the area underlying the GA (Choi et al.,
2015; Ferrara et al., 2014; Sarks et al., 1988; Schuman et al., 2009;
Sohrab et al., 2012). These deeper vessels supply and drain blood from
other areas of the choroid, which are not necessarily involved with
atrophy. In areas of CRORA these larger vessels are readily seen to have
ﬂow, and the course of the larger vessels can be followed under the
adjacent intact RPE where they appear dark. Thus the ability to see ﬂow
in the larger choroidal vessels is inﬂuenced by the optical eﬀects of the
RPE, choriocapillaris and potentially the middle sections of the chor-
oidal thickness. This implies light scattering, rather than just fringe
wash-out is the main reason why ﬂow usually cannot be seen in the
deep choroid with OCTA.
The site of where the initial insult in the development of atrophy is
seen depends, in part, on the imaging modality used. There is a general
loss of choriocapillaris ﬂow associated with drusen and subretinal
drusenoid deposits in histologic examination. This is supported by
OCTA examination. Hyper-transmission through the RPE seems to
occur over larger drusen implying a physical separation of the RPE from
the choriocapillaris may also play a role. The rate oxygen delivery from
the choriocapillaris has been shown to decrease with increasing dis-
tance from the choriocapillaris (Linsenmeier and Padnick–Silver,
2000). The RPE secretes factors, such as VEGF that help maintain the
vitality of the choriocapillaris. It is possible that a large deposit of
Fig. 54. Choriocapillaris loss under geographic atrophy. This ﬁgure shows a color fundus photo (A) and a fundus autoﬂuorescence image (B) of a patient with geographic atrophy (GA).
The area of GA is outlined. Image C is an OCTA of the choriocapillaris slab underlying the area of GA outlined in yellow. Loss of choriocapillaris can be seen, and the larger choroidal
vessels are seen occupying the space that would ordinarily be occupied by the choriocapillaris. Also note that there appears to be some CC thinning in some of the areas surrounding the
area of atrophy.
Fig. 55. Semi-quantitative OCT angiography using variable interscan time analysis in a
patient with geographic atrophy. Red represents fast ﬂow and blue represents slow ﬂow.
Note that there is both choriocapillaris loss and slowing of ﬂow underlying the area of
geographic atrophy. Surrounding the area of atrophy, some areas have vessels with
slower ﬂow (between arrows) while other areas do not have slowing of ﬂow.
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lipoproteinaceous material, a druse, could impede the diﬀusion of re-
leased VEGF. OCT has shown ﬁndings of nascent GA can precede RPE
atrophy, as does outer retinal atrophy; a recent OCTA study revealed an
association between regions of nascent GA and choriocapillaris altera-
tion (Moult et al., 2016). Using a reductivist approach may help sim-
plify the search for the cause of atrophy if only one exists, but a systems
approach would suggest there may be more than one pathway that
leads to a phenotypically similar outcome.
11.6. Exudative age related macular degeneration
Perhaps the most immediate clinical applicability of OCTA in the
diagnosis and management of disease is in neovascular age related
macular degeneration. Neovascular AMD is characterized by new vessel
growth, either underneath the RPE (Type 1 MNV), or between the RPE
and the retina (Type 2 MNV) or starting within the retina (Type 3 MNV)
(Freund et al., 2010). Note Type 3 neovascularization may not have a
choroidal component. Therefore it is not accurate to call it CNV, but
rather it is more precise to call it macular neovascularization or MNV.
In other conditions such as pathologic myopia pseudoxanthoma elas-
ticum (RXE) or multifocal choroiditis and panuveitis, Type 3 neo-
vascularization does not occur, so the term CNV is also appropriate.
Several studies have shown the utility of OCTA in the diagnosis and
monitoring of the various kinds of MNV (Carnevali et al., 2016; Inoue
et al., 2016; Jia et al., 2014; Kuehlewein et al., 2015b; Moult et al.,
2014; Souied et al., 2016; Spaide, 2015a).
11.6.1. Diagnosis of macular neovascular disease
OCTA is useful in the diagnosis of the various forms of MNV, and
even more so since the angiographic image on OCTA comes co-regis-
tered with a structural OCT. Since structural OCT has been used to
describe the OCT based classiﬁcation system of MNV, this direct cor-
relation between the structural and angiographic image aids in the di-
agnosis and classiﬁcation of the MNV in a more direct manner than FA
which tried to correlate leakage characteristics to structural char-
acteristics (Coscas et al., 2015). Type 1 MNV can be visualized as a
network of vessels lying between the RPE and the Bruch's membrane,
often in the setting of a ﬁbrovascular pigment epithelial detachment
(PED) visualized on the OCT (Inoue et al., 2016). Fluid clefts within the
PED suggest the presence of active MNV, and there may also be sub-
retinal ﬂuid seen. Type 2 MNV, on the other hand, is seen as a network
of vessels in the normally avascular outer retina (Souied et al., 2016)
(Fig. 56). This may be associated with subretinal and intraretinal ﬂuid
as well as the presence of subretinal hyper-reﬂective material on the
structural OCT scans. While feeder vessels were occasionally seen in
type 1 and type 2 MNV on video indocyanine green angiography, type 1
and 2 MNV often show one or more trunk vessels on OCTA imaging,
consistent with known histology (Green and Enger, 1993).
The trunk vessels are generally large in diameter and branch to form
vessels within the lesions. These vessels show limited branching and
prominent anastomotic connections between the larger-diameter ves-
sels including peripheral anastomosis at the edges of the lesions (Gong
et al., 2016; Kuehlewein et al., 2015a; Spaide, 2015a). There are ﬁne
ﬁbrillary vessels arising from these larger blood vessels both within the
substance of the lesion as well as at its margins. Also, as had been
previously described histopathologically, there may be drop out of the
choriocapillaris surrounding areas of MNV (Bhutto and Lutty, 2012).
Loss of the RPE and underlying choriocapillaris can occur in areas of
chronic subretinal ﬂuid from exudation. However, decreases in chor-
iocapillaris ﬂow are detectable by OCTA in eyes with MNV and in their
Fig. 56. En face OCTA (A) and B scan with ﬂow overlay (B) of a patient with type 1
macular neovascularization (MNV). The B scan shows a pigment epithelial detachment
with ﬂow noted within the pigment epithelial detachment (white arrows).
Fig. 57. A type 3 (A1-A3) and mixed type 1 and 2 (B1-B3) MNV is seen. A1 is a ﬂuor-
escein angiogram showing the type 3 lesion. On OCTA, the feeder vessel (A2) that extends
from the retina through the break in the RPE (arrowhead A3) and into the pigment
epithelial detachment is seen. B1-B3 demonstrate a mixed type 1 and 2 MNV with a type 1
component seen on choriocapillaris segmentation (B2) and a type 1 component seen on
outer retinal segmentation. Note the trunk vessel centrally and the arborizing network of
vessels around it.
R.F. Spaide et al. Progress in Retinal and Eye Research 64 (2018) 1–55
37
fellow eyes uninvolved with MNV. It has been postulated that the hy-
poxic environment created by the choriocapillaris loss may induce re-
lease of VEGF by the intact overlying retinal pigment epithelial cells,
which may, in turn, give rise to the MNV (Bhutto and Lutty, 2012). The
growth of neovascularization in these eyes may recapitulate the func-
tions of the impaired choriocapillaris. These areas of choriocapillaris
loss surrounding MNV, similar to the ones reported on histopathologic
studies, have also been reported using OCTA (Moult et al., 2014).
Type 3 MNV, on the other hand, (previously known as retinal an-
giomatous proliferation and previous to that deep retinal anomalous
complexes) generally arises from the retina, and on OCTA can be vi-
sualized as a discrete high ﬂow linear structure extending from the
middle retinal layers into the deep retina and occasionally also past the
RPE (Fig. 57). This vascular structure may be associated with a pigment
epithelial detachment, hyper-reﬂective foci in the outer retina as well as
intraretinal hemorrhages and cystic changes. As the type 3 MNV de-
velops, it can be seen as branching vessels that anastomose with the
deep retinal capillary plexus, extends into the outer retina and even-
tually into the sub-RPE space (Kuehlewein et al., 2015b).
One of the big challenges of diagnosing MNV on OCTA is elim-
inating artifacts that may mimic MNV. These include projection arti-
facts from the more superﬁcial retinal vasculature that may give the
appearance of MNV where there is none (Bhutto and Lutty, 2012).
Additionally, and especially in type 3 MNV, bright projection artifacts
from overlying retinal vessels on the highly reﬂective PED may some-
times make it appear as if there is MNV where there is none (Falavarjani
et al., 2017a; Zhang et al., 2015a). Moreover, in patients with areas of
macular atrophy and corresponding choriocapillaris atrophy, the dis-
placement of the larger choroidal vessels into the space ordinarily oc-
cupied by the choriocapillaris may cause the appearance of MNV. A
careful mapping of the vessels to the structural layers in which they ﬁrst
start appearing can avoid this misinterpretation. In OCTA of MNV as in
real estate, location is key. Careful mapping of the superﬁcial vessels
and comparing these vascular patterns to those seen in the presumed
MNV can avoid misinterpreting projection artifacts from these over-
lying vessels as MNV. The projection artifact tools on the commercial
machines, although imperfect, can often remove many of these arti-
facts. Finally, in the case of larger choroidal vessels beneath areas of
atrophy, the location of these vessels beneath (and not above) the
Bruch's membrane helps diﬀerentiate them from MNV.
Studies have looked at the sensitivity and speciﬁcity of OCTA in
identifying MNV (de Carlo et al., 2015a; Gong et al., 2016). Looking at
all types of MNV, initial studies demonstrated a sensitivity of ∼50%
and a speciﬁcity above 80% (de Carlo et al., 2015a). This, however,
included cases that had large amounts of subretinal hemorrhage. Pre-
sence of hemorrhage blocks penetration of OCT signal and therefore
visualization of MNV, causing a false negative result on OCTA. In a
small study, Bonini et al. showed a much higher sensitivity (ap-
proaching 100%) in patients with type 1 MNV, and more recently, the
larger COFT 1 study demonstrated a similarly high sensitivity for de-
tection of type 1 MNV (66.7%) (Bonini Filho et al., 2015b; Inoue et al.,
Fig. 58. This shows the acute response of MNV 1 month following an injection of anti-
VEGF agents. A1, B1 and C1 represent pre-injection MNV while A2-C2 represent the
corresponding MNVs one month post injection of anti-VEGF agents. The overall size of the
MNV shrinks, best noted in A2. The density of the vasculature within the MNV is seen to
decrease as are the ﬁner vessels that occupy the margins of the MNV (B2 and C2).
Meanwhile, the larger vessels may become larger and occupy more of the lesion. Also
note the choriocapillaris loss surrounding the MNV.
Fig. 59. Artefactual appearance of MNV as a result of atrophy. A loss of the chor-
iocapillaris as a result of atrophy (demarcate by the arrows in B) and the resultant su-
perﬁcial migration of the larger choroidal vessels into the area normally occupied by the
choriocapillaris gives the appearance of an MNV (A) when segmentation is performed at
the choriocapillaris level (red line).
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2016). This was increased to over 87% when structural OCT data was
used in conjunction with the OCTA data.
11.6.2. Discrimination between active and inactive MNV
There is much eﬀort being put into whether OCTA can be used to
discriminate between active and inactive MNV (Liang et al., 2016). One
major diﬃculty is that there is no accepted deﬁnition of what active
MNV is. Some authors have concluded that features on OCTA such as
the presence of ﬁne vessels at the MNV edge and a peri-lesional dark
halo may indicate activity while the presence of many large ‘dead tree’
like vessels and a paucity of ﬁne branching vessels may indicate
quiescence (Coscas et al., 2015). However, a paucivascular ﬁbrotic scar
would appear to have low vascularity, but these lesions also are asso-
ciated with poor acuity. Lesions with extensive vascularity, although
potentially associated with signs of ﬂuid exudation, often have good
acuity. MNV is living tissue produced at the behest of living tissue, and
its eradication may obviate the goal of recapitulating the chor-
iocapillaris. Of course, not every aspect of MNV is desirable, but the
future of MNV treatment in AMD may be management and selection of
desirable aspects as compared with eradication of the whole lesion
(Spaide, 2017b).
Care should be taken in evaluating OCTA images for MNV to avoid
mistaking areas of atrophy for neovascularization (Fig. 58). As a rule of
thumb the en face images should be evaluated in the context of the B-
scan images from which it was derived to assure the intended layer is
imaged. Projection artifacts from the retina to retinal elevations such as
serous pigment epithelial detachments, drusen, drusenoid pigment
epithelial detachments, and pigmented scars, to name a few, can su-
perﬁcially appear like neovascularization.
11.6.3. Follow-up of MNV with treatment
Because OCTA allows for the quantitative and qualitative evaluation
Fig. 60. Variable interscan time analysis for blood ﬂow speed shows high speeds of ﬂow
approximating that of the larger retinal vessels in the larger trunk vessels of the MNV
(seen in red) and slower ﬂow speeds (yellow and blue) in the smaller vessels and in the
marginal vessels of the MNV.
Fig. 61. Multimodal imaging of a patients with myopic
choroidal neovascularization. MultiColor imaging of a pa-
tient with pathologic myopia shows white areas of focal
chorioretinal atrophy (A). Blue light fundus AF shows a
hypoautoﬂuorescent area (B). Early phase of indocyanine
green angiography (ICGA) (C) and FA (FA) (E) reveal an
hyperﬂuorescence area that become more intense with
moderate leakage in the late phase (D and F, respectively),
as type II classic active choroidal neovascularization. En
face OCT angiography section (G) just below retinal pig-
ment epithelium (H) shows type II neovascular network
with well circumscribed appearance.
Fig. 62. Multimodal imaging of a patient with angioid streak complicated by choroidal
neovascularization. ICGA (A) and FA (B) reveal the light hyperﬂuorescence corresponding
to the angioid streak as the results of the rupture of Bruch's membrane and the hyper-
ﬂuorescence of the choroidal neovascularization. Infrared reﬂectance (C) displays the
angioid streaks as linear hyporeﬂective area starting from optic nerve head. Optical co-
herence tomography angiography (D) shows macular neovascularization with a network
that closely followed the trajectory of angioid streak.
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of MNV, it is a powerful tool for the monitoring and follow-up of MNV
(Fig. 59). After injection with anti-VEGF agents, MNV has been shown
to both decrease in size as well as to lose some of the ﬁner, ﬁbrillary
vessels at the edges and within the substance of the MNV (Lumbroso
et al., 2015; Marques et al., 2016). In a series of patients serially fol-
lowed up with OCTA, Rispoli, Lumbroso and group have shown that the
MNV shows maximal regression at about 1–2 weeks post treatment and
starts increasing in size thereafter, while ﬂuid accumulation lags behind
lesion growth (Lumbroso et al., 2016). Thus OCTA can be used to
monitor treatment response to MNV. It is also intriguing to wonder
whether the regression-recurrence patterns seen on OCTA could point
to the higher eﬃcacy of a lower dose, more frequent dosage regimen as
has been seen in various cancers.
11.6.4. Long term follow-up and future directions
OCTA has enabled us to understand longitudinally the morphologic
changes that occur in MNV. In a study about MNV, Spaide et al. pro-
posed, based on OCTA ﬁndings, the vascular ‘abnormalization’ occurs
as a response to recurrent periodic anti-VEGF therapy (Spaide, 2015a).
It is hypothesized that this abnormalization is a result of the periodic
pruning of smaller vessels in response to recurrent anti-VEGF therapy as
shown in numerous short term follow-up OCTA studies of MNV. Vessels
with pericyte coverage remain and are still faced with the forces of
arteriogenesis, which is VEGF independent. Over time, this pruning, in
the face of unimpeded arteriogenesis, allows for the persistence of large
vessels with high ﬂow. The vessels have few branch points and many
vascular anastomotic connections among larger vessels (Bellou et al.,
2013). The hydrostatic pressure in the shunt vessels is higher than what
would be expected in a normal network showing fractal branching
patterns and as a consequence any proliferating capillary would be
exposed to comparatively high hydrostatic pressure. This may be one of
the reasons that periodic recurrent therapy is needed with anti-VEGF
agents. It is possible that the larger vessels may eventually be the tar-
gets of newer drugs. This is borne by quantitative OCTA ﬂow studies
that show high ﬂow in the trunk vessels approaching that of retinal
vessels, and that show persistence of high ﬂow in these trunk vessels
even in the face of therapy with anti-VEGF agents (Moult et al., 2016).
The current iterations of OCTA instruments show a limited dynamic
range for ﬂow velocity, with the output saturating at low ﬂow rates.
Being able to quantify ﬂow rates may be helpful in more accurately
identifying MNV and its response to treatment. (Fig. 60).
11.7. Optical coherence tomography angiography in myopic MNV
High myopia is a major cause of vision impairment and its pre-
valence has rapidly increased in the past 50 years (Morgan et al., 2012).
In eyes with high axial length the progressive posterior segment elon-
gation and deformation may lead to the development of several lesions,
including myopic choroidal neovascularization (MCNV), lacquer
cracks, macular retinoschisis, chorioretinal atrophy and posterior sta-
phyloma (Flores-Moreno et al., 2013; Morgan et al., 2012; Ohno-Matsui
et al., 2011). These degenerative changes in the sclera, retina and
choroid are considered the hallmarks to deﬁne high myopia as patho-
logic myopia (Avila et al., 1984). MCNV has a poor prognosis in the
preservation of central vision and can be diagnosed using several
imaging techniques.
The current standard to diagnose and evaluate MCNV is to use of FA
associated with SD OCT (Leveziel et al., 2013; Neelam et al., 2012). SD
OCT revealed MCNV as hyper-reﬂective material above the RPE, with
or without the presence of sub-retinal ﬂuid and intraretinal cysts. On
FA, active MCNV appears as well deﬁned hyperﬂuorescent lesion with
typical leakage in the late phase of the examination as classic or type 2
MNV pattern. However, FA is invasive and results in varying degrees of
patient discomfort, including nausea, vomiting and anaphylactic reac-
tions. ICGA is another imaging technique which provides valuable de-
tails of choroidal vasculature in highly myopic eyes because of its
longer wavelength ﬂuorescence with limited diﬀusion within the
choriocapillaries compared to FA (Ohno-Matsui et al., 1998; Quaranta
et al., 1996).
While ICGA image collects all the ﬂuorescence coming from the
entire retina, OCTA shows only the layer sampled. Vessels not perfused
are not visible in OCTA but are seen in the structural OCT and are
indirectly visible in ICGA as masking tissue over the normal choroidal
vasculature. OCTA shows MCNV as a loose lacy group of ﬁlamentous
vessels and few large branches or a tortuous capillary network with
many hyperdense vascular ramiﬁcations above RPE (Fig. 61). To obtain
the best view of the vascular network, the slab segmentation should be
manually just above the RPE band. Pathologic myopia is often char-
acterized by posterior macular staphyloma, irregular surface, RPE
atrophy, choroidal thinning and consequently highest scleral
Fig. 63. Vascular occlusion in retinal vasculitis with subsequent retinal neovasculariza-
tion. (A) The most salient feature of the ﬂuorescein angiogram is the area of intense
hyperﬂuorescence from retinal neovascularization (arrow). Temporal and inferior to this
are areas seemingly devoid of smaller branch vessels. (B) The OCT angiogram at the level
of the retina shows blunted branch vessels and regions of non-perfusion (asterisk). (C)
More pronounced pruning is evident with multiple areas of non-perfusion (asterisks). (D)
OCT angiography set above the level of the retina shows the retinal neovascularization.
Fig. 64. A 49-year-old HLA-B27 + woman with ankylosing spondylitis. (A) There is
subtle sheathing of the vein in the superotemporal arcade (yellow arrowheads), and areas
of focal caliber changes (highlighted by white arrowhead). (B) FA shows perivascular
leakage and staining extending variable distances from this vein as well as other vessels.
The fellow eye showed widespread leakage and staining around larger vessels as well.
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reﬂectivity which are the causes of diﬃcult automatic segmentation. To
overcome errors in segmentation creating poor en face images, manual
B-scan segmentation should be used.
One further typical ﬁnding in pathologic myopia is the presence of
patchy chorioretinal atrophy at the posterior pole. In areas of patchy
atrophy OCTA ﬂow can be seen in the underlying larger choroidal
vessels, in contrast to the adjacent areas having RPE and chor-
iocapillaris coverage where both SD and SS-OCT based methods have
diﬃculty in demonstrating ﬂow. Projection artifacts may also limit the
accuracy of diﬀerentiating between neovascularization and atrophy.
With some instruments it is possible to use the scroll wheel on the
mouse to move the segmentation up and down to help diﬀerentiate
atrophy from neovascularization. OCTA in evaluating myopic eyes is
not a standalone imaging test. It is part of a larger multimodal imaging
approach that can better characterize MCNV and help the treatment
decision.
Fig. 65. Optical coherence tomography (OCT) ﬁndings of
perivascular inﬁltration before and after treatment. Along
each row of images, the left panel shows an infrared scan-
ning laser ophthalmoscopic image showing the scan loca-
tion, the middle panel shows the entire OCT scan, and the
right panel shows a highlighted area as demarcated by the
white rectangle in the middle panel. (A) Horizontal OCT
section through an involved segment of the superotemporal
arcade vein. There is an annular zone of increased peri-
vascular reﬂectivity (arrowheads) around a vein (arrow).
Adjacent to this is a region of loss of the laminations of the
retina (double arrow). Contained within this region is a
zone of increased reﬂectivity of the inner nuclear layer. It is
possible this could be called paracentral acute middle ma-
culopathy, but this term ignores the associated changes in
other layers of the retina and the area imaged is not within
the anatomic macula. (B) A scan perpendicular to that
shown in (A) shows the variable thickening of the retina in
the region of loss of laminations. Note the focal area of
thinning (blue arrow). The choroid shows increased re-
ﬂectivity and a loss of visible structure. (C) One week after
intravitreal triamcinolone the retina shows thinning in the
region of the double arrow. The perivascular reﬂectivity is
thinner (arrowheads) around the retinal vein (arrow). (D)
An OCT scan taken perpendicular to (C) shows the thinning
as compared with (B). Note the decrease in the choroidal
reﬂectivity with enhanced visualization of choroidal details
(open arrowhead). Reprinted from Spaide (2017c).
Fig. 66. OCT angiograms of aﬀected area in the patient shown in Fig. 64 and 65. (A) The
green line corresponds to the OCT sections shown in Fig. 65. Note the poor perfusion,
particularly to the right side of the vein. (B) One week after intravitreal triamcinolone the
perfusion showed no signiﬁcant change. Reprinted from Spaide (2017c).
Fig. 67. One month after intravitreal triamcinolone. (A)
Left panel shows the location of the scan, which is the same
as Fig. 65 B and D. The right panel shows continued retinal
thinning. (B) Enlarged depiction of the area enclosed by the
rectangle in (B). (C) A heat map of the change in retinal
thickness from prior to intravitreal triamcinolone. The area
of retinal thinning as shown by the heat map is similar to
the region of ﬂuorescein leakage and staining seen in
Fig. 64 B. Reprinted from Spaide (2017c).
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11.8. OCT angiography in angioid streaks
Angioid streaks (AS) are more commonly found such in patients
with pseudoxanthoma elasticum, Ehler-Danlos syndrome, Paget's dis-
ease of bone, sickle cell disease, and thalassemia; in some cases angioid
streaks are thought to be idiopathic (Aessopos et al., 1994; Dabbs and
Skjodt, 1990; Gliem et al., 2013a; Green et al., 1966).279−282 Of these
pseudoxanthoma elasticum is probably the most common and its as-
sociated ocular ﬁndings classically include AS, optic nerve drusen, peau
d'orange, areas of subretinal ﬂuid prior to the development of MNV, a
pattern dystrophy appearance with eventual RPE atrophy, and ﬁnally
CNV (Yang et al., 2003b).
Angioid streaks (AS) are angular branching breaks in Bruch's
membrane rendered brittle because of abnormal thickening and calci-
ﬁcation. AS appear as irregular reddish or brownish lines of varying
width with jagged borders (Gliem et al., 2013a). The cracks in Bruch's
membrane occur in regions where there appears to be conﬂuent calci-
ﬁcation as opposed to spotty calciﬁcation of Bruch's membrane, which
creates the appearance of peau d’ orange (Spaide, 2015b). The rupture
of Bruch's membrane causes associated breaks in the overlying RPE
monolayer. If the AS passes directly under the fovea, a patient may
develop decreased or distorted vision. A major cause of visual impair-
ment in these patients is the development of CNV, typically Type 2,
leading to retinal hemorrhage, edema, and a ﬁbrotic scar with perma-
nent corresponding visual loss (Gliem et al., 2013b). Patients with
pseudoxanthoma elasticum with AS may also develop areas of RPE loss
around the streaks.
Because of the concurrent abnormalities, imaging modalities such as
FA, ICGA and structural OCT produce ambiguous images that preclude
making a diagnosis of early CNV with certainty. Since the eyes have a
pattern dystrophy including both hyperpigmentation and RPE loss in
conjunction with AS, the FA may show widespread abnormalities in the
posterior pole that can obscure the presence of early coexistent CNV.
With ICGA there are also confounding factors such as the intrinsic hy-
perﬂuorescence of streaks which is sometimes present and the diﬀuse
irregularities that reduce contrast between the lesion and the sur-
rounding choroid. Structural OCT shows undulation of the posterior
pole, large ruptures of rupture of Bruch's membrane, vitelliform accu-
mulations, shifting areas of subretinal ﬂuid without the presence of
MNV, and regions of thickening at the level of the RPE associated with
the pattern dystrophy.
OCTA, due to its ability to produce high contrast retinal and chor-
oidal vascular network images, can show the CNV in eyes with AS (Gal-
Or et al., 2015) (Fig. 62). The spatial relationship between Bruch's
membrane and CNV can be precisely studied using OCTA where seems
to be a close relationship between the morphology of Bruch's membrane
defects and the topographic pattern of MNV. Deeper than Bruch's
membrane is the choriocapillaris, which shows profound abnormalities
even prior to observable atrophy or CNV (Spaide, 2017a).
11.9. Optical coherence tomography angiography of ocular inﬂammatory
disease
OCTA is a useful imaging tool in chorioretinal inﬂammatory dis-
eases. While there are many potential applications, currently two have
the greatest clinical utility. First is the ability to examine the retinal
circulation for signs of compromise. Examination of the retinal vascu-
lature traditionally has been done with FA by which inﬂammatory
Fig. 68. Comparison of presumed inﬂammatory versus neovascular lesions in multifocal
choroiditis and panuveitis. The left column of images shows a conical inﬁltration of
material that is relatively homogenous and has no demonstrable ﬂow. The lesions in the
right column show greater heterogeneity, structure, and contain ﬂow signal.
Fig. 69. Multifocal choroiditis with chorioretinal scars in a
patient previously treated with intravitreal anti-VEGF in-
jections. (A) The patient has 2 visible chorioretinal scars
and myopic disc changes. (B) The ﬂuorescein shows late
staining around the lesion in the fovea. (C) OCT angio-
graphy shows a vessel complex most prominently seen at
the superior border of the lesion. (D) B-scan with ﬂow
overlay shows a tumefaction containing discrete areas of
ﬂow signal, consistent with persistent choroidal neovascu-
larization.
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damage of and ﬂuorescein leakage from the higher order retinal arteries
and veins are readily visible. However ﬂuorescein leakage obscures
imaging of smaller vessels such as the capillaries and the deeper vas-
cular plexus is not visible in FA even in normal eyes (Spaide et al.,
2015b). OCT angiography can't detect leakage, which is a weakness in a
sense, but also is a strength in that imaging of the retinal micro-
vasculature is not impeded by leakage. In addition, OCT angiography
can image the deep vascular plexus. The second main use of OCT an-
giography is to evaluate patients for secondary CNV.
11.9.1. Vascular damage associated with uveitis
By its nature, intraocular inﬂammation requires recruitment of
various components of the immune system to form an attack against a
perceived abnormality. In infection the body's produces a coordinated
and orchestrated attack against a foreign invader. Inﬂammation ap-
pears as an undesirable manifestation in non-infectious uveitis, in that
situation the body mounts an attack against some component in the
eye. Inﬂammatory inﬁltrates around vessels, vasculitis, may occur in
association with a systemic vasculitis (Androudi et al., 2013) or occur as
an isolated ocular event, which in turn may be related to infectious or
non-infectious causes (El-Asrar et al., 2009; Perez et al., 2004;
Rosenbaum et al., 2012; Talat et al., 2014; Walton and Ashmore, 2003).
Inﬂammation that primarily involves the retinal arterioles is associated
with conditions such as giant cell arteritis, polyarteritis nodosa, gran-
ulomatosis with polyangiitis (Wegener's granulomatosis), and systemic
lupus erythematosus. The retinal veins are principally aﬀected by
clinically evident inﬂammation in association with sarcoidosis, multiple
sclerosis, tuberculosis, and intermediate uveitis (Arnold et al., 1984;
Engell and Andersen, 1982; Green et al., 2010; Hsu et al., 2001; Iida
et al., 2002). As in systemic vasculitides, inﬂammation of retinal vessels
can be associated with vascular occlusion (Fig. 63). Inﬂammation af-
fecting the arterioles, for example, may be associated with arterial oc-
clusion while retinal phlebitis may lead to veno-occlusive disease. OCT
angiography can demonstrate larger vascular occlusions as well as
retinal neovascularization that can grow in response to consequent
ischemia.
Occlusion of arteries or veins axiomatically would have secondary
eﬀects on associated capillaries. A group of patients with clinically
evident inﬂammatory changes involving large vessels, but no frank
occlusion of any higher order vessels, were found to develop the OCT
appearance in the inner and middle layers of the retina, simulating that
seen in retinal ischemia, which then was followed by retinal thinning of
the same layers (Spaide, 2017d). These patients had no evidence by
ﬂuorescein or OCT angiography of larger vessel occlusion. Indeed the
main circulatory anomaly they appeared to have were widespread ca-
pillary perfusion abnormalities in both the superﬁcial plexus and deep
vascular plexus, but not the usual stigmata of cotton-wool spots or
deeper areas of ischemic retinal whitening. Given the diagnosis of ret-
inal vasculitis was made because of perivascular inﬂammatory in-
ﬁltration accompanied by ﬂuorescein leakage and staining, capillary
problems distant to the larger retinal vessels implies potential for ret-
inal damage in excess of what would be intuitive to expect on the basis
of ophthalmoscopy (Figs. 64–67).
Inﬂammatory attack of vessels can occur through a variety of me-
chanisms. Infection causes vasculitis by the traﬃcking of immune cells
to sites of infection or direct attack of the infectious organism on blood
vessels. Common modes include Type I, II, II, and IV hypersensitivity
reactions with or without subsequent intravascular thrombosis. The
retina seems susceptible to damage by another mechanism, capillary
leukostasis. Release of inﬂammatory mediators such as tumor necrosis
factor alpha (TNFα), interleukin (IL) 1β, and IL-4 among many others
lead to expression of various cell markers such as E- and P- selectin,
vascular cell adhesion molecule (VCAM) -1, leukocyte adhesion pro-
teins chemokine (C-X3-C motif) ligand 1 (CX3CL1), and intercellular
adhesion molecule (ICAM), which bind to leukocyte cell receptors
(Fong et al., 1998; Kim et al., 2001; Krieglstein and Granger, 2001;
Lipowsky and Chien, 1989; Simon and Goldsmith, 2002; Steeber et al.,
1999; Tailor and Granger, 2000; Von Andrian and Arfors, 1992;
Zarbock and Ley, 2009). As part of the inﬂammatory cascade, binding
of leukocytes leads to cytoskeletal rearrangement, stiﬀening, and al-
teration on the blood ﬂow in the vessel (Akenhead et al., 2015; Schmid-
Schönbein, 1993). Diapedesis of leukocytes usually occurs in the post-
capillary venules (Sainte-Marie et al., 1967; Steeber and Tedder, 2000;
Vestweber, 2015), but in a number of pathologic situations leukocytes
may occlude capillaries. Leukocyte adhesion and leukostasis involved
with ischemia-reperfusion injury in many types of tissue, and also has
been implicated in inﬂammatory damage to the brain, liver, lung,
muscle, and kidney (Amantea et al., 2009; Gane and Stockley, 2012;
Gute et al., 1998; Hokama et al., 2000; Ishikawa et al., 2016; P Basile
and C Yoder, 2014; Tanaka, 2016; Yadav et al., 1999). More relevant to
the retina is the ﬁnding that leukostasis is a major component in the
development and progression of diabetic retinopathy (Joussen et al.,
2002, 2004). The retina may be particularly susceptible to ischemic
damage because of its inherently high metabolic rate, its segmental,
non-redundant blood supply distribution, and the lack of regenerative
capabilities of the constituent terminally diﬀerentiated cells. As a me-
chanism of injury, microvascular occlusion in retinal vasculitis may be
Fig. 70. New onset multifocal choroiditis complicated by choroidal neovascularization.
A, B, C successive sections showing widespread inﬁltration of the outer retina with loss of
the ellipsoid layer. (D) The OCT angiogram shows discrete areas of CNV, implying the
more diﬀuse deposit is composed of inﬂammatory collections, exudation from the CNV,
or a mixture of both.
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important and needs to be studies in larger patient series. Early treat-
ment of retinal vasculitis may be in order, if only to prevent retinal loss
associated with microvascular ﬂow abnormalities.
11.9.2. Choroidal neovascularization
Multifocal choroiditis and panuveitis is more commonly found in
young myopic women. (For the purposes of discussion punctate inner
choroidopathy will be considered a subset of multifocal choroiditis and
panuveitis) (Spaide et al., 2013). There are two main ways the disease
can cause damage, through inﬂammation or choroidal neovascular-
ization. The inﬂammation is chieﬂy manifested as subretinal and sub-
retinal pigment epithelial inﬂammatory inﬁltrates. These appear as
conical hyperreﬂective mounds that elevate the retinal pigment
epithelium (RPE) and can break through to the outer retina. If severe
the inﬂammatory deposit can expand in the outer retina/subretinal
space. In the absence of choroidal neovascularization these lesions can
leave a legacy of scarring and destruction of the RPE. The ingrowth of
choroidal neovascularization can produce somewhat similar ﬁndings,
although the subRPE and subretinal material may have a greater het-
erogeneity in reﬂection in the structural OCT. Both appear to be asso-
ciated with subretinal ﬂuid. During FA CNV generally shows greater
ﬂuorescence and more pronounced leakage than does the inﬂammatory
inﬁltrate. Chorioretinal scars can show varying amounts of late
staining. In many cases it is diﬃcult to be certain if CNV is present or
not.
OCT angiography appears to be well suited to detect CNV
Fig. 71. New onset multifocal choroiditis and panuveitis
with CNV. (A) This highly myopic patient was seen for her
yearly examination. In the past she had surgical repair of a
retinal detachment. (B) When seen a year later she had
multiple chorioretinal punched out lesions, one of which
was ringed by pigment (arrow). (C) FA shows some staining
of the pigmented lesion in (B). The depigmented lesions
show modest staining. (D) En-face view of OCT angio-
graphy shows a lesion containing vessels at the location of
the pigmented lesion (arrow). (E) B-scan with ﬂow overlay
shows an elevated lesion with internal ﬂow signals that are
not projection artifacts from the overlying retina. Because
the lesion was pigmented and showed no exudation, the eye
was observed with no treatment.
Fig. 72. Multimodal imaging of patient with Best vitelli-
form macular dystrophy. Fundus AF (A) and infrared re-
ﬂectance (B) show central mixed hyper/hypoauto-
ﬂuorescent lesion with mixed hyper-reﬂective and
hyporeﬂective material. FA (C) and ICGA (D) reveal a round
hypoﬂuorescence area with central hyperﬂuorescence as
window defect and staining, but no leakage. Spectral do-
main optical coherence tomography (E) shows a ﬂattened
lesion by the resorption of the majority of ﬂuid, between
retinal pigment epithelium (RPE)/Bruch's membrane and
the ellipsoid zone of the photoreceptors with subtle eleva-
tion of the RPE. Optical coherence tomography angio-
graphy shows the displacement of blood vessels at both the
superﬁcial (F) and deep capillary plexuses of the retina (G).
Choriocapillaris (H) reveals a choroidal neovascularization
(arrow) vascular network, while choroid segmentation (I)
shows a well-deﬁned, large circular area corresponding to
the limits of the retinal elevation due to limitation of light
penetration.
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complicating multifocal choroiditis and panuveitis (Levison et al., 2017;
Nakao et al., 2016) (Figs. 68–71). Eyes with multifocal choroiditis and
panuveitis may have signiﬁcant amounts of myopia, which generally is
a diﬃculty for present segmentation routines, and therefore produce
en-face images that are not reliable. The images from eyes with nu-
merous segmentation defects show ﬂow, but the resultant image is not
necessarily of areas relevant for accurate diagnosis or disease quanti-
ﬁcation. The ﬂow overlay on the b-scan is often the most useful way to
evaluate lesions. It is often necessary to scroll through multiple b-scans
to achieve a mental picture of the lesions.
Treatment of the CNV is possible with intravitreal injections of anti-
VEGF agents in some cases. More aggressive disease is not adequately
managed by monotherapeutic anti-angiogenic methods because recur-
rence of the neovascularization is common and frequent. The CNV is
driven by the inﬂammatory component, which is capable of causing
damage on its own. Therefore a two pronged approach attacking the
neovascularization and the inﬂammation is typically used. Local cor-
ticosteroid injections can help in the acute management of disease.
Patients often require years of treatment and to avoid corticosteroid
side eﬀects, immunosuppression is used. There have been no published
studies concerning the relative eﬃcacy of these medications. A common
medication to use is mycophenolate mofetil, in part because of the re-
latively low proportion of patients exhibiting signiﬁcant side eﬀects
(Thorne et al., 2005). The use of anti-tumor necrosis factor alpha agents
is becoming increasingly common (Cordero-Coma and Sobrin, 2015).
The goal of treatment is to reduce the inﬂammatory deposits and pre-
vent exacerbations of the CNV. With successful treatment the lesions
regress, sometimes without a trace. With OCT angiography remnants of
CNV can still be detected. Immunosuppressive agents have to be
withdrawn if pregnancy is contemplated. The inﬂammatory and often
neovascular complications of the disease can be managed with local
corticosteroids during this interval. Although FA is not necessarily
contraindicated during pregnancy, the ability to image neovascular-
ization without dye is a welcome attribute in this situation.
There are still many aspects of ocular inﬂammatory disease and the
Fig. 73. Optical coherence tomography angiography (A),
fundus AF (B), FA (C) and ICGA (D) of a patient with
Stargardt disease. Optical coherence tomography angio-
graphy shows no residual choriocapillaris inside the areas
of atrophy where large choroidal vessels are clearly visible.
Outside these regions, choriocapillaris lobules appear
normal in density (A). Fundus AF (B) reveals a large hy-
poautoﬂuorescent area due to the loss of the retinal pig-
ment epithelium. FA (C) and ICGA reveal the hypo-
ﬂuorescence area, conﬁrming the absence of
choriocapillaris.
Fig. 74. Optical coherence tomography angiography of a patient with retinitis pigmen-
tosa. Image of the fundus (A) and blue light fundus AF (B) of a patient with retinitis
pigmentosa. OCTA shows narrowed vessels with a progressive vascular rarefaction, from
the papilla towards the periphery at the superﬁcial and deep capillary plexuses (C and D,
respectively). No vascular abnormalities were detectable at the choriocapillaris and
choroid segmentation (E and F, respectively).
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retinal and choroidal vascular changes that remain unknown. OCT
angiography oﬀers opportunity to investigate both in ways not possible
with dye based angiography. There are numerous areas that could be
investigated, particularly once the ability of OCT angiography to image
the choroid is improved. Many inﬂammatory diseases of the posterior
pole involve or originate from the choroid. Increased understanding of
disease pathogenesis, earlier detection of disease, and improved disease
monitoring are achievable goals in the near future.
11.10. OCT angiography in dystrophies
11.10.1. Vitelliform macular dystrophy
Vitelliform macular dystrophy (VMD), also known as Best disease, is
a slowly progressive disease with onset generally in childhood, is
caused by mutations in the BEST1 gene (Best, 1905; Deutman and
Hoyng, 2001; Stone et al., 1992). The diagnosis of VMD is based on
fundus appearance with yellow yolk-like macular lesion, an abnormal
electrooculogram and family history (Godel et al., 1985). The material
in the subretinal space starts to accumulate in early childhood. OCT
shows varying amounts of subretinal ﬂuid and collection of material on
the back surface of the retina and also immediately above the RPE. The
outer retina can have a ‘shaggy photoreceptor’ appearance much like
that seen in central serous chorioretinopathy. Over the years the ma-
terial increases in amount, and ﬁlls the subretinal space. The lesions
generally get larger with age. In the teen years or thereafter, many
patients develop scarring and CNV.
The material is hyperautoﬂuorescent on fundus AF while on FA and
ICGA, lesions can have blocked ﬂuorescence due to the presence of the
vitelliform material and pigment in the foveal area, and this can be
surrounded by a ring of defective transmission corresponding to an area
Fig. 75. Retinal nerve ﬁber layer and radial peripapillary capillary changes in glaucoma. Left panel. Anarcuate visual ﬁeld defect is present. Middle panel, the retinal nerve ﬁberlayer
analysis shows a region of inferotemporal retinal nerve ﬁber layer thinning.Right panel. The redial peripapillary capillary network shows a sector defect(arrow) corresponding to the
nerve ﬁber layer defect.
Fig. 76. Optic nerve damage in a 38-year-old with a history of optic neuritis. A. The
normal uninvolved eye shows a dense pattern of radial peripapillary vessels. B. The in-
volved eye shows a global loss of the radial peripapillary capillaries.
Fig. 77. Both eyes of a patient with papilledema due to
idiopathic intracranial hypertension (top row – right eye,
bottom row – left eye). Color photos (left panels) demon-
strate the bilateral disk edema. Disk edema is also evident
on the en face OCT images (middle panel). OCT angiogram
(slab from internal limiting membrane to lamina cribosa)
demonstrates increased prominence of the optic nerve head
and peripapillary capillaries.
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of atrophied RPE. In the recirculation phase, staining of the vitelliform
material by the ﬂuorescein dye is often evident, and the staining pattern
can be mistaken for CNV. At the same time, CNV may complicate the
natural course of VMD (Miller et al., 1976; Noble et al., 1978). In this
case, a combination of clinical assessment and multimodal imaging may
be required in order to conﬁrm or exclude the presence of CNV. OCTA is
helpful in this regard because it is not impeded by staining as seen in
dye based angiography (Fig. 72). It allows visualization of a vascular
network which may be masked by the vitelliform material on both FA
and ICGA.
11.10.2. Stargardt disease
Recessive Stargardt disease (STGD) is the most common inherited
retinal dystrophy and is caused by mutations in the ABCA4 gene. A
reduction in ABCA4 activity in the photoreceptor outer segments results
in the increased production and accumulation of A2E and related bis-
retinoids within RPE cells. The result of these pathophysiologic events
is a progressive loss of RPE and photoreceptors (Sparrow et al., 2008;
Weng et al., 1999).
In STGD, FA is characterized by the absence of normal background
choroidal ﬂuorescence mainly due to the presence of RPE lipofuscin
that absorbs the blue excitatory light (Fish et al., 1981). ICGA is able to
deﬁne the lesion as ICG emits light in the near-infrared spectrum, and
allows better penetration (Holz et al., 1998; Schwoerer et al., 2000). In
particular, lesions are characterized by the presence of late hypo-
ﬂuorescence (dark atrophy) in late ICGA, possibly indicating a greater
amount of choriocapillaris loss than what is typically seen in atrophy
related to AMD (Giani et al., 2012).
Although FA and ICGA are common clinical techniques to study
retinal and choroidal vasculature, these imaging modalities are not able
to image vessels deep to the RPE very well. OCTA displays severe loss of
choriocapillaris within the area of atrophy in eyes aﬀected by STGD
(Fig. 73). Residual lobules of choriocapillaris can be found at the inner
margins of the atrophic area, where choriocapillaris appear normal in
density. At the same time, ICGA shows the presence of residual lobules
of choriocapillaris at the edges of the area of RPE atrophy identiﬁed in
fundus AF revealing a typical isoﬂuorescent ring. In STGD, RPE cells
appear to atrophy, and the choriocapillaris and Sattler's layer conse-
quently disappears (Pellegrini et al., 2016).
11.10.3. Retinitis pigmentosa
Retinitis pigmentosa (RP) is heterogeneous group of hereditary
dystrophies characterized by the progressive degeneration of the pho-
toreceptors (rods and cones) leading to progressive visual loss (An and
Wang, 2008; Mariampillai et al., 2008). Typical symptoms of RP in-
clude night blindness, photopsia, and progressive visual ﬁeld loss;
however, vision can also be aﬀected by cataracts and cystoid macular
edema (Berson, 1993; Hartong et al., 2006). The clinical features of
typical RP include arteriolar narrowing, “waxy pallor” of the optic
nerve head, alteration in pigmentation and atrophy of the retinal pig-
ment epithelium and migration into the retina with intraretinal
clumping of melanocytic cells, appearing most often as coarse clumps in
a “bone spicule” conﬁguration.
OCTA allows the detection of ﬂow abnormalities and the vascular
anatomy in both the retina and choroid; to date there has not been
much in the published literature concerning RP (Parodi et al., 2017).
OCTA shows narrowed vessels in the superﬁcial capillary plexus of the
retina and a progressive vascular rarefaction, from the papilla towards
the periphery, of the superﬁcial and deep capillary plexuses (Fig. 74). In
macular edema, OCTA reveals focal dislocation of the vascular network
at the superﬁcial capillary level in correspondence of the intraretinal
cysts. In this case, the ﬂuid accumulates between the inner plexiform
layer and the outer plexiform layer causing a preferred distortion of the
deep capillary plexus compared to superﬁcial. OCTA is an imaging tool
with able to show both retinal and choroidal vascular structures.
Fig. 78. Right (top panels) and left eyes (bottom panels) of a patient who presented with
sudden vision loss in the right eye. Patient was noted to have disk edema in the right eye
(top right panel) and very small cups (both eyes). A diagnosis of anterior ischemic optic
neuropathy was made. OCT angiogram demonstrated patchy loss of ONH capillaries in
the right eye (top right panel) compared to the normal left eye (bottom left panel).
Fig. 79. Patient with optic atrophy in the left eye following anterior ischemic neuropathy
(Right eye – top panels, Left eye – lower panels). Pallor of the left optic nerve is evident
(lower left panel), most prominent superotemporally. The optic nerve head capillary
density on OCT angiography is decreased in this superotemporal region (lower left panel)
compared to the normal fellow eye (upper right panel).
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11.11. OCT angiography of the optic nerve
The nerve ﬁbers in the retina are unmyelinated; from a teleologic
standpoint myelination would degrade the image produced by the un-
derlying photoreceptor layer. However unmyelinated retinal nerve ﬁ-
bers require large amounts of energy to maintain ion concentration
gradients (Andrews et al., 1999; Bristow et al., 2002; Carelli et al.,
2013). The retinal nerve ﬁber layer is invested by the radial peripa-
pillary capillary network to supply oxygen and metabolites to the nerve
ﬁber layer. As the capillary circulation of the optic nerve head and the
peripapillary region are well-seen by OCT angiography, there is an
opportunity to use OCTA to evaluate microvascular abnormalities in
various optic nerve disorders. It is possible that the vascularity of the
nerve ﬁber layer, the radial peripapillary network, may serve as a
surrogate measure for the metabolic activity in that area. The metabolic
activity in turn may correlate with the number and vitality of the nerve
ﬁbers present.
Jia and colleagues (Jia et al., 2012a) demonstrated a reduction in
optic nerve head vessel density and ﬂow index (average of the dec-
orrelation values) in perperimetric glaucoma patients compared to
normal controls. Their method was to reduce the thickness of the radial
peripapillary capillary network by using maximal intensity projection
and then to quantify the proportion of area occupied by the detected
microvascular ﬂow. Leveque and colleagues also observed a 20–25%
reduction in ONH vessel density in a cohort of glaucoma patients
compared with normals (Lévêque et al., 2016). The vessel density re-
duction also correlated with visual ﬁeld parameters as well as structural
OCT ﬁndings in these subjects. Bojikian et al. compared three diﬀerent
ONH perfusion metrics (ﬂux, vessel area density, and normalized ﬂux)
among normal, open angle glaucoma (OAG), and normal tension
glaucoma (NTG) subjects (Bojikian et al., 2016; Chen et al., 2016a).
While ONH perfusion was signiﬁcantly reduced in both glaucoma
groups compared to normal, there was no diﬀerence between NTG and
OAG groups with similar levels of visual ﬁeld loss. Rather than evaluate
the ONH vessel density, Akagi et al. quantiﬁed the peripapillary ca-
pillary density in glaucomatous eyes and normals (Akagi et al., 2016).
The reduction of peripapillary density in the glaucomatous eyes
(without high myopia) spatially co-localized with the region of the vi-
sual ﬁeld defect. These studies as well as others have highlighted the
potential value of OCTA in better characterizing patients with glau-
coma. OCTA lacks standardized methods to measure vascular density
and ﬂow and consequently nomograms for these indices are not yet
available. As a consequence, simple metrics such as sensitivity and
speciﬁcity in diagnosing glaucoma are not known at present.
The best use of OCTA in the management of glaucoma, however,
still needs to be deﬁned in careful longitudinal studies with multimodal
imaging. One potential application is diagnosis of glaucoma in high
myopes, which can be challenging. High myopes can have schisis
around the nerve and expansion and distortion of the nerve head which
can make nerve ﬁber layer thickness measurements impossible to ob-
tain. It is possible that vascular density of the radial peripapillary ca-
pillary network may prove to be a suitable surrogate measure of nerve
ﬁber thickness. Some studies have used OCTA as a means of diﬀer-
entiating among normals, preperimetric glaucoma or ocular hyperten-
sion, and glaucoma (Akil et al., 2017; Chihara et al., 2017). The diag-
nosis of preperimetric glaucoma (or ocular hypertension) is based on a
normal visual ﬁeld, using a test with imperfect sensitivity and speciﬁ-
city. It is possible that with follow-up studies there are features of OCTA
imaging of the radial peripapillary capillary network that will predict or
augment the diagnostic capability of the visual ﬁeld test. Lamina cri-
brosa defects occur in glaucomatous eyes and these defects are pre-
dictive of future ﬁeld loss. Eyes with lamina cribrosa defects have cir-
cumpapillary perfusion defects that spatially correlate to the defect in
the lamina (Suh et al., 2016).
OCTA has also been used in the evaluation of other optic nerve and
central nervous system disorders. Wang and colleagues observed an
apparent reduction in the ﬂow index in patients with multiple sclerosis
(Wang et al., 2014). Optic neuritis may be associated with signiﬁcant
loss of the radial peripapillary capillaries (Fig. 75). In patients with
papilledema for example due to idiopathic intracranial hypertension,
OCTA can demonstrate an increased prominence of the ONH and
peripapillary retinal capillaries (Fig. 76). In contrast, patients with disk
edema from anterior ischemic optic neuropathy may demonstrate some
patchy loss of ONH capillaries (Fig. 77). Treatment of ischemic optic
neuropathy is diﬃcult, in part, because it is diﬃcult to evaluate the
perfusion of the nerve head. OCTA oﬀers the potential to evaluate ﬂow
in a precise and longitudinal manner.
With optic atrophy from various etiologies, OCTA demonstrates loss
of capillaries in the region aﬀected by the injury. This leads to char-
acteristic patterns with certain diseases such as segmental or altitudinal
ONH capillary loss in anterior ischemic optic neuropathy (Fig. 78), and
capillary loss in the temporal ONH and papillo-macular bundle in cases
of dominant optic atrophy. Patients with Leber's Hereditary Optic
Neuropathy may show an evolution of ﬁndings on OCTA with increased
prominence of the peripapillary capillaries in the acute and subacute
phases, and prominent loss of the optic nerve head capillaries in the
chronic phase. We can expect the potential OCTA applications for the
evaluation of optic nerve disorders to continue to expand with new
insights gained into disease pathophysiology and response to therapy.
The vascular vs mechanical contributions to the pathogenesis of glau-
coma remain unresolved and may be further elucidated with OCTA.
OCTA oﬀers the potential to be able to evaluate the blood ﬂow in the
prelaminar nerve as well as elsewhere in the pathway from the retinal
nerve ﬁber layer to the postlaminar nerve and to gauge eﬀects of var-
ious medications on ﬂow which may open the opportunity for the de-
velopment of novel therapeutic agents (see Fig. 79).
12. OCTA in clinical practice
This paper described the past development of OCTA and current
research. Investigations of new imaging modalities often follow a
common pattern. The ﬁrst papers often compare a new imaging tech-
nique to an old technique to determine if the new method can image the
same things as the old. In case of diabetic retinopathy these studies
might examine if microaneurysms are visible and in what layer. These
types of papers establish a foothold for the new imaging modality, but
have little clinical utility. Imaging enthusiasts are happy because it is
interesting to image the eye. A cost-conscious practitioner may well
wonder about the need for the modality given the ease of looking in the
eye as a simple means of detecting microaneurysms. The next level of
papers follows with features of disease that couldn't have been de-
termined using older methods of imaging. Imaging aﬁcionados and
researchers in the particular ﬁeld are intrigued and elated. The cost-
conscious practitioner is mystiﬁed because the new imaging approach
doesn't directly lead to any measurable beneﬁt, medically or ﬁnan-
cially.
The next stages of development evaluate the imaging modality in
terms of enhanced diagnosis of disease or a clue to new approaches in
managing disease. These studies often take years. Not all are successful.
The people in imaging are often centrally involved, while the cost-
conscious practitioner has long lost interest. Over time, practical and
necessary uses of the imaging modality can start to crystalize, making
the approach indispensable. At that point everyone wants to adopt the
technology, even the practical practitioner. Note the adoption of a new
imaging technology is somewhat diﬀerent than what is described as the
Gartner hype cycle (http://www.gartner.com/technology/research/
methodologies/hype-cycle.jsp).
OCT angiography is still in the earliest stages of development. There
are several indications in which OCTA is better than or equivalent to
accepted approaches and many instances where it shows us ﬁndings
that were unexpected. None of these older imaging modalities can be
replaced by OCTA at present. That raises questions about the need for
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OCTA. One answer to this question is to start thinking about how
treatments of today started. Ideas based on imaging along with pa-
thophysiology were at the heart of many modern ophthalmic treat-
ments. Imaging from the 1970's and 80's formed the basis of larger
studies, which led to theories of disease. In the 1990's these were used
to form plans of attack, pharmacologic, surgical, or both, that were
eventually implemented after numerous trials many years later. Our
treatments today are better than what came before, but revolutionary
advances from what we have now is not likely to come from mining
ideas of the 1970's. The basis for treatments decades in the future are
being laid now with our current eﬀorts including OCTA.
The rate of change in OCTA over the last few years has been phe-
nomenal. The safest and easiest way to predict the future is to imagine a
continuation of the immediate past. Henry Ford's apocryphal quote, “If I
had asked people what they wanted, they would have said faster
horses” illustrates the main problem. It is impossible to predict new
disruptive technology or what eﬀect it may have. Sometimes it seems
like one can notice disruptive technology when it is just starting. It
seems like OCTA is a truly disruptive technology. It is powerful. It is
exciting (at least to the authors, all imaging zealots). It is probably
going to change the practice of retinal diseases. One really interesting
part of OCTA is that it is relatively inexpensive and available to nearly
everyone. So, its development can and will be a group eﬀort. Let's get to
work!
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